Skip to Content

'
Ritsuko U. Komaki, MD, FACR, FASTRO

Present Title & Affiliation

Primary Appointment

Adjunct Professor, School of Health Sciences, Houston, TX
Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Gloria Lupton Tennison Distinguished Professorship in Lung Cancer, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Program Director and Section Chief, Thoracic Radiation Oncology, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Director, Thoracic Center, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1969 Hiroshima University School of Medicine, Hiroshima, Japan, MD, Medicine
1965 Hiroshima University, Hiroshima, Japan, BS, Biology

Postgraduate Training

1979-1980 Fellow, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
1/1977-1/1978 Fellow, Radiation Oncology, The Medical College of Wisconsin, Milwaukee, WI
1/1974-1/1977 Residency, Radiation Oncology, The Medical College of Wisconsin, Milwaukee County General Hospital, Milwaukee, WI
1/1973-1/1974 Fellow, Hematology Oncology, VA Hospital, Hematology/Oncology Department, Milwaukee, WI
1/1972-1/1973 Intern, General, St. Mary's Hospital, Milwaukee, WI
1/1971-1/1972 Extern, St. Mary's Hospital, Milwaukee, WI
1/1969-1/1970 Intern, Medicine, Radiation Effects Research Foundation, Atomic Bomb Casualty Commission, Hiroshima, Japan

Board Certifications

1/1977 American Board of Radiology (Therapeutic Radiology), 1/1977 (Permanent) 1/2001 (Recertification for new system)

Honors and Awards

2015-present NRG Oncology Outstanding Manuscript, NRG Oncology
2015-present President's Recognition for Faculty Excellence, The University of Texas MD Anderson Cancer Center
2014-present 2014 Gilbert Fletcher Gold Medal, Gilbert Fletcher Society
2014-present 2014 Hall of Fame, Greater Houston Women's Chamber of Commerce
2014 Honoree, Texas Medical Center Women's History Project
2013 America's Top Doctors
2013 America's Top Doctor, Castle Connolly Medical Ltd
2012-present Distinguished Emeritus Member, National Council on Radiation Protection & Measurements
2011-2012 America's Top Doctors for Cancer, Castle Connolly Medical Ltd.
2010-present America's Top Doctors for Cancer, Castle Connolly Medical Ltd.
2010-2011 Gold Medal Award, Japanese Association of Radiation Oncology
2010 Certificate of Appreciation, Japan Radiological Society
2009-present America's Top Doctors, Castle Connolly
2009-present America's Top Doctors for Cancer, Castle Connolly Medical, LTD
2009-present America's Top Oncologists, SLD Industries, Inc
2009-2010 Gold Medal Award, Japan Radiological Society
2009 2009 ASCO Cancer Foundation Merit Award, ASCO
2009 Best Doctors in America, Castle Connolly Top Doctors Recognitions
2009 Gold Medal Award, Japan Lung Cancer Society (JLCS)
2009 Houston's Top Doctors, H Texas Magazine
2009 Podcast on CR Magazine, CR magazine
2008-present America's Top Doctors In Radiation Oncology, Castle Connolly Guide
2008 Juan del Reato Gold Medal, 32nd Annual J. del Regato Gold Medal Lecture
2007 President of American Radium Society (ARS)
2007 America’s Top Doctors, Nation’s Leading Medical Specialists, Castles Connolly Guide
2006 America's Top Doctors, Nation's Leading Medical Specialists, Castles Connolly Guide
2006 Award from The Society in Tribute to Marie Sklodowska-Curie in Warsaw, Poland
2006 Fellow of ASTRO, American Society for Therapeutic Radiology and Oncology (ASTRO)
2006 Medical College of Wisconsin Alumni of the Year
2005 (AAWR) Marie Sklodowska-Curie Award
2005 Business Professional Women of Texas Award
2005 Centenary of Discovery of Radium Medal, The Society in Tribute to Marie Sklodowska-Curie
2004 America’s Top Doctors, Nation’s Leading Medical Specialists, Castle Connolly Guide
2004 Distinguished Service Award, American Board of Radiology
2003 Japan Society for the Promotion of Science (JSPS)
2003 Best Doctors in America
2003 Fellowship, Foundation for Promotion of Cancer Research (FPCR)
2002 Best Doctors in Houston, Houstonian
2002 Best Women Doctors, Inside Houston
2001 America’s Top Doctors, Nation’s Leading Medical Specialists, Castle Connolly Guide
1999 Top 318 Cancer Doctors for Women, Good Housekeeping
1998 Best Doctors in Houston, Houston Today
1998 Gloria Lupton Tennison Professorship in Lung Cancer Research
1997 Professional Leadership Award, AAWR Research and Education Foundation
1995 Best Doctors in America, U.S. News and World Report
1994 Best Doctors in America, U.S. News and World Report
1993 ACS Traveling Oncology Consultant, ACS
1993 Honorary Member of General Thoracic Surgical Club, General Thoracic Surgical Club
1989 Fellow of ACR, American College of Radiology

Selected Publications

Peer-Reviewed Original Research Articles

1. Wang XS, Shi Q, Williams LA, Komaki r, Gomez DR, Lin SH, Chang JY, O'reilly MS, Bokhari RH, Cox JD, Mohan R, Cleeland CS, Liao ZX. Prospective study of patient-reported symptom burden in patients with non-small cell lung cancer undergoing proton or photon chemoradiation therapy. J Pain Symptom Manage. e-Pub 2/2016. PMID: 26891607.
2. Sudo K, Wang X, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Rice DC, Lee JH, Weston B, Bhutani MS, Hiremath A, Charalampakis N, Komaki R, Blum MA, Swisher SG, Maru DM, Skinner HD, Garris JL, Rogers JE, Hofstetter WL, Ajani JA. Anomogram to predict distant metastases after multimodality therapy for patients with localized esophageal cancer. J Natl Compr Canc Netw 14(2):173-179, 2016. PMID: 26850487.
3. Yu J, Zhang X, Liao L, Li H, Zhu R, Park PC, Sahoo N, Gillin M, Li Y, Chang JY, Komaki R, Lin SH. Motion-robust intensity-modulated proton therapy for distal esophageal cancer. Med Phys 43(3), 2016. PMID: 26936698.
4. Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge Dr, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Dilling TJ, Dobelbower MC, Govindan R, Grannis FW Jr, Horn L, Jahan TM, Komaki R, Krug LM, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Schild SE, Shapiro TA, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M. NCCN guidelines insights: non-small cell lung cancer, Version 4.2016. J Natl Compr Canc Netw 14(3):255-264, 2016. PMID: 26957612.
5. Liu H, Wang Y, Diao L, Potter A, Zhang J, Qiao Y, Wang J, Proia D, Komaki R, Lin S. Hsp90 Inhibitor ganetespib enhances the anti-tumor effect of platinum-doublet chemoradiotherapy in non-small cell lung cancer. Clin Cancer Res, 12/2015.
6. Cortez MA, Valdecanas D, Niknam S, Peltier HJ, Diao L, Giri U, Komaki R, Calin GA, Gomez DR, Chang JY, Heymach JV, Bader AG, Welsh JW. In Vivo delivery of miR-34a sensitizes lung tumors to radiation through RAD51 regulation. Mol Ther Nucleic Acids 15(4):e270, 12/2015.
7. Paesmans M, Garcia C, Wong CY, Patz EF Jr, Komaki R, Eschmann S, Govindan R, Vansteenkiste J, Meert AP, de Jong WK, Altorki NK, Higashi K, Van Baardwijk A, Borst GR, Ameye L, Lafitte JJ, Berghmans T, Flamen P, Rami-Porta R, Sculier JP. Primary tumour standardized uptake value is prognostic in non small cell lung cancer: a multivariate pooled analysis of individual data. Eur Respir J 46(6):1751-7161, 12/2015.
8. Lin SH, Zhang N, Godby J, Wang J, Marsh GD, Liao Z, Komaki R, Ho L, Hofstetter WL, swisher SG, Mehran RJ, Buchholz TA, Elting LS, Giordano SH. Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer. Cancer. e-Pub 12/2015.
9. Videtic GM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, Schild SE, Komaki R, Urbanic JJ, Choy H. A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG Oncology RTOG 0915 (NCCTG N0927). Int J Radiat Oncol Biol Phys 93(4):757-764, 11/2015.
10. Cortez MA, Ivan C, Valdecanas D, Wang X, Peltier HJ, Ye Y, Araugo L, Carbone DP, Shilo K, Giri DK, Kelnar K, Martin D, Komaki R, Gomez DR, Krishnan S, Calin GA, Bader AG, Welsh JW. PDL1 regulation by p53 via MiR-34. J Natl Canc Inst 108(1), 11/2015.
11. Hong J, Liao Z, Zhuang Y, Levy LB, Sheu T, Heymach JV, Nguyen QN, Xu T, Komaki R, Gomez DR. Prognostic factors as a function of disease-free interval after definitive (chemo)radiation for non-small cell lung cancer using conditional survival analysis. Am J Clin Oncol. e-Pub 11/2015.
12. Movsas B, Hu C, Sloan J, Bradley J, Komaki R, Masters G, Kavadi V, Narayan S, Michalski J, Johnson DW, Koprowski C, Curran WJ Jr, Garces YI, Gaur R, Wynn RB, Schallenkamp J, Gelblum DY, MacRae RM, Paulus R, Choy H. Quality of life analysis of a radiation dose-escalation study of patients with non-small cell lung cancer: A secondary analysis of the radiation therapy oncology group 0617 randomized clinical trial. JAMA 25:1-9, 11/2015.
13. Seyedin SN, Schoenhals JE, Lee DA, Cortez MA, Wang X, Miknam S, Tang C, Hong DS, Naing A, Sharma P, Allison JP, Chang JY, Gomez DR, Heymach JV, Komaki R, Cooper LJ, Welsh JW. Strategies for combining immunotherapy with radiation for anticancer therapy. Immunotherapy 7(9):967-980, 9/2015.
14. Tang C, Lee MS, Gomez D, Levy LB, Zhuang Y, Lu C, Liao Z, Komaki R. Effects of chemotherapy regimen and radiation modality on hematologic toxicities in patients receiving definitive platinum-based doublet chemoradiation for non-small cell lung cancer. Am J Clin Oncol, 7/2015.
15. Komaki R, Allen PK, Wei X, Blumenschein GR, Tang X, Lee JJ, Welsh JW, Wistuba II, Liu DD, Hong WK. Adding erlotinib to chemoradiation improves overall survival but not progression-free survival in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 92(2):317-324, 6/2015.
16. Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, Groen HJM, McRae SE, Widder J, Feng L, Kresl JJ, Dingemans AM, Dawood O, Haasbeek CJA, Carpenter LS, Jaeger KD, Komaki R, Slotman BJ, Smit EF, Roth JA. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. The Lancet Oncl 16(6):630-637, 6/2015.
17. Nguyen QN, Ly NB, Komaki R, Levy LB, Gomez D, Chang JY, Allen PK, Mehran RJ, Lu C, Gillin M, Liao Z, Cox JD. Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer. Radio Oncol, 5/2015.
18. Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge Dr, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Dilling TJ, Dobelbower MC, Govindan R, Grannis FW Jr, Horn L, Jahan TM, Komaki R, Krug LM, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW Jr, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Schild SE, Shapiro TA, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M. Non-small cell lung cancer, Version 6.2015. J Natl Compr Canc Netw 13(5):515-524, 5/2015.
19. Burdett S, Pignon JP, Tierney J, Tribodet H, Stewart L, Le Pechoux C, Aupérin A, Le Chevalier T, Stephens RJ, Arriagada R, Higgins JP, Johnson DH, Van Meerbeeck J, Parmar MK, Souhami RL, Bergman B, Douillard JY, Dunant A, Endo C, Girling D, Kato H, Keller SM, Kimura H, Knuuttila A, Kodama K, Komaki R, Kris MG, Lad T, Mineo T, Piantadosi S, Rosell R, Scagliotti G, Seymour LK, Shepherd FA, Sylvester R, Tada H, Tanaka F, Torri V, Waller D, Liang Y; for the Non‐Small Cell Lung Cancer Collaborative Group. Adjuvant chemotherapy for resected early-stage non-small cell lung cancer. Cochrane Database Syst Rev, 3/2015.
20. Wang J, Palmer M, Bilton SD, Vu KN, Greeg S, Frame R, Liao Z, Komaki R, Cox JD, Lin SH. Comparing proton beam to intensity modulated radiation therapy plannin esophageal cancer. Int J Particle Ther 1(4):866-877, 3/2015.
21. Wang J, Milton DR, He L, Komaki R, Liao Z, Crane CH, Minsky BD, Thall PF, Lin SH. Comparison of locoregional versus extended locoregional radiation volumes for patients with nonmetastatic gastro-esophageal junction carcinomas. J Thorac Oncol 10(3):518-526, 3/2015.
22. Neishboori N, Wadhwa R, Nogueras-Gonzalez G, Elimova E, Shiozaki H, Sudo K, Charalampakis N, Hiremath A, Lee J, Bhutani M, Weston B, Blum M, Rogers J, Garris J, Rice D, Komaki R, Swisher S, Skinner H, Hofstetter W, Ajani J. Distribution of resistant esophageal adenocarcinoma in the resected specimens of clinical stage III patients after chemoradiation: Its clinical implications. Oncology. e-Pub 3/2015.
23. He LR, Qiao W, Liao ZX, Komaki R, Ho L, Hofstetter WL, Lin SH. Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma. BMC Cancer 15(111), 3/2015.
24. Wang J, Milton DR, He L, Komaki R, Liao Z, Crane CH, Minsky BD, Thall PF, Lin HL. Patients with nonmetastatic gastro-esophageal junction carcinomas. J Thor Oncol 10(3):518-526, 3/2015.
25. Lassman AB, Pugh SL, Gilbert MR, Aldape KD, Geinoz S, Beumer JH, Christner SM, Komaki R, DeAngelis LM, Gaur R, Youssef E, Wagner H, Won M, Mehta MP. Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627). Neuro Oncol. e-Pub 3/2015.
26. Swanick CW, Lin SH, Sutton J, Naik NS, Allen PK, Levy LB, Liao Z, Welsh JW, Komaki R, Chang JY, Gomez DR. Use of simultaneous radiation boost achieves high control rates in patients with non-small-cell lung cancer who are not candidates for surgery or conventional chemoradiation. Clin Lung Cancer 16(2):156-163, 3/2015.
27. Shiozaki H, Slack R, Sudo K, Elimova E, Wadhwa R, Chen H, Maru K, Komaki R, Lee J, Weston B, Bhutani M, Blum M, Skinner H, Hofstetter W, Ajani A. Geographic distribution of regional metastatic nodes affects outcome of trimodality-eligible patients with esophageal adenocarcinoma. Oncology, 2/2015.
28. Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, Bobart J, Hu C, Forster K, Magliocco A, Kavadi V, Garces YI, Narayan S, Iyengar P, Robinson C, Wynn RB, Koprowski C, Meng J, Beitler J, Gaur R, Curran W Jr, Choy H. Standard-dose versus high-dose conformal radiotherapy with concurrent and consilidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer(RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol 16(2):187-199, 2/2015.
29. Neishaboori N, Wadhwa R, Nogueras-Gonzalez GM, Elimova E, Shiozaki H, Sudo K, Charalampakis N, Hiremath A, Lee JH, Bhutani MS, Weston B, Blum MA, Rogers JE, Garris JL, Rice DC, Komaki R, Swisher SG, Skinner HD, Hofstetter WL, Ajani JA. Patients after chemoradiation: Its clinical implications. Oncology 89(2):65-69, 2015. PMID: 25765719.
30. Li P, Wang X, Liu Z, Liu H, Xu T, Wang H, Gomez DR, Nguyen QN, Wang LE, Teng Y, Song Y, Komaki R, Welsh JW, Wei Q, Liao Z. Single nucleotide polymorphisms in CBLB, a regulator of T-cell response, predict radiation pneumonitis and outcomes after definitive radiotherapy for non-small-cell lung cancer. Clin Cancer Res, 2015. PMID: 26732495.
31. Etttinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Dilling TJ, Govindan R, Grannis FW Jr, Horn L, Jahan TM Komaki R, Kris MG, Krug LM, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW JR, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Schild S, Shapiro TA, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M. Non-small cell lung cancer, version 1.2015. J Natl Compr Canc Netw 12(12):1738-1761, 12/2014.
32. Xu T, Liao Z, O'Reilly MS, Levy LB, Welsh JW, Wang LE, Lin SH, Komaki R, Luiz Z, Wei Q, Gomez DR. Serum inflammatory miRNAs predict radiation esophagitis in patients receiving definitive radiochemotherapy for non-small cell lung cancer. Radiother Oncol 113(3):379-384, 12/2014.
33. McAvoy S, Ciura K, Wei C, Rineer J, Liao Z, Chang JY, Palmer MB, Cox JD, Komaki R, Gomez DR. Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes. Int J Radiat Oncol Biol Phys 90(4):819-827, 11/2014.
34. Wu X, Pu X, Wang L, Chang J, Hildebrandt N, Ye Y, Lu C, Skinner H, Niu N, Jenkins G, Komaki R, Minna J, Roth J, Weinshlboum R. Inflammation-related genetic variants predict toxicities following definitive radiotherapy for lung cancer. Clin Pharm Therp 96(5):609-615, 11/2014.
35. Sudo K, Xiao L, wadhwa R, Shiozaki H, Elimova E, taketa T, Blum MA, Lee JH, Bhutani MS, Weston B, Ross Wa, Komaki R, Rice DC, Swisher SG, Hofsetter WL, Maru DM, Skinner HD, Ajani JA. Importance of surveillance and success orf salvage strategies after definitive chemoradiation in patients with esophageal cancer. J Clin Oncol 32(30):3400-3005, 10/2014.
36. Gomez Dr, Yusuf SW, Munsell MF, Welsh JW, Liao Z, Lin SH, Pan HY, Chang JY, Komaki R, Cox JD, McAleer MF, Grosshans DR. Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure. J Thorac Oncol 9(10):1554-1560, 10/2014.
37. Swanick CW, Lin SH, Sutton J, Naik NS, Allen PK, Levy LB, Liao Z, Welsh JW, Komaki R, Chang JY, Gomez DR. Use of simultaneous radiation boost achieves high control rates in patients with non-small-cell lung cancer who are not candidates for surgery or conventioinal chemoradiation. Clin Lung Cancer. e-Pub 10/2014.
38. Xu T, Gomez D, O'Reilly M, Nguyen Q, Levy LB, Komaki R, Mohan R, Liao Z. Serum VEGF associated with survival in non-small cell lung cancerpatients treated with definitive chemoradiation therapy. Int J Radiat Oncol Biol Phys, 9/2014.
39. Tang C, Liao Z, Gomez D, Levy L, Zhuang Y, Gebremichael RA, Hong DS, Komaki R, Welsh JW. Lymphopenia association with gross tumor volume and lung v5 and its effects on non-small cell lung cancer patient outcomes. Int J Radiat Oncol Biol Phys 89(5):1084-1091, 8/2014. PMID: 25035212.
40. Dad L, Shah MM, Mutter R, Olsen J, Dominello M, Miller SM, Fisher B, Lee N, Komaki R. Why target the globe?: 4-year report (2-009-2013) of the association of residents in radiation oncology global health initiative. Int J Radiat Oncol Biol Phys 89(3):485-491, 7/1/2014. PMID: 24929159.
41. Komaki R, Paulus R, Blumenschein GR Jr, Curran WJ Jr, Robert F, Thariat J, Werner-Wasik M, Choy H, Hirsch FR, Ang KK. EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: A secondary analysis of RTOG 0324. Radiother Oncol. e-Pub 7/2014.
42. Wen J, Liu H, Wang Q, Liu Z, Li Y, Xiong H, Xu T, Li P, Wang LE, Gomez DR, Mohan R, Komaki R, Liao Z, Wei Q. Genetic variants of the LIN28B gene predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy. Eur J Cancer 50(10):1706-16, 7/2014. e-Pub 4/26/2014. PMID: 24780874.
43. Chi a, Nguyen NP, Komaki R,. The potential role of respiratory motion management and image guidance in the reduction of severe toxicities following stereotactic ablative radiation therapy for patients with centrally located early stage non-small cell lung cancer or lung metastases. Front Oncol 25(4):151, 6/2014.
44. Cortez MA, Valdecanas D, Zhang X, Zhan Y, Bhardwaj V, Calin GA, Komaki R, Giri DK, Quini CC, Wolfe T, Peltier HJ, Bader AG, Heymach JV, Meyn RE, Welsh JW. Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer. Mol Ther. e-Pub 5/5/2014. PMID: 24791940.
45. Zhu Z, Liu W, Gillin M, Gomez DR, Komaki R, Cox JD, Mohan R, Chang JY. Assessing the robustness of passive scattering proton therapy with regard to local recurrence in stage III non-small cell lung cancer: a secondary analysis of a phase II trial. Radiat Oncol 6(9):108, 5/2014.
46. Owen JB, Khalid N, Ho A, Kachnic LA, Komaki R, Tao ML, Currey A, Wilson JF. Can patient comorbidities be included in clinical performance measures for radiation oncology? J Oncol Pract 10(3):e175-81, 5/2014. e-Pub 3/18/2014. PMCID: PMC4018459.
47. Wang J, Suir JS, Allen PK, Liao Z, Komaki R, Ho L, Hofstetter WL, Lin SH. Factors predictive of improved outcomes with multimodality local therapy after palliative chemotherapy for stage IV esophageal cancer. Am J Clin Oncol. e-Pub 5/2014.
48. Rengan R, Ho A, Owen JB, Komaki R, Khalid N, Wilson JF, Movasas B. Impact of sociodemographic factors on the radiotherapeutic management of lung cancer: Results of a Quality Research in Radiation Oncology survey. Pract Radiat Oncol 4(3):e167-169, 5/2014.
49. Juloori A, Tucker SL, Komaki R, Liao Z, Correa AM, Swisher SG, Hofstetter WL, Lin SH. Influence of preoperative radiation field on postoperative leak rates in esophageal cancer patients after trimodality therapy. J Thorac Oncol 9(4):534-540, 4/2014. PMCID: PMC3989552.
50. Tang C, Liao Z, Zhuang Y, Levy LB, Hung C, Li X, Krafft SP, Martel MK, Komaki R, Gomez DR. Acute phase response before treatment predicts radiation esophagitis in non-small cell lung cancer. Radiother Oncol 110(3):493-8, 3/2014. e-Pub 2/20/2014. PMID: 24560756.
51. Rimner A, Gomez DR, Wu AJ, Shi W, Yorke ED, Moreira AL, Rice D, Komaki R, Rosenzweig KE, Riely GJ, Huang J. Failure patterns relative to radiation treatment fields for stage II-IV thymoma. J Thorac Oncol 9(3):403-409, 3/2014. PMID: 24518091.
52. Kong FM, Cuneo KC, Wang L, Bonner JA, Gaspar LE, Komaki R, Sun A, Morris DE, Sandler HM, Movsas B. Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation Oncology. Pract Radiat Oncol 4(2):e133-141, Mar-Apr, 3/2014. e-Pub 6/12/2013. PMID: 24890359.
53. Amini A, Byers LA, Welsh JW, Komaki R. Progress in the management of limited-stage small cell lung cancer. Cancer 120(6):790-8, 3/2014. e-Pub 12/2013. PMCID: PMC3947683.
54. Tang C, Gomez DR, Wang H, Levy LB, Zhuang Y, Xu T, Nguyen Q, Komaki R, Liao Z. Association between white blood cell count following radiation therapy with radiation pneumonitis in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 88(2):319-325, 2/1/2014. PMID: 24411603.
55. Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova E, Song S, Ye Y, Huang M, Ajani J, Wu X. A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. Cancer 120(23):3635-3641, 2/2014.
56. Ajani JA, Wang X, Song S, Suzuki A, Taketa T, Sudo K, Wadhwa R, Hofstetter WL, Komaki R, Maru DM, Lee JH, Bhutani MS, Weston B, Baladandayuthapani V, Yao Y, Skinner HD, Johnson RL, Berry D. ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients. Molecular Oncology 8(142-149), 2/2014.
57. Wang J, Myles B, Wei C, Chang JY, Hofstetter WL, Ajani J, Swisher SG, Cox JD, Komaki R, Liao Z, Lin SH. Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma. Dis Esophagus 27(2):168-175, 2/2014.
58. Li Y, Kardar L, Li X, Li H, Cao W, Chang JY, Liao L, Zhu RX, Sahoo N, Gillin M, Liao Z, Komaki R, Cox JD, Lim G, Zhang X. On the interplay effects with proton scanning beams in stage III lung cancer. Med Phys 41(2):021721, 2/2014. PMID: 24506612.
59. Gomez DR, Gladish GW, Wei X, Kotamarti KR, Allen PK, Cox JD, O'Reilly MS, Erasmus JJ, Fossella FV, Komaki R. Prognostic value of positron emission tomography/computed tomography findings in limited-stage small cell lung cancer before chemoradiation therapy. Am J Clin Oncol 37(1):77-80, 2/2014. PMID: 23111360.
60. Gomez D, Komaki R, Yu J, Ikushima H, Bezjak A. Radiation therapy definitions and reporting guidelines for thymic malignancies. Zhongguo Fei Ai Za Zhi 17(2):110-115, 2/2014. PMID: 24581161.
61. Modh A, Rimner A, Allen PK, Greenfield B, Marom EM, Rice D, Huang J, Rosenzweig KE, Komaki R, Gomez DR. Treatment modalities and outcomes in patients with advanced invasive thymoma or thymic carcinoma: A retrospective multicenter study. Am J Clin Oncol. e-Pub 1/1/2014. PMID: 24390276.
62. Amini A, Ajani J, Komaki R, Allen PK, Minsky BD, Blum M, Xiao L, Suzuki A, Hofstetter W, Swisher S, Gomez D, Liao Z, Lee JH, Bhutani MS, Welsh JW. Factors associated with local-regional failure after definitive chemoradiation for locally advanced esophageal cancer. Ann Surg Oncol 21(1):306-314, 1/2014. e-Pub 11/7/2013. PMID: 24197760.
63. Komaki R, Gomez DR. Radiotherapy for thymic carcinoma: Adjuvant, inductive, and definitive. Front Oncol 3:330, 1/2014. e-Pub 1/2014. PMCID: PMC3887269.
64. Chang JY, Li Q, Xu Q, Allen PK, Rebueno N, Gomez DR, Balter P, Komaki R, Mehran R, Swisher SG, Roth JA. Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: How to fly in a "No fly Zone". Int J Radiat Oncol Biol Phys 88(5):1120-1128, 1/2014.
65. Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova E, Song S, Ye Y, Huang M, Ajani J, Wu X. A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. Cancer. e-Pub 2014. PMID: 25091571.
66. Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WL,. Clinical staging of patients with early esophageal adenocarcinoma: Does FDG-PET/CT have a role? J Thorac Oncol 9(8):1202-1206, 2014. PMID: 25157774.
67. Tang C, Wang X, Soh H, Seyedin S, Cortez MA, Krishnan S, Massarelli E, Hong D, Naing A, Diab A, Gomez D, Ye H, Heymach J, Komaki R, Allison JP, Sharman P. Welsh JW. Combining radiation and immunotherapy: A new systemic therapy for solid tumors? Cancer immunology research. Cancer Immunol Res 2(9):831-838, 2014.
68. Kardar L, LiY, LiX, Li H, Cao W, Chang JY, Liao L, Zhu RX, Sahoo N, Gillin M, Liao Z, Komaki R, Cox JDLim G, Zhang X. Evaluation and mitigation of the interplay effects of intensity modulated proton therapy for lung cancr in a clinical setting. Pract Radiat Oncol 4(6):e259-268, 2014.
69. Lin SH, Wang J, Saintigny P, Wu C, Giri U, Zhang J, Menju T, Diao L, Byers L, Weinstein JN, Coombes KR, Girard L, Komaki R, Wistuba II, Date H, Dinna JD, Heymach JV. Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition. BMC Genomics 15(1079-1094), 2014.
70. Taketa T, Sudo K, Correa AM, Wadhwa R, Shiozaki H, Elimova E, Campagna MC, Blum MA, Skinner HD, Komaki R, Lee JH, Bhutani MS, Weston BR, Rice DC, Swisher SG, Maru DM, Hofstetter WL, Ajani JA. Post-chemoradiation surgical pathology stage can customieze the surveillance strategy in patients with esophageal adenocarcinoma. J Natl Compr Canc Netw 12(8):1139-1144, 2014.
71. He L, Allen PK, Potter A, Wang J, Chang JY, Gomez Dr, Komaki R, Liao Z, Lin SH. Re-evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamos cell carcinoma. J Thor Oncol 9(9):1398-1405, 2014.
72. Sudo K, Taketa T, Correa AM, Campagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, Skinner HD, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies. J Clin Oncol 31(34):4306-10, 12/1/2013. e-Pub 10/21/2013. PMCID: PMC3837091.
73. Ajani JA, Xiao L, Roth J, Hofstetter W, Walsh G, Komaki R, Liao Z, Rice D, Vaporciyan A, Maru DM, Lee, J, Bhutani M, Eid A, Yao J, Phan A, Halpin A, Akihiro S, Taketa T, Thall P, Swisher S. A phase 2 randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 24(11):2844-2849, 11/2013.
74. Chi A, Wen S, Liao Z, Fowler J, Xu J, Nguyen NP, Welsh JS, Komaki R. What would be the most appropriate α/β ratio in the setting of stereotactic body radiation therapy for early stage non-small cell lung cancer. Biomed Res Int. e-Pub 11/2013.
75. Yang J, Amini A, Williamson R, Zhang L, Zhang Y, Komaki R, Liao Z, Cox J, Welsh J, Court L, Dong L. Automatic contouring of brachial plexus using a multi-atlas approach for lung cancer radiotherapy. Pract Radiat Oncol 3(4), 10/1/2013. PMCID: PMC3833708.
76. Evans JD, Gomez DR, Chang JY, Gladish GW, Erasmus JJ, Rebueno N, Banchs J, Komaki R, Welsh JW. Cardiac (18)F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy. Radiother Oncol 109(1):82-8, 10/2013. e-Pub 9/7/2013. PMID: 24016676.
77. McAvoy SA, Ciura KT, Rineer JM, Allen PK, Liao Z, Chang JY, Palmer MB, Cox JD, Komaki R, Gomez DR. Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer. Radiother Oncol 109(1):38-44, 10/2013. e-Pub 9/7/2013. PMID: 24016675.
78. Komaki R, Cox JD. Kie Kian Ang, M.D. Ph.D., 1950-2013. Radiat Res 180(4):433-5, 10/2013. PMID: 24138530.
79. Machtay M, Duan F, Siegel BA, Snyder BS, Gorelick JJ, Reddin JS, Munden R, Johnson DW, Wilf LH, DeNittis A, Sherwin N, Cho KH, Kim SK, Videtic G, Neumann DR, Komaki R, Macapinlac H, Bradley JD, Alavi A. Prediction of survival by [18F] fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial. J Clin Oncol 31(30):3823-30, 10/2013. e-Pub 9/2013. PMCID: PMC3795891.
80. Shirvani SM, Juloori A, Allen PK, Komaki R, Liao Z, Gomez D, O'Reilly M, Welsh J, Papadimitrakopoulou V, Cox JD, Chang JY. Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer. Int J Radiat Oncol Biol Phys 87(1):139-147, 9/2013.
81. Skinner HD, McCurdy MR, Echeverria AE, Lin SH, Welsh JW, O'Reilly MS, Hofstetter WL, Ajani JA, Komaki R, Cox JD, Sandulache VC, Myers JN, Guerrero TM. Metformin use and improved response to therapy in esophageal adenocarcinoma. Acta Oncol 52(5):1002-1009, 9/2013.
82. Welsh JW, McGovern SL, Wefel JS, Komaki R, Brown PD, Soh HE. Reply to V. R. Bhatt et Al and M.C. Chamberlain. J Clin Oncol 31(25):3165-3166, 9/2013.
83. Murphy CC, Correa AM, Ajani JA, Komaki R, Welsh JW, Swisher SG, Hofstetter WL. Surgery is an essential component of multimodality therapy for patients with locally advanced esophageal adenocarcinoma. J Gastrointest Surg 17(8):1359-1369, 8/2013.
84. Gomez DR, Gillin M, Liao Z, Wei C, Lin SH, Swanick C, Alvarado T, Komaki R, Cox JD, Chang JY. Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 86(4):665-670, 7/2013.
85. Taketa T, Xiao L, Sudo K, Suzuki A, Wadhwa R, Blum MA, Lee JH, Weston B, Bhutani MS, Skinner H, Komaki R, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JA. Propensity-based matching between esophagogastric cancer patients who had surgery and who declined surgery after preoperative chemoradiation. Oncology 85(2):95-99, 7/2013.
86. Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Govindan R, Grannis FW Jr, Grant SC, Horn L, Jahan TM, Komaki R, Kong FM, Kris MG, Krug LM, Lackner RP, Lennes IT, Loo BW Jr, Martins R, Otterson GA, Patel JD, Pinder-Schenck MC, Pisters KM, Reckamp K, Riely GJ, Rohren E, Shapiro TA, Swanson SJ, Tauer K, Wood DE, Yang SC, Gregory K, Hughes M. Non-small cell lung cancer, version 2.2013. JNatl Compr Canc Netw 11(6):645-653, 6/2013.
87. Chang JY, Liu YH, Zhu Z, Welsh JW, Gomez DR, Komaki R, Roth JA, Swisher SG. Stereotactic ablative radiotherapy: A potentially curable approach to early stage multiple primary lung cancer. Cancer 119(18). e-Pub 6/2013.
88. Yuan X, Wei Q, Komaki R, Liu Z, Yang J, Tucker SL, Xu T, Heymach JV, Lu C, Cox JD, Liao Z. TGFβ1 polymorphisms predict distant metastasis-free survival in patients with inoperable non-small-cell lung cancer after definitive radiotherapy. PLos one 8(6):e65659, 6/2013.
89. Lawrence YR, Paulus R, Langer C, Werner-Wasik M, Buyyounouski MK, Komaki R, Machtay M, Smith C, Axelrod RS, Wasserman T, Bradley JD, Movsas B. The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801. Lung Cancer 80(3):298-305, 6/2013.
90. Chi A, Ma P, Fu G, Hobbs G, Welsh JS, Nguyen NP, Jang SY, Dai J, Jin J, Komaki R. Critical structure sparing in stereotactic ablative radiotherapy for central lung lesions: helical tomotherapy vs. volumetric modulated arc therapy. PLos One 8(4):e59729, 5/2013.
91. Bhardwaj V, Cascone T, Cortez MA, Amini A, Evans J, Komaki R, Heymach JV, Welsh JW. Modulation of c-Met signaling and cellular sensitivity to radiation: Potential implications for therapy. Cancer 119(10):1768-1775, 5/2013. PMID: 23423860.
92. Ettinger DS, Riely GJ, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Govindan R, Grannis FW Jr, Grant SC, Horn L, Jahan TM, Komaki R, Kong FM, Kris MG, Krug LM, Lackner RP, Lennes IT, Loo BW Jr, Martins R, Otterson GA, Patel JD, Pinder-Schenck MC, Pisters KM, Reckamp K, Rohren E, Shapiro TA, Swanson SJ, Tauer K, Wood DE, Yang SC, Gregory K, Hughes M. Thymomas and thymic carcinomas: clinical practice guidelines in oncology. J Natl Compr Canc Nertw 11(5):562-576, 5/2013.
93. Pang Q, Wei Q, Xu T, Yuan X, Lopez Guerra JL, Levy LB, Liu Z, Gomez DR, Zhuang Y, Wang LE, Mohan R, Komaki R, Liao Z. Functional Promoter Variant rs2868371 of HSPB1 Is Associated With Risk of Radiation Pneumonitis After Chemoradiation for Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 85(5):1332-1339, 4/2013. PMID: 23374503.
94. Wang J, Myles, B, Caimiao C, Chang JY, Hofstetter W, Ajani J, Swisher S, Cox JD, Wogan C, Komaki R, Liao Z, Lin S,. Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma. Cancer. e-Pub 4/2013.
95. Wang J, Wei C, Tucker SL, Myles B, Palmer M, Hofstetter WL, Swisher SC, Ajani JA, Cox JD, Komaki R, Liao Z, Lin SH. Predictors of postoperative complications after trimodality therapy for esophageal cancer. Int J Radiat Oncol Biol Phys 86(5):885-891, 4/2013.
96. Komaki R, Khalid N, Langer CJ, Spring Kong FM, Owen JB, Crozier CL, Wilson JF, Wei X, Movsas B. Penetration of recommended procedures for lung cancer staging and management in the United States over 10 years: A quality research in radiation oncology survey. Int J Radiat Oncol Biol Phys 85(4):1082-9, 3/15/2013. e-Pub 12/27/2012. PMID: 23273996.
97. Sperduto PW, Wang M, Robins HI, Schell MC, Werner-Wasik M, Komaki R, Souhami L,Buyyounouski MK, Khuntia D, Demas W, Shah SA, Nedzi LA, Perry GA, Suh JH, Mehta MP. A phase III Trial of whole brain radiation therapy (WBRT) and stereotactic radiosurgery (R) alone versus WBRT and SRS with temozolomide (TMZ) or erlotinib for non-small cell lung cancer and 1-3 brain metastases: Radiation Therapy Oncology Group 0320. Int J Radiat Oncol Biol Phys 85:1312-1318, 3/2013.
98. Xiong H, Liao Z, Liu Z, Xu T, Wang Q, Liu H, Komaki R, Gomez D, Wang LE, Wei Q. ATM polymorphisms predict severe radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys 85(4):1066-1073, 3/2013. e-Pub 11/2012. PMID: 23154078.
99. Welsh JW, Komaki R, Amini A, Munsell MF, Unger W, Allen PK, Chang JY, Wefel JS, McGovern SL, Garland LL, Chen SS, Holt J, Liao Z, Brown P, Sulman E, Heymach JV, Kim ES, Stea B. Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer. J Clin Oncol 31(7):895-902, 3/2013.
100. Evans JD, Gomez DR, Amini A, Rebueno N, Allen PK, Martel MK, Rineer JM, Ang KK, McAvoy S, Cox JD, Komaki R, Welsh JW. Aortic dose constraints when reirradiating thoracic tumors. Radiother Oncol. e-Pub 2/27/2013. PMID: 23453540.
101. Gomez D, Hong DS, Allen PK, Welsh JS, Mehran RJ, Tsao AS, Liao Z, Bilton SD, Ritsuko R, Rice DC. Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma. J Thor Oncol 8(2):238-245, 2/2013.
102. Wang HM, Liao ZX, Komaki R, Welsh JW, O'Reilly MS, Chang JY, Zhuang Y, Levy LB, Lu C, Gomez DR. Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy. Ann Oncol. e-Pub 1/8/2013. PMID: 23300016.
103. Lopez Guerra JL, Gomez DR, Lin SH, Levy LB, Zhuang Y, Komaki R, Jaen J, Vaporciyan AA, Swisher SG, Cox JD, Liao Z, Rice DC. Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy. Ann Oncol 24(1):67-74, 1/2013. e-Pub 9/20/2012. PMCID: PMC3525136.
104. Murphy CC, Hofstetter WL, Correa AM, Ajani JA, Komaki R, Swisher SG. Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting. Dis Esophagus. e-Pub 1/2013. PMID: 23350713.
105. Welsh J, Amini A, Ciura K, Nguyen N, Palmer M, Soh H, Allen PK, Paolini M, Liao Z, Bluett J, Mohan R, Gomez D, Cox JD, Komaki R, Chang JY. Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer. Med Dosim 38(4):442-447, 2013.
106. Wadhwa R, Taketa T, Correa A, Sudo K, Campagna M, Blum M, Komaki R, Skinner H, Lee J, Bhutani M, Weston B, Rice D, Swisher S, Hofstetter W, Ajani J. Incidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: implications for screening and surveillance. Oncology 85(4):204-207, 2013.
107. Zuzuki A, Xiao L, Taketa T, Sodo K, Wadhua R, Blum MA, Skinner H, Komaki R, Weston B, Lee JH, Bhutani MS, Rice DC, Maru DM, Erasmus J, Swisher SG, Hofstetter WL, Ajani A. Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation. Ann Oncol 24(11):2854-8259, 2013.
108. Skinner HD, Komaki R. Proton radiotherapy in the treatmnet of lung cancer. Translational Cancer Research 1(4), 12/2012.
109. Welsh J, Palmer M, Jaffer A, Zhongxing L, Swisher S, Hofstetter W, Allen P, Settle S, Gomez D, Likhacheva A, Cox J, Komaki R. Esophageal cancer dose escalation using a simultaneous integrated boost technique. Int J Rad Onc Biol 82(1):468-474, 11/2012.
110. Machtay M, Bea K, Movsas B, Paulus R, Gore E, Komaki R, Albain K, Sause W, Curran W. Higher biologically equivalent dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: An analysis of the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 82(1):425-434, 11/2012.
111. Jiang ZQ, Yang K, Komaki R, Wei X, Tucker SL, Zhunag Y, Martel MK, Vedam S, Balter P, Zhu G, Gomez D, Lu C, Mohan R, Cox JD Liao Z. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small-cell lung cancer: The MD Anderson Experience. Int J Radiat Oncol Biol Phys 83(1):332-339, 11/2012.
112. Liu H, Zhang X, Vinogradskiy YY, Swisher S, Komaki R, Chang JY. Predicting radiation pneumonitis after stereotactic ablative radiotherapy in patients previously treated with conventional thoracic radiotherapy. Int J Radiat Oncol Biol Phys 84(4):1017-1023, 11/2012. PMID: 22543216.
113. Gomez DR, Tucker SL, Martel MK, Mohan R, Balter PA, Lopez Guerra JL, Liu H, Komaki R, Cox JD, Liao Z. Predictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 84(4):1010-1016, 11/2012. PMID: 2292097.
114. Kong FM, Ritter T, Quint D, Marsh L, Senan S, GAspar L, Komaki R, Hurkmans C, Timmerman R, Choy H, Bezjak A, Bradley J, Mosvas B, Okunieff P, Curran W. In reply to Zagar and Marks. Int J Radiat Oncol Biol Phys 84(2):305-306, 10/2012.
115. Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW Jr, Horn L, Jahan Tm, Jahanzeb M, Kessinger A, Komaki R, Kong FM, Dris MG, Krug LM, Lennes IT, Loo BW Jr, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pinder-Schenck MC, Pisters KM, Reckamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC, Hughes M, Gregory KM,. Non-small cell lung cancer. J Natl Compr Canc Netw 10:1236-12371, 10/2012.
116. Guerra JL, Gomez D, Wei Q, Liu Z, Wang LE, Yuan X, Zhuang Y, Komaki R, Liao Z. Association between single nucleotide polymorphisms of the transforming growth factor b1 gene and the risk of severe radiation esophagitis in patients with lung cancer. Radiother Oncol, 9/2012.
117. Chang JY, Liu H, Balter P, Komaki R, Liao Z, Welsh J, Mehran RJ, Roth JA, Swisher SG. Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer. Radiat Oncol 10:152, 9/2012. PMID: 22963661.
118. Swisher S, Ajani J, Correa A, Komaki R, Hofstetter W. Minimally invasive versus open oesophagectomy for oesophageal cancer. Lancet 380(9845):883, 9/2012.
119. Lopez Guerra JL, Gomez D, Zhuang Y, Hong DS, Heymach JV, Swisher SG, Lin SH, Komaki R, Cox JD, Liao Z. Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis. Int J Radiat Oncol Biol Phys 84(1):e61-7, 9/2012. PMID: 22503522.
120. Lopez Guerra JL, Gomez D, Lin S, Levy L, Zhuang Y, Komaki R, Jean J, Vaporciyan A, Swisher S, Cox JD, Liao Z, Rice D. Risk factors for local and regional recurrence in patients with resected N0-N1 non-smal cell lung cancer, with implications for patient selection for adjuvant radiation therapy. Ann Oncol. e-Pub 9/2012.
121. Curran WJ Jr, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E, Machtay M, Sause W, Cox JD. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst 103(19):1452-1460, 9/2012.
122. Amini A, Correa AM, Komaki R, Chang JY, Tsao AS, Roth JA, Swisher SG, Rice DC, Vaporciyan AA, Lin SH. The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy. Ann Thorac Surg 94(3):914-920, 9/2012.
123. Bhardwaj V, Zhan Y, Cortez MA, Ang KK, Molkentine D, Munshi A, Raju U, Komaki R, Heymach JV, Welsh J. C-met inhibitor MK-8003 radiosensitizes c-met-expressing non-small-cell lung cancer cells with radiation-induced c-met-expression. J Thorac Oncol 7(8):1211-1217, 8/2012. PMID: 22617250.
124. Lopez Guerra JL, Gomez D, Zhuang Y, Levy L, Eapen G, Liu H, Mohan R, Komaki R, Cox J, Liao Z. Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 83(5):1573-1579, 8/2012.
125. Xiang ZL, Erasmus J, Komaki R, Cox JD, Chang JY. FDG uptake correlates with recurrence and survival after treatment of unresectable stage III non-small cell lung cancer with high-dose proton therapy and chemotherapy. Radiat Oncol 7:144, 8/2012.
126. Lin SH, Myles B, Wang L, Thall PF, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao Z. Propensity score based comparison of long term outcomes with 3D conformal radiotherapy (3DCRT) versus intensity modulated radiation therapy (IMRT) in the treatment of esophageal cancer. Inter J Radiat Oncol Biol Phys. e-Pub 8/2012. PMID: 22867894.
127. Ajani J, Correa A, Hofstetter W, Rice D, Blum M. Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 10:2638-2642, 7/2012. PMID: 22831985.
128. Amini A, Xiao L, Allen PK, Susuki A, Hayashi Y, Liao Z, Hofstetter W, Crane C, Komaki R, Bhutani MS. Lee JH, Ajani JA, Welsh J. Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era. Int J Radiat Oncol Biol Phys 83(2):e231-e239, 6/2012.
129. Lopez Guerra JL, Gomez D, Zhuang Y, Levy LB, Eapen G, Liu H, Mohan R, Komaki R, Cox JD, Liao Z,. Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 83:e537, 6/2012.
130. Welsh J, Settle S, Amini A, Xiao L, Suzuki A, Hayashi Y, Hofstetter W, Komaki R, Liao Z. Failure patterns in patients with esophageal cancer treated with definitive chemoradiation. Cancer 118(10):2632-2640, 5/2012. PMID: 22565611.
131. Komaki R, Paulus R, Ettinger DS, Videtic G MM, Bradley JD, Glisson BS, Langer CJ, Sause WT,. Curran WJ Jr., Choy H. Phase II study of accelerated high-dose radiation therapy with current chemotherapy for patients with limited small cell lung cancer: RTOG 0239. Int J Radiat Oncol Biol Phys 83(4):e531-536, 5/2012. PMID: 22560543.
132. Zhang X, Liu H, Balter P, Allen PK, Komaki R, Pan T, Chuang HH, Chang JY. Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small cell lung cancer. Int J Radiat Onc Biol Phys 83(5):1558-1565, 5/2012.
133. Swisher SG, Winter KA, Komaki R, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CG. A phase II study of a paclitaxel based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: Initial reporting of RTOG 0246. Int J Radia Oncol Biol Phys 82(5):1967-1972, 4/2012.
134. Koay EJ, Lege D, Mohan R, Komaki R, Cox JD, Chang JY. Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 84(5). e-Pub 4/2012.
135. Machtay M, Paulus R, Moughan J, Komaki R, Bradley J, Choy H, Albain K, Movsas B, Sause WT, Curran WJ. Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma: A Radiation Therapy Oncology Group Analysis. J Thorac Oncol 7(4):716-722, 4/2012.
136. Chi A, Liao Z, Nguyen NP, Xu J, Welsh JS, Jang SY, Howe C, Komaki R. Dosimetric selection for helical tomotherapy based stereotactic ablative radiotherapy for early-stage non-small cell lung cancer or lung metastases. PloS One 7(4):e35809, 4/2012.
137. Shirvani SM, Komaki R, Heymach JV, Fossella FV, Chang JY. Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 82(1):e91, 4/2012.
138. Lopez Guerra JL, Gomez D, Zhuang Y, Hong DS, Heymach JV, Swisher SG, Lin SH, Komaki R, Cox JD, Liao Z. Prognostic impact of radiation therapy to the primary tumor in patients with non-small cell lung cancer and oligometastasis at diagnosis. Int J Radiat Oncol Biol Phys. e-Pub 4/2012.
139. Amini A, Lin SH, Wei C, Allen P, Cox JD, Komaki R. Accelerated hypofractionated radiation therapy compared to conventionally fractionated radiation therapy for the treatment of inoerable non-small cell lung cancer. Radiat Oncol 15(7):33, 3/2012.
140. Amini A, Yang J, Williamson RT, McBurney ML, Erasmus J Jr., Allen PK, Karhade M, Komaki R, Liao Z, Gomez D, Cox JD, Dong L, Welsh J. Dose constraints to prevent radiation-induced brachial plexopathy in patients treated for lung cancer. Int J Radiat Oncol Biol Phys 82(3):e391, 3/2012.
141. Gomez D, Komaki R. Postoperative radiation therapy for non-small cell lung cancer and thymic malignancies. Cancer 4(1):307-322, 3/2012.
142. Lin SH, Komaki R, Liao Z, Wei C, Myles B, Guo X, Palmer M, Mohan R, Swisher SG, Hofstetter WL, Ajani JA, Cox JD. Proton beam therapy and concurent chemotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 83(3). e-Pub 3/2012.
143. Wang J, Lin SH, Dong L, Balter P, Mohan R, Komaki R, Cox JD, Starkschall G. Quantifying the interfractional displacement of the gastroesophageal junction during radiation therapy for esophageal cancer. Int J Radiat Oncol Biol Phys 83(2):e273-80, 3/2012. PMID: 22440040.
144. Takahashi O, Komaki R, Smith PD, Jurensmeier JM, Ryan A, Bekele BN, Wistuba II, Jacoby JJ, Korshunova MV, Biernacka A, Erez B, Hosho K, Herbst RS, O'Reilly MS. Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis. Clin Cancer Res 18(6):1-14, 2/2012.
145. Gomez DR, Cox JD, Roth JA, Allen PK, Wei X, Mehran RJ, Kim JY, Swisher SG, Rice DC, Komaki R. A prospective phase II study of surgery followed by chemotherapy and radiation for superior sulcus tumors. Cancer 118(2):444-451, 1/2012.
146. Yin M, Liao Z, Liu Z, Wang LE, O'Reilly M, Gomez D, Li M, Komaki R, Wei Q. Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in non small cell lung cancer patients treated with definitive radiotherapy. Cancer 118(2):528-535, 1/2012.
147. Lopez Guerra JL, Gladish G, Komaki R, Gomez D, Zhuang Y, Liao Z. Large decreases in standardized uptake values after fefinitive radiation are associated with better survival of patients with locally advanced non-small cell lung cancer. J Nucl Med 53(2):225-233, 1/2012.
148. Ettinger DS, Akerley W, Borghaei H, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW, Horn L, Jahan TM, Jahanzeb M, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Lennes IT, Loo BW, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Schenck MP, Pister KM, Reckamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC. Malignant pleural mesothelioma. J Natl Compr Canc Netw 1(10):26-41, 1/2012.
149. Kong FM, Ritter T, Quint DJ, Senan S, Gaspar LE, Komaki R, Hurkmans CW, Timmerman R, Bezjak A, Bradley JD, Movsas B, Marsh L, Okunieff P, Choy H, Curran W. Consideration of dose limits for organs at risk for thoracic radiotherapy: Atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys 81(5):1142-1457, 12/2011.
150. Komaki R, Wei X, Allen PK, Liao Z, Milas L, Cox JD, O'Reilly MS, Chang JY, McAleer MF, Jeter M, Blumenschein GR, Kies MS. Phase I study of celecoxib with concurrent irinotecan, cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer. Front Thorac Oncol 2(52):1-7, 12/2011.
151. Welsh J, Thomas J, Shah D, Allen PK, Wei X, Mitchell K, Gao S, Balter P, Komaki R, Chang JY. Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 81(1):91-96, 9/1/2011. e-Pub 6/11/2010. PMID: 20542388.
152. Chang JY, Komaki R, Wen HY, De Gracia B, Bluett JB, McAleer MF, Swisher SG, Gillin M, Mohan R, Cox JD. Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 80(5):1350-1357, 8/1/2011. e-Pub 1/20/2011. PMCID: PMC3117089.
153. Marom EM, Milito MA, Moran CA, Liu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SG. Computed Tomography Findings Predicting Invasiveness of Thymoma. J Thorac Oncol 6(7):1274-1281, 7/2011. PMID: 21623235.
154. Sejpal S, Komaki R, Tsao A, Chang JY, Liao Z, Wei X, Allen PK, Lu C, Gillin M, Cox JD. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer. Cancer 117(13):3004-13, 7/2011. e-Pub 1/2011. PMID: 21264827.
155. Gomez D, Komaki R, Yu J, Ikushima H, Bezjak A. Radiation therapy definitions and reporting guidelines for thymic malignancies. J Thorac Oncol 6(7 Suppl 3):S1743-S1748, 7/2011. PMID: 21847057.
156. Chi A, Komaki R, Liao Z, Nam N, Howe C. Intensity-modulated radiotherapy after extrapleural pneumonectomy in combined-modality treatment of malignant pleural mesothelioma. J Thorac Oncol 6(6), 6/2011.
157. Blumenschein GR, Paulus R, Curran WJ, Robert F, Fossella F, Werner-Wasik M, Herbst RS, Doescher PO, Choy H, Komaki R. Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA/B non-small-cell lung cancer: RTOG:0324. J Clin Oncol 29(17):2312-2318, 6/2011. e-Pub 5/2011. PMCID: PMC3107747.
158. Welsh J, Amini A, Likhacheva A, Erasmus J J, Gomez D, Davila M, Mehran RJ, Komaki R, Liao Z, Hofstetter WL, Lee H J, Bhutani MS, Ajani JA. Update: Modern Approaches to the Treatment of Localized Esophageal Cancer. Curr Oncol Rep 13(3):157-67, 6/2011. e-Pub 3/2011. PMID: 21365188.
159. Grosshans D, Boehling NS, Palmer M, Spicer C, Erice R, Cox JD, Komaki R, Chang JY. Improving cardiac dosimerty: Alternative beam arrangements for intensity modulated radiation therapy planning in patients with carcinoma of the distal esophagus. PRO 2:41-45, 4/2011.
160. Welsh J, Gomez D, Palmer M, Riley B, Mayankkumar A, Komaki R, Dong L, Zhu R, Likhacheva A, Zhongxing L, HofstetterW , Jaffer A, Likhacheva A, Cox JD. Intensity-modulated proton therapy further reduces normal-tissue exposure during definitive therapy for locally advanced distal esophageal tumors: A dosimetric study. Int J Radiat Oncol Biol Phys 81(5):1336-1342, 4/2011.
161. Kountourakis P, Correa AM, Hofstetter WL, Lee JH, Bhutani MS, Rice DC, Komaki R, Maru DM, Ross WA, Vaporciyan A, Swisher SG, Ajani JA. Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience. Cancer 117(5):925-930, 3/1/2011. e-Pub 10/19/2010. PMCID: PMC3080168.
162. Kachnic LA, Winter K, Wasserman T, Kelson D, Ginsberg R, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Willett CG, Minsky BD. A longitudinal quality of life analysis of RTOG 94-05 (INT 0123): A phase III trial of definitive chemoradiation for esophageal cancer. Gastrointest Cancer Res 4(2):45-52, 3/2011.
163. Yin M, Liao Z, Liu Z, Wang LE, Gomez D, Komaki R, Wei Q. Functional polymorphisms of base-excision repair genes XRCC1 and APEX1 predict risk of radiation-induced pneumonitis in patients with non-small cell lung cancer Treated with Definitive radiatio therapy. Int J Radiat Oncol Biol Phys 81(3):e67-73, 3/2011.
164. Chang JY, Komaki R, Lu C, Wen HY, Allen PK, Tsao A, Gillin M, Mohan R, Cox JD. Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III non small cell lung cancer. Cancer 117(20):4707-4713, 3/2011. PMCID: PMC3174272.
165. Ikushima H, Balter P, Komaki R, Hunjun S, Bucci MK, Liao Z, McAleer MF, Yu ZH, Zhang Y, Chang JY, Dong L. Daily alignment results of in-room computed tomography-Guided stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 79(2):473-480, 2/1/2011. e-Pub 4/14/2010. PMID: 20399032.
166. Fukui H, Toyoshima K, Komaki R. Psychological and neuroendocrinological effects of odor of saffron (Crocus sativus). Phytomedicine 18(8-9):726-730, 1/2011. PMID: 21242071.
167. Komaki R, Wei X, Allen PK, O'Reilly M, Fossella FV, Liao Z, Heymach JV, Herbst RS, Chang JY, Cox JD. (S044) Factors to predict long-term 5-year overall survival (OS) among patients with limited small-cell lung cancer treated with radiation treatment (RT) and chemotherapy. Oncology 25(1):27-28, 2011.
168. Bourhis J, Blanchard P, Maillard E, Brizel DM, Movsas B, Buentzel J, Langendik JA, Komaki R, Leong SS, Levendag P, Pignon JP. Effect of amifostine on survival among patients treated with radiotherapy: A meta-analysis of individual patient data. J Clin Oncol 29(18):2590-2597, 2011, 2011.
169. Turner LM, Howard JA, Dehghanpour P, Barrett RD, Rebueno N, Palmer M, Vedam S, Klopp A, Komaki R, Welsh JW. Exploring the feasibility of dose escalation positron emission tomography-positive disease with intensity-modulated radiation therapy and the effects on normal tissue structures for thoracic malignancies. Med Dosim 36(4):383-388, 2011. e-Pub 12/2010. PMID: 21144734.
170. Chi A, Jang SY, Welsh JS, Nguyen NP, Ong E, Gobar L, Komaki R. Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage Non-small-cell lung cancer or lung metastases. Int J Radiat Oncol Biol Phys 81(3):856-862, 2011. PMID: 21255942.
171. Wolfson A, Bae K, Komaki R, Meyers C, Movsas, Le Pechoux C, Werner-Wasik M, Videtic G, Garces Y, Choy H. Primary analysis of a phase II randomized trial radiation therapy oncology group (RTOG) 0212: Impact of different total dose and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited disease small cell lung cancer. Int J Radiat Oncol Biol Phys 81(1):77-84, 2011.
172. Guan X, Liao Z, Ma H, Qian J, Liu Z, Yuan X, Gomez D, Komaki R, Wang LE, Wei Q. TNFRSF1B +676 T>G polymorphism predicts survival of non-small cell lung cancer patients treated with chemoradiotherapy. BMC Cancer 14(11):447, 2011. e-Pub 10/14/2011. PMCID: PMC3220654.
173. Kelly P, Balter PA, Rebueno N, Sharp HJ, Liao Z, Komaki R, Chang JY. Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. Int J Radiat Oncol Biol Phys 78(5):1387-1393, 12/1/2010. e-Pub 4/8/2010. PMID: 20381271.
174. Turner LM, Howard JA, Dehghanpour P, Barrett RD, Rebueno N, Palmer M, Vedam S, Klopp A, Komaki R, Welsh JW. Exploring the feasibility of dose escalation positron emission tomography–positive disease with intensity-modulated radiation therapy and the effects on normal tissue structures for thoracic malignancies. Med Dos, 12/2010. e-Pub 12/2010.
175. Chi A, Komaki R. Treatment of brain metastasis from lung cancer. Cancer 2(4):2100-2137, 12/2010.
176. Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Govindan R, Grannis FW Jr, Jahan T, Johnson DH, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Le QT, Lennes IT, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pisters KM, RecKamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC; National Comprehensive Cancer Network. Thymic malignancies. J Natl Compr Canc Netw 8:1302-1315, 11/2010.
177. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Ajani JA, Erasmus J, Komaki R, Lee JH, Maru D, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Peters JH, Watson TJ, Swisher SG. A clinical nomogram predicting pathologic lymph-node involvement in esophageal cancer patients. Ann Surg 252(6):611-617, 10/2010.
178. Kountourakis P, Correa AM, Hofstetter WL, Lee JH, Bhutani MS, Rice DC, Komaki R, Maru DM Ross WA, Vaporciyan A, Swisher SG, Ajani JA. Combined modality therapy of cT2N0M0 esophageal cancer: the Universit of Texas MD Anderson Cancer Center experience. Cancer 117(5):925-930, 10/2010.
179. Kong FM, Ritter T, Quint DJ, Senan S, Gaspar LE, Komaki R, Hurkmans CW, Timmerman R, Bezjak A, Bradley JD, Movsas B, Marsh L, Okunieff P, Choy H, Curran WJ. Consideration of dose limits for organs at risk of thoracic radiotherapy: Atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys 81(5):1442-1457, 10/2010.
180. Machtay M, Bae K, Movsas B, Paulus R, Byhardt R, Komaki R, Albain K, Sause WT, Curran WJ. Higher biologically equivalent dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: An analysis of the Radiation Therapy Oncology Group. JCO 82(1):425-434, 10/2010.
181. Gomez D, Komaki R. Technical advances of radiation therapy for thymic malignancies. J Thorac Oncol 5(10 Suppl 4):S336-43, 10/2010. PMID: 20859129.
182. Ogo E, Komaki R, Abe T, Uchida M, Fujimoto K, Suzuki G, Tsuji C, Suefuji H, Etou H, Hattori C, Watanabe Y, Hayabuchi N. The clinical characteristics and non-steroidal treatment for radiation-induced bronchiolitis obliterans organizing pneumonia syndrome after breast-conserving therapy. Radiother Oncol 97(1):95-100, 10/2010. e-Pub 4/10/2010. PMID: 20385415.
183. Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Lee JH, Liao Z, Maru D, Mehran R, Patel S, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA. Improved Long-term Outcome with Chemoradiotherapy Strategies in Esophageal Cancer. Ann Thorac Surg 90(3):892-8; discussion 898-9, 9/2010. PMID: 20732514.
184. Hildebrandt M, Komaki R, Liao Z, Gu J, Chang J, Ye Y, Lu C, Stewart D, Minna J, Roth J, Lippman S, Cox J, Hong W, Spitz M, Wu X. Genetic variants in inflammation pathway genes are associated with the development of radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One 5(8):e12402, 8/2010.
185. Wang XS, Shi Q, Williams LA, Mao L, Cleeland CS, Komaki R, Mobley GM, Liao Z. Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. Brain Behav Immun 24(6):968-974, 8/2010. e-Pub 3/2010. PMCID: PMC2897921.
186. Wolfson AH, Bae K, Komaki R, Meyers C, Movsas B, Le Pechoux C, Werner-Wasik M, Videtic GM, Garces YI, Choy H. Primary analysis of a phase II randomized trial radiation therapy oncology group (RTOG) 0212: Impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited disease small cell lung cancer. Int J Radiat Oncol Biol Phys 81(1):77-84, 8/2010. PMCID: PMC3024447.
187. Tucker SL, Jin H, Wei X, Wang S, Martel MK, Komaki R, Liu HH, Mohan R, Chen Y, Cox JD, Liao Z. Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer. Int J Radiat Oncol Biol Phys 77(3):691-8, 7/1/2010. e-Pub 10/14/2009. PMID: 19836159.
188. Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW, Jahan T, Jahanzeb M, Johnson DH, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Le QT, Lennes IT, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Simon GR, Swanson SJ, Wood DE, Yang SC, NCCN Non-Small Cell Lung Cancer Panel Members. Non-small cell lung cancer. J Natl Compr Canc Netw 8(7):740-801, 7/2010. PMID: 20679538.
189. Lu C, Lee JJ, Komaki R, Herbst RS, Feng L, Evans WK, Choy H, Desjardins P, Esparaz BT, Truong MT, Saxman S, Kelaghan J, Bleyer A, Fisch MJ. Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: A randomized phase III trial. J Natl Cancer Inst 102(12):859-62, 6/16/2010. e-Pub 5/26/2010. PMCID: PMC2902826.
190. Zhang X, Li Y, Pan X, Xiaoqiang L, Mohan R, Komaki R, Cox JD, Chang JY. Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: A virtual clinical study. Int J Radiat Oncol Biol Phys 77(2):357-66, 6/1/2010. e-Pub 8/5/2009. PMCID: PMC2868090.
191. Chi A, Tomé WA, Fowler J, Komaki R, Nguyen NP, Mehta MP, Welsh JS. Stereotactic body radiation therapy in non-small-cell lung cancer: Linking radiobiological modeling and clinical outcome. Am J Clin Oncol 34(4):432-441, 6/2010. e-Pub 6/2010. PMID: 20539207.
192. Siddiqui F, Bae K, Langer CJ, Coyne JC, Gamerman V, Komaki R, Choy H, Curran WJ, Watkins-Bruner D, Movsas B. The influence of gender, race, and marital status on survival in lung cancer patients: analysis of Radiation Therapy Oncology Group trials. J Thorac Oncol 5(5):631-9, 5/2010. PMID: 20432520.
193. Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG. Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. Cancer 116(7):1656-63, 4/1/2010. PMID: 20143431.
194. Chang JY, Komaki R, Wen Hy, DeGracia B, Bluett JB, McAleer MF, Swisher SG, Gillin M, Mohan R, Cox JD. Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage. medically inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 80(5):1350-1357, 2011, 4/2010.
195. McAleer MF, Moughan J, Byhardt RW, Cox JD, Sause WT, Komaki R. Does response to induction chemotherapy predict survival for locally advanced non-small-cell lung cancer? Secondary analysis of RTOG 8804/8808. Int J Radiat Oncol Biol Phys 76(3):802-808, 3/1/2010. e-Pub 6/18/2009. PMID: 19540055.
196. Liao ZX, Komaki R, Thames HD, Liu HH, Tucker SL, Mohan R, Martel MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys 76(3):775-81, 3/2010. e-Pub 6/2009. PMID: 19515503.
197. Chi A, Liao Z, Nguyen NP, Xu J, Stea B, Komaki R. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol 94(1):1-11, 1/2010. e-Pub 1/13/2010. PMID: 20074823.
198. Hildebrandt MA, Komaki R, Liao Z, Gu J, Chang JY, Ye Y, Lu C, Stewart DJ, Minna JD, Roth JA, Lippman SM, Cox JD, Hong WK, Spitz MR, Wu X. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. PLoS One 5(8):e12402, 2010. e-Pub 8/25/2010. PMCID: PMC2928273.
199. Guan X, Yin M, Wei Q, Zhao H, Liu Z, Wang LE, Yuan X, O'Reilly MS, Komaki R, Liao Z. Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy. BMC Cancer 10:431, 2010. e-Pub 8/16/2010. PMCID: PMC2939547.
200. Ikushima H, Dong L, Erasmus J, Allen P, McAleer MF, Zhuang Y, Sasaki R, Komaki R. Predictive value of (18)F-Fluorodeoxyglucose uptake by positron emission tomography for non-small cell lung cancer patients treated with radical radiotherapy. J Radiat Res 51(4):465-71, 2010. e-Pub 5/28/2010. PMID: 20508373.
201. Movsas B, Moughan J, Sarna L, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Wasserman T, Bruner DW. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. J Clin Oncol 27(34):5816-22, 12/2009. e-Pub 10/2009. PMCID: PMC2793002.
202. Ito A, Miyoshi M, Ueki S, Fukada M, Komaki R, Watanabe T. "Green odor" inhalation by rats down-regulates stress-induced increases in Fos expression in stress-related forebrain regions. Neurosci Res 65(2):166-74, 10/2009. e-Pub 6/27/2009. PMID: 19563846.
203. Bolton WD, Hofstetter WL, Francis AM, Correa AM, Ajani JA, Bhutani MS, Erasmus J, Komaki R, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg 133(4):831-836, 10/2009. e-Pub 4/9/2009. PMID: 19660349.
204. Komaki R, Cox JD. Molecular and physical targeting: A platform for improving the therapeutic ratio in cancer treatment. J Jpn Soc Ther Radiol Oncol 22:66, 9/2009.
205. Vallieres E, Shepherd FA, Crowley J, Van Houtte P, Postmus PE, Carney D, Chansky K, Shaikh Z, Goldstraw P. The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 4(9):1049-59, 9/2009.
206. Smith A, Gillin M, Bues M, Zhu XR, Suzuki K, Mohan R, Woo S, Lee A, Komaki R, Cox J, Hiramoto K, Akiyama H, Ishida T, Sasaki T, Matsuda K. The M. D. Anderson Proton Therapy System. Med Phys 36(9):1-16, 9/2009. PMID: 19810479.
207. Sun M, Behrens C, Feng L, Ozburn N, Tang X, Yin G, Komaki R, Varella-Garcia M, Hong WK, Aldape KD, Wistuba II. HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors. Clin Cancer Res 15(15):4829-37, 8/1/2009. e-Pub 7/21/2009. PMID: 19622585.
208. Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele BN, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J Thorac Cardiovasc Surg 138(2):412-418, 8/2009. e-Pub 5/28/2009. PMCID: PMC2731793.
209. Bolton WD, Rice DC, Correa AM, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Influence of age on choice of therapy and surgical outcomes in patients with non small cell lung cancer. Am Surg 75(7):598-603, 7/2009. PMID: 19655604.
210. McGovern SL, Liao Z, Bucci MK, McAleer MF, Jeter MD, Chang JY, O'Reilly MS, Cox JD, Allen PK, Komaki R. Is sex associated with the outcome of patients treated with radiation for non small cell lung cancer? Cancer 115(14):3233-42, 7/2009. e-Pub 5/2009. PMID: 19472405.
211. Oh Y, Taylor S, Bekele BN, Debnam JM, Allen PK, Suki D, Sawaya R, Komaki R, Stewart DJ, Karp DD. Number of metastatic sites is a strong predictor of survival in patients with non small cell lung cancer with or without brain metastases. Cancer 115(13):2930-2938, 7/2009. e-Pub 5/2009. PMID: 19441110.
212. Zhang Z, Chen Y, Chen Y, Jeter M, Hofstetter WL, Ajani J, Swisher SG, Chang JY, Allen PK, Cox JD, Komaki R, Liao ZX. Outcomes with esophageal cancer radiation therapy. J Thorac Oncol 4(7):880-8, 7/2009. e-Pub 5/2009. PMID: 19458557.
213. Yuan X, Liao Z, Liu Z, Wang LE, Tucker SL, Mao L, Wang XS, Martel M, Komaki R, Cox JD, Milas L, Wei Q. Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol 27(20):3370-8, 7/2009. e-Pub 4/2009. PMID: 19380441.
214. Chansky K, Sculier JP, Crowley JJ, Giroux D, Van Meerbeeck J, Goldstraw P. The international association for the study of lung cancer staging project: Prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol 4(7):792-801, 7/2009. PMID: 19458556.
215. Smith GL, Smith BD, Buchholz TA, Liao Z, Jeter M, Swisher SG, Hofstetter WL, Ajani JA, McAleer MF, Komaki R, Cox JD. Patterns of Care and Locoregional Treatment Outcomes in Older Esophageal Cancer Patients: The SEER-Medicare Cohort. Int J Radiat Oncol Biol Phys 74(2):482-9, 6/1/2009. e-Pub 3/14/2009. PMID: 19289262.
216. Jin H, Tucker SL, Liu HH, Wei X, Yom SS, Wang S, Komaki R, Chen Y, Martel MK, Mohan R, Cox JD, Liao Z. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol 91(3):427-32, 6/2009. e-Pub 10/18/2008. PMID: 18937989.
217. Bolton WD, Rice DC, Goodyear A, Correa AM, Erasmus J, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Superior sulcus tumors with vertebral body involvement: a multimodality approach. J Thorac Cardiovasc Surg 137(6):1379-87, 6/2009. PMID: 19464452.
218. Maru DM, Luthra R, Correa AM, White-Cross J, Anandasabapathy S, Krishnan S, Guha S, Komaki R, Swisher SG, Ajani JA, Hofstetter WL, Rashid A. Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival. Cancer 115(7):1576-85, 4/1/2009. PMID: 19156915.
219. Péchoux CL, Dunant A, Senan S, Wolfson A, Quoix E, Finn CF, Ciuleanu T, Arriagada R, Jones R, Wanders R, Lerouge D, Laplanche, A. Standard-dose versus higher-dose prophylactic cranial. Lancet 10(5):467-74, 4/2009.
220. Javeri H, Xiao L, Rohren E, Komaki R, Hofstetter W, Lee JH, Maru D, Bhutani MS, Swisher SG, Wang X, Ajani JA. Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation. Cancer 115(3):624-30, 2/1/2009. PMID: 19130466.
221. Rosenzweig KE, Movsas B, Bradley J, Gewanter RM, Gopal RS, Komaki R, Kong FM, Lee HK, Feins RH, Langer CJ. ACR appropriateness criteria on nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent. J Am Coll Radiol 6(2):85-95, 2/2009. PMID: 19179235.
222. Gayed IW, Liu HH, Wei X, Liao Z, Yusuf SW, Chang JY, Bassett R, Komaki R. Patterns of cardiac perfusion abnormalities after chemoradiotherapy in patients with lung cancer. J Thorac Oncol 4(2):179-84, 2/2009. PMID: 19179893.
223. Britton KR, Starkschall G, Liu H, Chang JY, Bilton S, Ezhil M, John-Baptiste S, Kantor M, Cox JD, Komaki R, Mohan R. Consequences of anatomic changes and respiratory motion on radiation dose distributions in conformal radiotherapy for locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 73(1):94-102, 1/1/2009. e-Pub 10/17/2008. PMID: 18929448.
224. Zinner RG, Komaki R, Cox JD, Glisson BS, Pisters KM, Herbst RS, Kies M, Liao Z, Hong WK, Fossella FV. Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: A phase I trial in patients with stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 73(1):119-27, 1/1/2009. e-Pub 6/14/2008. PMID: 18556142.
225. Cen P, Correa AM, Lee JH, Le JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA, Vaporciyan A, Ajani JA. Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation. Dis Esophagus 22(1):32-41, 2009. e-Pub 11/19/2008. PMID: 19021684.
226. Sulman EP, Komaki R, Klopp AH, Cox JD, Chang JY. Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer. Radiat Oncol 4(1):5, 2009. PMCID: PMC2651897.
227. McDonald JM, Pelloski CE, Ledoux A, Sun M, Raso G, Komaki R, Wistuba II, Bekele BN, Aldape K. Elevated phospho-S6 expression is associated with metastasis in adenocarcinoma of the lung. Clin Cancer Res 14(23):7832-7, 12/1/2008. PMCID: PMC2614348.
228. Sarna L, Swann S, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Byhardt R, Wasserman T, Movsas B. Clinically Meaningful Differences in Patient-Reported Outcomes With Amifostine in Combination With Chemoradiation for Locally Advanced Non-Small-Cell Lung Cancer: An Analysis of RTOG 9801. Int J Radiat Oncol Biol Phys 75(5):1378-84, 12/2008. PMID: 18501528.
229. Rice D, Swisher S, Pisters K, Fossella F, Herbst R, Hofstetter W, Kies M, Komaki R, Lippman S, Mehran R, Roth J, Stewart D, Vaporciyan A, Walsh G, Cox J. Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)". Chest 134(6):1349; author reply 1350, 12/2008. PMID: 19059972.
230. Zhang X, Zhao KL, Guerrero TM, McGuire SE, Yarmko B, Komaki R, Cox J, Hui Z, Li Y, Newhauser WD, Mohan R, Liao Z. Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophagel cancer. Int J Radiat Oncol Bilo Phys 72(1):278-87, 9/2008. PMID: 18722278.
231. Wang H, Garden AS, Zhang L, Wei X, Ahamad A, Kuban DA, Komaki R, O'Daniel J, Zhang Y, Mohan R, Dong L. Performance evaluation of automatic anatomy segmentation algorithm on repeat or four-dimensional computed tomography images using deformable image registration method. Int J Radiat Oncol Biol Phys 72(1):210-9, 9/2008. PMID: 18722272.
232. Gayed IW, Chang J, Kim EE, Nunez R, Chaen B, Liu HH, Kobayashi K, Zhang Y, Liao Z, Gohar S, Jeter M, Henderson L, Erwin W, Komaki R. Lung perfusion imaging can risk stratify lung cancer patients for the development of pulmonary complications after chemoradiation. J Thorac Oncol 3(8):858-64, 8/2008. PMID: 18670303.
233. Maru DM, Khurana H, Rashid A, Correa MA, Anandasabapathy S, Krishnan S, Komaki R, Ajani JA, Swisher SG, Hofstetter WL. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol 32(9):1404-11, 8/2008. PMID: 18670347.
234. Ajani JA, Winter K, Komaki R, Kelsen DP, Minsky BD Liao Z, Bradley J, Fromm M, Hornback D, Willett CF. Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus RTOG 0113. J Clin Oncol Epub ahead of print, 6/2008. PMID: 18574157.
235. Ogo E, Komaki R, Fujimoto K, Uchida M, Abe T, Nakamura K , Mitsumori M, Kenji Sekiguchi K , Kaneyasu Y, Hayabuchi N. Lung lesions beyond the radiation field after tangential breast radiation - Radiation induced bronchiolitis obliterans organizing pneumonia (BOOP) syndrome after breast conserving therap. International Journal of Radiation Oncology and Physics 71(1):123-31, 5/2008.
236. Tetzlaff ED, Correa A, Komaki R, Swisher SG, Maru D, Ross W, Ajani JA. The Significance of Thromboembolic Phenomena Occurring Before and During Chemoradiotherapy for Localized Carcinoma of the Esophagus and Gastroesophageal Junction. Dis Esophagus 21(7):575-81, 5/2008.
237. Hui Z, Zhang X, Starkschall G, Li Y, Mohan R, Komaki R, Cox J, Chang J. Effects of Interfractional Motion and Anatomic Changes on Proton Therapy Dose Distribution in Lung Cancer. Int. J. Radiation Oncology Biol. Phys 72(5):1385-1395, 3/2008.
238. Ettinger DS, Akerley W, Bepler G, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Feigenberg SJ, Figlin RA, Govindan R, Grannis FW Jr, Jahan T, Jahanzeb M, Kessinger A, Komaki R, Kris MG, Langer CJ, Le QT, Martins R, Otterson GA, Patel JD, Robert F, Sugarbaker DJ, Wood DE. Non-small cell lung cancer. J Natl Compr Canc Netw 6(3):228-69, 3/2008. PMID: 18377844.
239. Grosshans DR, Meyers CA, Allen PK, Davenport SD, Komaki R. Neurocognitive function in patients with small cell lung cancer : effect of prophylactic cranial irradiation. Cancer 112:589-595, 2/2008.
240. Ogo E, Komaki R, Fujimoto K, Uchida M, Abe T, Nakamura K, Mitsumori M, Sekiguchi K, Kaneyasu Y, Hayabuchi N. A survey of radiation-induced bronchiolitis obliterans organizing pneumonia syndrome after breast-conserving therapy in Japan. International Journal of Radiation Oncology Biology and Physics 71:123-131, 2008.
241. Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu C, Ajani JA, Phan A, Swisher SG, Mohan R, Cox JD, Komaki R. Association between systemic chemotherapy before chemoradiation and increased risk of treatment-related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy. Journal of Thoracic Oncology 3(3):277-282, 2008.
242. Yaremko BP, Guerrero TM, McAleer MF, Bucci MK, Noyola-Martinez J, Nguyen LT, Balter PA, Guerra R, Komaki R, Liao Z. Determination of respiratory motion for distal esophagus cancer using four-dimensional computed tomography. International Journal of Radiation Oncology Biology and Physics 70:145-153, 2008.
243. Chang JY, Dong L, Liu H, Starkschall G, Balter P, Mohan R, Liao Z, Cox JD, Komaki R. Image-guided radiation therapy for non-small cell lung cancer. Journal of Thoracic Oncology 3(2):177-186, 2008.
244. Bruzzi JF, Komaki R, Walsh GL, Truong MT, Gladish GW, Munden RF, Erasmus JJ. Imaging of non-small cell lung cancer of the superior sulcus: part 1: anatomy, clinical manifestations, and management. Radiographics 28:551-560, 2008.
245. Bruzzi JF, Komaki R, Walsh GL, Truong MT, Gladish GW, Munden RF, Erasmus JJ. Imaging of non-small cell lung cancer of the superior sulcus: part 2: initial staging and assessment of resectability and therapeutic response. Radiographics 28:561-572, 2008.
246. Kased N, Erasmus JJ, Komaki R, Cox JD. Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: a brief review. Journal of Thoracic Oncology 3:534-538, 2008.
247. Cox JD, Sejpal S, Komaki R, Chang JY, McAleer MF, Liao Z, Tsao A, Kim ES, Wei X, Allen PK. Proton therapy with concurrent chemotherapy can reduce toxicity and allow higher radiation doses in advanced non-small cell lung cancer. J Thorac Oncol 3(Suppl 4):S303-S304, 2008.
248. Wei X, Liu H, Komaki R. Risk Factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive. Int J Radiat Oncol Biol Phys 70(3):707-714, 2008.
249. Zhang X, Komaki R, Wang L, Fang B, Chang JY. Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. Clinical Cancer Research 14:2813-2823, 2008.
250. Ezhil M, Starkschall G, Mohan R, Cox J, Komaki R. Validation of a model-based segmentation approach to propagating normal anatomic regions of interest through the 10 phases of respiration. Int J Radiat Oncol Biol Phys 71:900-906, 2008.
251. Fukui H, Komaki R, Okui M, Toyoshima K, Kuda K. The effects of odor on cortisol and testosterone in healthy adults. Neuro Endocrinol Lett 28(4):433-7, 8/2007. PMID: 17693981.
252. Liu HH, Balter P, Tutt T, Choi B, Zhang J, Wang C, Chi M, Luo D, Pan T, Hunjan S, Starkschall G, Rosen I, Prado K, Liao Z, Chang J, Komaki R, Cox JD, Mohan R, Dong L. Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys 68:531-40, 6/2007.
253. Yaremko BP, Guerrero TM, Noyola-Martinez J, Guerra R, Lege DG, Nguyen LT, Balter PA, Cox JD, Komaki R. Reduction of Normal Lung Irradiation in Locally Advanced Non-small cell lung cancer patients using ventilation images for functional avoidance. Int J Radiat Oncol Bol Phys 68:562-71, 6/2007.
254. Mell LK, Malik R, Komaki R, Movsas B, Swann RS, Langer C, Antonadou D, Koukourakis M, Mundt AJ. Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: A meta-analysis. Int J Radiat Oncol Biol Phys 68:111-8, 5/2007. PMID: 17289291.
255. Yom SS, Liao Z, Liu HH, Tucker SL, Hu CS, Wei X, Wang X, Wang S, Mohan R, Cox JD, Komaki R. Initial Evaluation of Treatment-Related Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemotherapy and Intensity-Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 68:94-102, 5/2007.
256. Podoloff DA, Advani RH, Allred C, Benson AB 3rd, Brown E, Burstein HJ, Carlson RW, Coleman RE, Czuczman MS, Delbeke D, Edge SB, Ettinger DS, Grannis FW Jr, Hillner BE, Hoffman JM, Kiel K, Komaki R, Larson SM, Mankoff DA, Rosenzweig KE, Skibber JM, Yahalom J, Yu JM, Zelenetz AD. NCCN Task Force Report: Positron Emission Tomography (PET)/Computed Tomography (CT) Scanning in Cancer. J Natl Compr Canc Netw Suppl 1:S1-S22, 5/2007.
257. Kang Y, Zhang X, Chang JY, Wang H, Wei X, Liao Z, Komaki R, Cox JD, Balter PA, Liu H, Zhu XR, Mohan R, Dong L. 4D Proton treatment planning strategy for mobile lung tumors. Int J Radiat Oncol Biol Phys 67:906-14, 3/2007. PMID: 17293240.
258. Itasaka S, Komaki R, Herbst RS, Shibuya K, Shintani T, Hunter NR, Onn A, Bucana CD, Milas L, Ang KK, O'Reilly M S. Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice. Int J Radiat Oncol Biol Phys 67:870-8, 3/2007. PMID: 17293237.
259. Guerrero T, Castillo R, Noyola-Martinez J, Torres M, Zhou X, Guerra R, Cody D, Komaki R, Travis E. Reduction of pulmonary compliance found with high-resolution computed tomography in irradiated mice. Int J Radiat Oncol Biol Phys 67:879-87, 3/2007. PMID: 17293238.
260. Gao XS, Qiao X, Wu F, Cao L, Meng X, Dong Z, Wang X, Gao G, Wu TT, Komaki R, Chang JY. Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma. Int J Radiat Oncol Biol Phys 67:389-96, 2/2007. PMID: 17236963.
261. Wu W, Onn A, Isobe T, Itasaka S, Langley RR, Shitani T, Shibuya K, Komaki R, Ryan AJ, Fidler IJ, Herbst RS, O'Reilly MS. Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade. Mol Cancer Ther 6:471-83, 2/2007. PMID: 17308046.
262. Britton KR, Starkschall G, Tucker SL, Pan T, Nelson C, Chang, JY, Cox JD, Mohan R, Komaki R. Assessment of gross tumor volume regression and motion changes during radiation therapy for non-small-cell lung cancer as measured by four-dimensional computed tomography. Int J Radiat Oncol Biol Phys 68:1036-1046, 2007.
263. Yendamuri S, Komaki R, Blackmon S, Correa A, Wynn B, Allen P, Hofstetter W, Rice, Roth J, Swisher S, Vapociyan AA, Walsh GL Mehran RJ. Comparison of Limited Surgery and Three-Dimetional Conformal Radiation in High-Risk Patients with Stage I Non-Small Cell Lung Cancer. Journal of Thoracic Oncology 2(11):1022-8, 2007.
264. Huang EH, Liao Z, Cox JD, Guerrero TM, Chang JY, Jeter M, Borghero Y, Wei X, Fossella F, Herbst RS, Blumenschein GR, Moran C, Allen PK, Komaki R. Comparison of Outcomes for Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer Treated with Induction Chemotherapy Followed by Concurrent Chemoradiation versus Concurrent Chemoradiation Alone. International Journal of Radiation Oncology Biology and Physics 68:779-786, 2007.
265. Bruzzi JF, Swisher SG, Truong MT, Munden RF, Hofstetter WL, Macapinlac HA, Correa AM, Mawlawi O, Ajani JA, Komaki R, Fukami N, Erasmus JJ. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy. Cancer 109:125-34, 2007.
266. Rice DC, Smythe WR, Liao Z, Guerrero T, Chang JY, McAleer MF, Jeter MD, Correa A, Vaporciyan AA, Liu HH, Komaki R, Forster KM, Stevens CW. Dose-Dependent Pulmonary Toxicity After Postoperative Intensity-Modulated Radiotherapy for Malignant Pleural Mesothelioma. Int J Radiat Oncol Biol Phys 69:350-357, 2007.
267. Zhao KL, Liao Z, Bucci MK, Komaki R, Cox JD, Yu ZH, Zhang L, Mohan R, Dong L. Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction. Radiotherapy and Oncology 84:283-289, 2007.
268. Rohatgi PR, Correa AM, Swisher SG, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Lee JH, Rice DC, Roth JA, Ajani JA. Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcome. Dis Esophagus 19:152-7, 2007. PMID: 16722991.
269. Klopp AH, Chang JY, Tucker SL, Sulman EP, Balter PA, Liu HH, Bucci MK, Macapinlac HA, Komaki R, Cox JD. Intrathoracic Patterns of Failure for Non-Small Cell Lung Cancer with Positron Emission Tomography/ Computed Tomgraphy-Difined Target Delineation. International Journal of Radiation Oncology Biology and Physics 69(5):1409-1416, 2007.
270. Shioyama Y, Jang SY, Liu HH, Guerrero T, Wang X, Gayed IW, Erwin WD, Liao Z, Chang JY, Jeter M, Yaremko BP, Borghero YO, Cox JD, Komaki R, Mohan R. Preserving Functional Lung Using Perfusion Imaging and Intensity-Modulated Radiation Therapy for Advanced-Stage Non-Small-Cell Lung Cancer. Intl J Rad Oncol Biol Phys 68(5):1349-58, 2007.
271. Hofstetter WL, Correa AM, Ajani JA, Phan A, Komaki R, Liao Z, Wu T-T, Blackmon S, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Proposed Modification of Nodal Status in AJCC esophageal cancer staging system. Annuals of Thoracic Surgery 84:365-375, 2007.
272. Rice DC, Smyth RW, Liao Z, Guerrero T, Chang, JY, McAleer MF, Jeter MD, Correa A, Vaporcian AA, Lio HH, Komaki R, Forsater KM, Stevens CW. Pulmonary Toxicity Following Postoperative Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma. International Journal of Radiation Oncology Biology and Physics 69:350-357, 2007.
273. Guerrero T, Johnson V, Hart J, Pan T, Khan M, Luo D, Liao Z, Ajani J, Stevens C, Komaki R. Radiation pneumonitis: Local dose versus [(18)F]-fluorodeoxyglucose uptake response in irradiated lung. Int J Radiat Oncol Biol Phys 68:1030-1035, 2007.
274. Liao Z, Cox JD, Komaki R. Radiochemotherapy of Esophageal Cancer. J Thor Oncol 2:553-568, 2007.
275. Shibuya K, Komaki R, Shintani T, Itasaka S, Ryan A, Jurgensmeier JM ,Milas L, Ang KK, Herbst RS, O’Reilly MS. Targeted therapy against VEGFR and EGFR with ZD 6474 enhances the therapeutic efficacy of irradiation in orthotopic model of human non-small lung cancer. International Journal of Radiation Oncology Biology and Physics 69:1534-1543, 2007.
276. Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu CS, Mohan R, Cox JD, Komaki R. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 66:1399-407, 12/2006.
277. Komaki R, Liao Z, Liu H, Tucker S, Rice D. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma: in regard to Allen et al. (Int J Radiat Oncol Biol Phys 2006;65:640-645). Int J Radiat Oncol Biol Phys 66:1595-6; author reply 1596, 12/2006. PMID: 17126220.
278. Erasmus JJ, Munden RF, Truong MT, Ho JJ, Hofstetter WL, Macapinlac HA, Correa AM, Wu T, Bruzzi JF, Marom EM, Sabloff BS, Ajani JA, Komaki R, Liao Z, Lee JH, Fukami N, Bresalier R, Swisher S. Pre-Operative Chemoradiation –Induced Ulceration in Patients with Esophageal Cancer: A Confounding Factor in Tumor Response Assessment in Integrated CT-PET Imaging. J Thor Oncol 1:478-486, 12/2006.
279. Tucker SL, Liu HH, Wang S, Wei X, Liao Z, Komaki R, Cox JD, Mohan R. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 66:754-61, 11/2006. PMID: 16965865.
280. Klopp AH, Eapen GA, Komaki R. Endobronchial brachytherapy: an effective option for palliation of malignant bronchial obstruction. Clin Lung Cancer 8:203-7, 11/2006. PMID: 17239296.
281. Sims-Mourtada J, Izzo JG, Apisarnthanarax S, Wu TT, Malhotra U, Luthra R, Liao Z, Komaki R, van der Kogel A, Ajani J, Chao KS. Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response. Clin Cancer Res 12:6565-72, 11/2006. PMID: 17085672.
282. Gayed IW, Liu HH, Yusuf SW, Komaki R, Wei X, Wang X, Chang JY, Swafford J, Broemeling L, Liao Z. The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer. J Nucl Med 47:1756-62, 11/2006. PMID: 17079807.
283. Wang KL, Yang Q, Cleary KR, Swisher SG, Correa AM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT. The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation. Cancer 107:1467-74, 10/2006. PMID: 16955509.
284. Fang LC, Komaki R, Allen P, Guerrero T, Mohan R, Cox JD. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 66:108-16, 9/2006. PMID: 16904517.
285. Wang S, Liao Z, Liu H, Chen Y, Ajani J, Swisher S, Cox JD, Komaki R. Intensity-modulated radiotherapy (IMRT) with concurrent chemotherapy is an innovative treatment modality for locally advanced cervical and upper thoracic esophageal cancer. World J Gastroenterol 34:5501-8, 9/2006.
286. Wang XS, Fairclough DL, Liao Z, Komaki R, Chang JY, Mobley GM, Cleeland CS. Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol 24(27):4485-91, 9/2006. PMID: 16983118.
287. Wei X, Liu HH, Tucker SL, Liao Z, Hu C, Mohan R, Cox JD, Komaki R. Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66:100-7, 9/2006. PMID: 16839700.
288. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki R, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Wu TT, Swisher SG. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma. Cancer 107:967-74, 9/2006. PMID: 16874819.
289. Lee JJ, Bekele BN, Zhou X, Cantor SB, Komaki R, Lee JS. Decision analysis for prophylactic cranial irradiation for patients with small-cell lung cancer. J Clin Oncol 24:3597-603, 8/2006. PMID: 16877726.
290. Ettinger DS, Bepler G, Bueno R, Chang A, Chang JY, Chirieac LR, D'Amico TA, Demmy TL, Feigenberg SJ, Grannis FW, Jr, Jahan T, Jahanzeb M, Kessinger A, Komaki R, Kris MG, Langer CJ, Le QT, Martins R, Otterson GA, Robert F, Sugarbaker DJ, Wood DE. Non-small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw 4:548-82, 7/2006. PMID: 16813724.
291. Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, Mohan R, Komaki R, Cox JD. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 65:1087-96, 7/2006. PMID: 16682145.
292. Chang JY, Moughan J, Johnstone DW, Komaki R, Goldberg M, Langer CJ, Beadle BM, Owen J, Movsas B. Surgical patterns of care in operable lung carcinoma treated with radiation. J Thorac Oncol 1(6):526-31, 7/2006. PMID: 17409912.
293. Erasmus JJ, Munden RF, Truong MT, Ho JJ, Hofstetter WL, Macapinlac HA, Correa AM, Wu TT, Bruzzi JF, Marom EM, Sabloff BS, Ajani JA, Komaki R, Liao Z, Lee JH, Fukami N, Bresalier R, Swisher SG. Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographis-positron emission tomographic imaging. J Thorac Onocl 1(5):478-86, 6/2006. PMID: 17409902.
294. Hu C, Chang EL, Hassenbusch SJ, 3rd, Allen PK, Woo SY, Mahajan A, Komaki R, Liao Z. Non small cell lung cancer presenting with synchronous solitary brain metastasis. Cancer 106(9):1998-2004, 5/2006. PMID: 16572401.
295. Chang JY, Zhang X, Komaki R, Cheung R, Fang B. Tumor-specific apoptotic gene targeting overcomes radiation resistance in esophageal adenocarcinoma. Int J Radiat Oncol Biol Phys 64(5):1482-94, 4/2006. PMID: 16580499.
296. Wang S, Liao Z, Chen Y, Chang JY, Jeter M, Guerrero T, Ajani J, Phan A, Swisher S, Allen P, Cox JD, Komaki R. Esophageal Cancer Located at the Neck and Upper Thorax Treated with Concurrent Chemoradiation: A Single-Institution Experience. J Thor Oncol 1:252-259, 3/2006.
297. Wang SL, Liao Z, Vaporciyan AA, Tucker SL, Liu H, Wei X, Swisher S, Ajani JA, Cox JD, Komaki R. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 64(3):692-9, 3/2006. PMID: 16242257.
298. Guerrero T, Castillo R, Sanders K, Price R, Komaki R, Cody D. Novel method to calculate pulmonary compliance images in rodents from computed tomography acquired at constant pressures. Phys Med Biol 51(5):1101-12, 3/2006. PMID: 16481680.
299. Liao Z, Liu H, Swisher SG, Wang L, Wu TT, Correa AM, Roth JA, Cox JD, Komaki R, Ajani JA, Wei Q. Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 64(3):700-8, 3/2006. PMID: 16242255.
300. Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, Liao Z, Komaki R, Rashid A, Hamilton SR, Wu TT. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 106(5):1017-25, 3/2006. PMID: 16456809.
301. Guerrero T, Sanders K, Castillo E, Zhang Y, Bidaut L, Pan T, Komaki R. Dynamic ventilation imaging from four-dimensional computed tomography. Phys Med Biol 51(4):777-91, 2/2006. PMID: 16467578.
302. Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Rice DC, Bresalier RS, Roth JA, Ajani JA. Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy. Cancer 106(3):552-8, 2/2006. PMID: 16353210.
303. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki R, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg 131(1):65-72, 2006. PMID: 16399296.
304. Wang S, Bruzzi J, Rodriguez-Garza VP, Komaki R. Lambert-eaton myasthenic syndrome in a patient with small-cell lung cancer. Clin Lung Cancer 7(4):282-4, 2006. PMID: 16512985.
305. Rohatgi P, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Rice DC, Roth JA, Ajani JA. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer 104:2365-72, 12/2005. PMID: 16245310.
306. Chandra A, Guerrero TM, Liu HH, Tucker SL, Liao Z, Wang X, Murshed H, Bonnen MD, Garg AK, Stevens CW, Chang JY, Jeter MD, Mohan R, Cox JD, Komaki R. Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiother Oncol 77(3):247-53, 12/2005. PMID: 16298001.
307. Martin LW, Correa AM, Hofstetter W, Hong WK, Komaki R, Putnam JB, Jr, Rice DC, Smythe WR, Swisher SG, Vaporciyan AA, Walsh GL, Roth JA. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution. J Thorac Cardiovasc Surg 130(6):1601-10, 12/2005. PMID: 16308005.
308. Machtay M, Hsu C, Komaki R, Sause WT, Swann RS, Langer CJ, Byhardt RW, Curran WJ. Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience. Int J Radiat Oncol Biol Phys 63:667-71, 11/2005. PMID: 15927409.
309. Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh G, Vaporciyan A, Lynch PM, Rice DC, Roth JA, Ajani JA. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 104(7):1349-55, 10/2005. PMID: 16130133.
310. Hong D, Lunagomez S, Kim EE, Lee JH, Bresalier RS, Swisher SG, Wu TT, Morris J, Liao Z, Komaki R, Ajani JA. Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma. Cancer 104(8):1620-6, 10/2005. PMID: 16118804.
311. Komaki R. What should the optimal timing be for amifostine administration relative to radiation and chemotherapy? J Clin Oncol 23(28):7232-3; author reply 7233-5, 10/2005. PMID: 16192612.
312. Zhang X, Cheung RM, Komaki R, Fang B, Chang JY. Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer. Clin Cancer Res 11(18):6657-68, 9/2005. PMID: 16166445.
313. Chang JY, Liu HH, Komaki R. Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancer. Curr Oncol Rep 7(4):255-9, 7/2005. PMID: 15946583.
314. Guerrero T, Sanders K, Noyola-Martinez J, Castillo E, Zhang Y, Tapia R, Guerra R, Borghero Y, Komaki R. Quantification of regional ventilation from treatment planning CT. Int J Radiat Oncol Biol Phys 62(3):630-4, 7/2005. PMID: 15936537.
315. Komaki R, Swann RS, Ettinger DS, Glisson BS, Sandler AB, Movsas B, Suh J, Byhardt RW. Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12. Int J Radiat Oncol Biol Phys 62(2):342-50, 6/2005. PMID: 15890573.
316. Wakelee HA, Stephenson P, Keller SM, Wagner H, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH. Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590. Lung Cancer 48(3):389-97, 6/2005. PMID: 15893008.
317. Liao Z, Komaki R, Milas L, Yuan C, Kies M, Chang JY, Jeter M, Guerrero T, Blumenschien G, Smith CM, Fossella F, Brown B, Cox JD. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer. Clin Cancer Res 11(9):3342-8, 5/2005. PMID: 15867233.
318. Agarwal B, Swisher SG, Ajani J, Kelly K, Komaki R, Abu-Hamda E, Correa AM, Roth JA. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux. Ann Thorac Surg 79(5):1716-23, 5/2005. PMID: 15854962.
319. Bradley JD, Paulus R, Graham MV, Ettinger DS, Johnstone DW, Pilepich MV, Machtay M, Komaki R, Atkins J, Curran WJ. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705. J Clin Oncol 23(15):3480-3487, 5/2005. PMID: 15908657.
320. Swisher SG, Hofstetter W, Wu TT, Correa AM, Ajani JA, Komaki R, Chirieac L, Hunt KK, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 241(5):810-7; discussion 817-20, 5/2005. PMID: 15849517.
321. Chang JY, Komaki R, Sasaki R, Liao Z, Stevens CW, Lu C, Fossella FV, Allen PK, Cox JD, Spitz MR, Wu X. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy. Clin Cancer Res 11(8):2894-8, 4/2005. PMID: 15837739.
322. Komaki R, Chang JY, Wu X, Allen PK, Milas L, Liao Z, Fossella FV, Travis E, Spitz MR. Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy. Seminars in Oncology 32(Suppl 3):S92-S98, 4/2005. PMID: 16015542.
323. Langer CJ, Moughan J, Movsas B, Komaki R, Ettinger D, Owen J, Wilson JF. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature? Lung Cancer 48(1):93-102, 4/2005. PMID: 15777975.
324. Chirieac LR, Swisher SG, Ajani JA, Komaki RR, Correa AM, Morris JS, Roth JA, Rashid A, Hamilton SR, Wu TT. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer 103(7):1347-55, 4/2005. PMID: 15719440.
325. Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Sarna L, Wasserman T, Byhardt R. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. J Clin Oncol 23(10):2145-54, 4/2005. PMID: 15800308.
326. Zhang Z, Liao Z, Jin J, Ajani J, Chang JY, Jeter M, Guerrero T, Stevens CW, Swisher S, Ho L, Yao J, Allen P, Cox JD, Komaki R. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 61(3):656-64, 3/2005. PMID: 15708243.
327. Chirieac LR, Swisher SG, Correa AM, Ajani JA, Komaki R, Rashid A, Hamilton SR, Wu TT. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma. Clin Cancer Res 11(6):2229-36, 3/2005. PMID: 15788671.
328. Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, Putnam JB, Herbst RS, Moran CA, Podoloff DA, Roth JA, Cox JD. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol 23(6):1136-43, 2/2005. PMID: 15718309.
329. Rice DC, Correa AM, Vaporciyan AA, Sodhi N, Smythe WR, Swisher SG, Walsh GL, Putnam JB, Jr, Komaki R, Ajani JA, Roth JA. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity. Ann Thorac Surg 79(2):391-7; discussionn 391-7, 2/2005. PMID: 15680801.
330. Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61(2):318-28, 2/2005. PMID: 15667949.
331. Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Jr, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys 60(5):1484-93, 12/2004. PMID: 15590179.
332. Koch N, Liu HH, Starkschall G, Jacobson M, Forster K, Liao Z, Komaki R, Stevens CW. Evaluation of internal lung motion for respiratory-gated radiotherapy using MRI: Part I--correlating internal lung motion with skin fiducial motion. Int J Radiat Oncol Biol Phys 60(5):1459-72, 12/2004. PMID: 15590177.
333. Liu HH, Koch N, Starkschall G, Jacobson M, Forster K, Liao Z, Komaki R, Stevens CW. Evaluation of internal lung motion for respiratory-gated radiotherapy using MRI: Part II-margin reduction of internal target volume. Int J Radiat Oncol Biol Phys 60(5):1473-83, 12/2004. PMID: 15590178.
334. Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki R, Hong D, Lee HK, Putnam JB, Jr, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 101(8):1776-85, 10/2004. PMID: 15386332.
335. Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 60(2):427-36, 10/2004. PMID: 15380576.
336. Arriagada R, Komaki R, Cox JD. Radiation dose escalation in non-small cell carcinoma of the lung. Semin Radiat Oncol 14(4):287-91, 10/2004. PMID: 15558502.
337. Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, Komaki R, Macapinlac H, Munden RF, Putnam JB, Rice D, Smythe WR, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78(4):1152-60; discussion 1152-60, 10/2004. PMID: 15464463.
338. Agarwal B, Swisher S, Ajani J, Kelly K, Fanning C, Komaki RR, Putnam JB, Jr, Abu-Hamda E, Molke KL, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol 99(7):1258-66, 7/2004. PMID: 15233663.
339. Keller SM, Vangel MG, Wagner H, Schiller JH, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. J Thorac Cardiovasc Surg 128(1):130-7, 7/2004. PMID: 15224032.
340. Kim ES, Putnam JB, Komaki R, Walsh GL, Ro JY, Shin HJ, Truong M, Moon H, Swisher SG, Fossella FV, Khuri FR, Hong WK, Shin DM. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 44(3):369-79, 6/2004. PMID: 15140551.
341. Ajani JA, Walsh G, Komaki R, Morris J, Swisher SG, Putnam JB, Jr, Lynch PM, Wu TT, Smythe R, Vaporciyan A, Faust J, Cohen DS, Nivers R, Roth JA. Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer 100(11):2347-54, 6/2004. PMID: 15160337.
342. Andratschke NH, Dittmann KH, Mason KA, Fan Z, Liao Z, Komaki R, Ang KK, Milas L. Epidermal growth factor receptor as a target to improve treatment of lung cancer. Clin Lung Cancer 5(6):340-52, 5/2004. PMID: 15217533.
343. Komaki R, Lee JS, Milas L, Lee HK, Fossella FV, Herbst RS, Allen PK, Liao Z, Stevens CW, Lu C, Zinner RG, Papadimitrakopoulou VA, Kies MS, Blumenschein GR, Jr, Pisters KM, Glisson BS, Kurie J, Kaplan B, Garza VP, Mooring D, Tucker SL, Cox JD. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial. Int J Radiat Oncol Biol Phys 58(5):1369-77, 4/2004. PMID: 15050312.
344. Murshed H, Liu HH, Liao Z, Barker JL, Wang X, Tucker SL, Chandra A, Guerrero T, Stevens C, Chang JY, Jeter M, Cox JD, Komaki R, Mohan R. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58(4):1258-67, 3/2004. PMID: 15001271.
345. Liu HH, Wang X, Dong L, Wu Q, Liao Z, Stevens CW, Guerrero TM, Komaki R, Cox JD, Mohan R. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58(4):1268-79, 3/2004. PMID: 15001272.
346. Komaki R, Liao Z, Milas L. Improvement strategies for molecular targeting: Cyclooxygenase-2 inhibitors as radiosensitizers for non-small cell lung cancer. Semin Oncol 31(1 Suppl 1):47-53, 2/2004. PMID: 14981580.
347. Butler LE, Forster KM, Stevens CW, Bloch C, Liu HH, Tucker SL, Komaki R, Liao Z, Starkschall G. Dosimetric benefits of respiratory gating: a preliminary study. J Appl Clin Med Phys 5(1):16-24, 2004. PMID: 15753930.
348. Taylor NA, Liao ZX, Cox JD, Stevens C, Roth J, Walsh G, Chang JY, Guerrero T, Jeter M, Putnam J, Jr, Fossella FV, Allen P, Komaki R. Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection. Int J Radiat Oncol Biol Phys 58(1):204-12, 2004. PMID: 14697440.
349. Brooks C, Starkschall G, Famiglietti R, Cox J, Frank S, Komaki R, Liao Z, Stevens C, Forster K. Heterogeneous planning for homogeneous protocols. Med Dosim 29(2):80-4, 2004. PMID: 15191752.
350. Cox JD, Le Chevalier T, Arriagada R, Choy H, Curran WJ, Fukuoka M, Harper P, Komaki R, Le Pechoux C, Lievens Y, Rami-Porta R, Ready N, Sause W, Stuschke M, Thatcher N. Management of unresectable non-small cell carcinoma of the lung (NSCLC). Lung Cancer 42 Suppl 1:S15-6, 12/2003. PMID: 14708518.
351. Lee HK, Vaporciyan AA, Cox JD, Tucker SL, Putnam JB, Jr, Ajani JA, Liao Z, Swisher SG, Roth JA, Smythe WR, Walsh GL, Mohan R, Liu HH, Mooring D, Komaki R. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys 57(5):1317-22, 12/2003. PMID: 14630268.
352. Movsas B, Moughan J, Komaki R, Choy H, Byhardt R, Langer C, Goldberg M, Graham M, Ettinger D, Johnstone D, Abrams R, Munden R, Starkschall G, Owen J. Radiotherapy patterns of care study in lung carcinoma. J Clin Oncol 21(24):4553-9, 12/2003. PMID: 14597743.
353. Ahamad A, Stevens CW, Smythe WR, Liao Z, Vaporciyan AA, Rice D, Walsh G, Guerrero T, Chang J, Bell B, Komaki R, Forster KM. Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest. Cancer J 9(6):476-84, 11/2003. PMID: 14740977.
354. Keller SM, Vangel MG, Wagner H, Schiller J, Herskovic A, Komaki R, Gray R, Marks RS, Perry MC, Livingston RB, Johnson DH. Second primary tumors following adjuvant therapy of resected stages II and IIIa non-small cell lung cancer. Lung Cancer 42(1):79-86, 10/2003. PMID: 14512191.
355. Ajani JA, Faust J, Yao J, Komaki R, Stevens C, Swisher S, Putnam JB, Vaporciyan A, Smythe R, Walsh G, Rice D, Roth J. Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancer. Oncology (Williston Park) 17(9 Suppl 8):20-2, 9/2003. PMID: 14569843.
356. Swisher SG, Ajani JA, Komaki R, Nesbitt JC, Correa AM, Cox JD, Lahoti S, Martin F, Putnam JB, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 57(1):120-7, 9/2003. PMID: 12909224.
357. Liao Z, Milas L, Komaki R, Stevens C, Cox JD. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer. Am J Clin Oncol 26(4):S85-91, 8/2003. PMID: 12902863.
358. Komaki R. Combined treatment for limited small cell lung cancer. Semin Oncol 30(4 Suppl 9):56-70, 8/2003. PMID: 12908137.
359. Frank SJ, Forster KM, Stevens CW, Cox JD, Komaki R, Liao Z, Tucker S, Wang X, Steadham RE, Brooks C, Starkschall G. Treatment planning for lung cancer: traditional homogeneous point-dose prescription compared with heterogeneity-corrected dose-volume prescription. Int J Radiat Oncol Biol Phys 56(5):1308-18, 8/2003. PMID: 12873675.
360. Johnson FM, Kurie JM, Peeples BO, Pisters KM, Fossella FV, Papadimitrakopoulou VA, Blumenschein GR, Komaki R, Glisson BS. Dose-dense therapy with a novel irinotecan regimen for small-cell lung cancer. Oncology (Williston Park) 17(7 Suppl 7):17-21, 7/2003. PMID: 12886869.
361. Johnson FM, Kurie JM, Peeples BO, Lee JJ, Feng L, Pisters KM, Fossella FV, Papadimitrakopoulou VA, Blumenschein GR, Komaki R, Glisson BS. Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer. Clin Lung Cancer 5(1):40-5, 7/2003. PMID: 14596703.
362. Taylor NA, Liao ZX, Stevens C, Walsh G, Roth J, Putnam J, Jr, Fossella F, Allen P, Cox JD, Komaki R. Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small-cell lung cancer treated with induction chemotherapy followed by surgery. Int J Radiat Oncol Biol Phys 56(3):616-25, 7/2003. PMID: 12788166.
363. Mehta MP, Rodrigus P, Terhaard CH, Rao A, Suh J, Roa W, Souhami L, Bezjak A, Leibenhaut M, Komaki R, Schultz C, Timmerman R, Curran W, Smith J, Phan SC, Miller RA, Renschler MF. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 21(13):2529-36, 7/2003. PMID: 12829672.
364. Lu C, Komaki R, Lee JS, Shin DM, Palmer JL, Coldman BJ, Pisters KM, Kurie JM, Fossella FV, Glisson BS. A phase I study of topotecan/paclitaxel alternating with etoposide/cisplatin and thoracic irradiation in patients with limited small cell lung cancer. Clin Cancer Res 9(6):2085-91, 6/2003. PMID: 12796372.
365. Gopal R, Starkschall G, Tucker SL, Cox JD, Liao Z, Hanus M, Kelly JF, Stevens CW, Komaki R. Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 56(1):114-20, 5/2003. PMID: 12694829.
366. Liao Z, Komaki R, Mason KA, Milas L. Role of cyclooxygenase-2 inhibitors in combination with radiation therapy in lung cancer. Clin Cancer Research 4(6):356-65, 5/2003. PMID: 14599301.
367. Gopal R, Tucker SL, Komaki R, Liao Z, Forster KM, Stevens C, Kelly JF, Starkschall G. The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys 56(1):106-13, 5/2003. PMID: 12694828.
368. Milas I, Komaki R, Hachiya T, Bubb RS, Ro JY, Langford L, Sawaya R, Putnam JB, Allen P, Cox JD, McDonnell TJ, Brock W, Hong WK, Roth JA, Milas L. Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases. Clin Cancer Res 9(3):1070-6, 3/2003. PMID: 12631609.
369. Ahamad A, Stevens CW, Smythe WR, Vaporciyan AA, Komaki R, Kelly JF, Liao Z, Starkschall G, Forster KM. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 55(3):768-75, 3/2003. PMID: 12573764.
370. Forster KM, Smythe WR, Starkschall G, Liao Z, Takanaka T, Kelly JF, Vaporciyan A, Ahamad A, Dong L, Salehpour M, Komaki R, Stevens CW. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. Int J Radiat Oncol Biol Phys 55(3):606-16, 3/2003. PMID: 12573747.
371. Swisher SG, Roth JA, Komaki R, Gu J, Lee JJ, Hicks M, Ro JY, Hong WK, Merritt JA, Ahrar K, Atkinson NE, Correa AM, Dolormente M, Dreiling L, El-Naggar AK, Fossella F, Francisco R, Glisson B, Grammer S, Herbst R, Huaringa A, Kemp B, Khuri FR, Kurie JM, Liao Z, McDonnell TJ, Morice R, Morello F, Munden R, Papadimitrakopoulou V, Pisters KM, Putnam JB, Jr, Sarabia AJ, Shelton T, Stevens C, Shin DM, Smythe WR, Vaporciyan AA, Walsh GL, Yin M. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clin Cancer Res 9(1):93-101, 2003. PMID: 12538456.
372. Kaplan B, Stevens CW, Allen P, Liao Z, Komaki R. Outcomes and patterns of failure in bronchial carcinoid tumors. Int J Radiat Oncol Biol Phys 55(1):125-31, 2003. PMID: 12504044.
373. Komaki R, Liao Z, Foster K, Lee H, Stevens C, Cox J. Target Definition and contouring in Carcinoma of the Lung and Esophagus. RAYS 28(3):225-236, 2003.
374. Grigsby P, Winter K, Komaki R, Marcial V, Eifel P, Doncals D, Stevens R, Rotman M, Gaffney D. Long-term follow-up of RTOG 88-05: twice-daily external irradiation with brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 54(1):51-7, 9/2002. PMID: 12182974.
375. Keller SM, Vangel MG, Adak S, Wagner H, Schiller JH, Herskovic A, Komaki R, Perry MC, Marks RS, Livingston RB, Johnson DH. The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer. Lung Cancer 37(3):303-9, 9/2002. PMID: 12234700.
376. Hofstetter W, Swisher SG, Correa AM, Hess K, Putnam JB, Jr, Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice DC, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Treatment outcomes of resected esophageal cancer. Ann Surg 236(3):376-84; discussion 384-5, 9/2002. PMID: 12192324.
377. Bubb RS, Komaki R, Hachiya T, Milas I, Ro JY, Langford L, Sawaya R, Putnam JB, Allen P, Cox JD, McDonnell TJ, Brock W, Hong WK, Roth JA, Milas L. Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion. Int J Radiat Oncol Biol Phys 53(5):1216-24, 8/2002. PMID: 12128123.
378. Komaki R, Seiferheld W, Ettinger D, Lee JS, Movsas B, Sause W. Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04. Int J Radiat Oncol Biol Phys 53(3):548-57, 7/2002. PMID: 12062596.
379. Liao Z, Komaki R, Stevens C, Kelly J, Fossella F, Lee JS, Allen P, Cox JD. Twice daily irradiation increases locoregional control in patients with medically inoperable or surgically unresectable stage II-IIIB non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 53(3):558-65, 7/2002. PMID: 12062597.
380. Bradley JD, Scott CB, Paris KJ, Demas WF, Machtay M, Komaki R, Movsas B, Rubin P, Sause WT. A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04). Int J Radiat Oncol Biol Phys 52(5):1173-9, 4/2002. PMID: 11955727.
381. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Kelsen DP. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20(5):1167-74, 3/2002. PMID: 11870157.
382. Lee JS, Scott CB, Komaki R, Ettinger DS, Sause WT. Impact of institutional experience on survival outcome of patients undergoing combined chemoradiation therapy for inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 52(2):362-70, 2/2002. PMID: 11872281.
383. Keller SM, Adak S, Wagner H, Herskovic A, Komaki R, Brooks BJ, Perry MC, Livingston RB, Johnson DH. A randomized trial of postoperative adjuvant therapy in patients with completely resected stages II and IIIA non-small cell lung cancer. . Am J Oncol Rev 1:39-46, 2002.
384. Swisher SG, Wynn P, Putnam JB, Mosheim MB, Correa AM, Komaki R, Ajani JA, Smythe WR, Vaporciyan AA, Roth JA, Walsh GL. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 123(1):175-83, 2002. PMID: 11782772.
385. Liebross RH, Starkschall G, Wong PF, Horton J, Gokaslan ZL, Komaki R. The effect of titanium stabilization rods on spinal cord radiation dose. Med Dosim 27(1):21-4, 2002. PMID: 12019961.
386. Rosen,, II, Fischer TA, Antolak JA, Starkschall G, Travis EL, Tucker SL, Hogstrom KR, Cox JD, Komaki R. Correlation between lung fibrosis and radiation therapy dose after concurrent radiation therapy and chemotherapy for limited small cell lung cancer. Radiology 221(3):614-22, 12/2001. PMID: 11719654.
387. Komaki R, Chasen MH, Travis WD, Putnam JB, Fossella FV, Byhardt RW, Ro JY. Oncodiagnosis panel: 1999. Cancer of the lung: oncodiagnosis. Radiographics 21(6):1573-96, 11/2001.
388. Stevens CW, Munden RF, Forster KM, Kelly JF, Liao Z, Starkschall G, Tucker S, Komaki R. Respiratory-driven lung tumor motion is independent of tumor size, tumor location, and pulmonary function. Int J Radiat Oncol Biol Phys 51(1):62-8, 9/2001. PMID: 11516852.
389. Roth JA, Grammer SF, Swisher SG, Komaki R, Nemunaitis J, Merritt J, Fujiwara T, Meyn RE, Jr. Gene therapy approaches for the management of non-small cell lung cancer. Semin Oncol 28(4 Suppl 14):50-6, 8/2001. PMID: 11605184.
390. Ajani JA, Komaki R, Putnam JB, Walsh G, Nesbitt J, Pisters PW, Lynch PM, Vaporciyan A, Smythe R, Lahoti S, Raijman I, Swisher S, Martin FD, Roth JA. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction. Cancer 92(2):279-86, 7/2001. PMID: 11466680.
391. Mason KA, Komaki R, Cox JD, Milas L. Biology-based combined-modality radiotherapy: workshop report. Int J Radiat Oncol Biol Phys 50(4):1079-89, 7/2001. PMID: 11429236.
392. Nag S, Kelly JF, Horton JL, Komaki R, Nori D. Brachytherapy for carcinoma of the lung. Oncology (Williston Park) 15(3):371-81, 3/2001. PMID: 11301833.
393. Schnirer,, II, Komaki R, Yao JC, Swisher S, Putnam J, Pisters PW, Roth JA, Ajani JA. Pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction. Am J Clin Oncol 24(1):91-5, 2/2001. PMID: 11232959.
394. Roth JA, Grammer SF, Swisher SG, Komaki R, Nemunaitis J, Merritt J, Meyn RE. P53 gene replacement for cancer--interactions with DNA damaging agents. Acta Oncol 40(6):739-44, 2001. PMID: 11765069.
395. Bynhardt R, Komaki R, Ettinger D, Johnstone D, Bradley J, Franko A, Gaspar L, Gillin M, Langer C, Layne E, Movsas B, Munden R, Sause W, Stern J, Hsu J, Hartsell W, Yesner R. Radiation Therapy Oncology Group. Research Plan 2002-2006. Lung Cancer Committee. Int J Radiat Oncol Biol Phys 51(3 Suppl 2):44-52, 2001. PMID: 11641014.
396. Okunieff P, Hammond E, Grignon D, Langer C, Pajak TF, Ang K, Bruner DW, Travis E, Greven K, Guha A, Moulder J, Pollack A, Scarantino C, Sneige N, Watson J, Amin M, Bondy M, Chakravarti A, Chapman JD, Dicker A, Harris J, Koch W, Komaki R, Lange C, McBride W, Mitchell J, Milas L, Movsas B, Pandya K, Pienta K, Regine W, Ritter M, Rubin P, Safran H, Sauter E, Schell M, Stevens C, Trotti A, Vikram B. Radiation Therapy Oncology Group. Research Plan 2002-2006. Translational Research Program. Int J Radiat Oncol Biol Phys 51(3 Suppl 2):75-87, 2001. PMID: 11641020.
397. Komaki R, Cox JD, Putnam Jr JB, Walsh G, Vaporcian A, Liao Z, Stevens C, Fossella FV, Lee JS, Hong WK, Roth J. The management of superior sulcus tumors. . J Jpn Soc Ther Radiol Onco 13(3):131-138, 2001.
398. Swisher SG, Pisters PW, Komaki R, Lahoti S, Ajani JA. Gastroesophageal junction adenocarcinoma. Curr Treat Options Oncol 1(5):387-98, 12/2000. PMID: 12057146.
399. Komaki R, Janjan NA, Ajani JA, Lynch PM, Fairweather JS, Raijman I, Blumenshein GR, Ho L, Pisters PW, Feig BW, Walsh GL, Pazdur R. Phase I study of irinotecan and concurrent radiation therapy for upper GI tumors. Oncology (Williston Park) 14(12 Suppl 14):34-7, 12/2000. PMID: 11200147.
400. Werner-Wasik M, Scott C, Cox JD, Sause WT, Byhardt RW, Asbell S, Russell A, Komaki R, Lee JS. Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival. Int J Radiat Oncol Biol Phys 48(5):1475-82, 12/2000. PMID: 11121651.
401. Yuen AR, Zou G, Turrisi AT, Sause W, Komaki R, Wagner H, Aisner SC, Livingston RB, Blum R, Johnson DH. Similar outcome of elderly patients in intergroup trial 0096: Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma. Cancer 89(9):1953-60, 11/2000. PMID: 11064352.
402. Keller SM, Adak S, Wagner H, Herskovic A, Komaki R, Brooks BJ, Perry MC, Livingston RB, Johnson DH. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med 343(17):1217-22, 10/2000. PMID: 11071672.
403. Kelly JF, Delclos ME, Morice RC, Huaringa A, Allen PK, Komaki R. High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: the 10-year M. D. Anderson cancer center experience. Int J Radiat Oncol Biol Phys 48(3):697-702, 10/2000. PMID: 11020566.
404. Komaki R, Roth JA, Walsh GL, Putnam JB, Vaporciyan A, Lee JS, Fossella FV, Chasen M, Delclos ME, Cox JD. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 48(2):347-54, 9/2000. PMID: 10974447.
405. Glisson B, Scott C, Komaki R, Movsas B, Wagner H. Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12. J Clin Oncol 18(16):2990-5, 8/2000. PMID: 10944132.
406. Sause WT, Byhardt RW, Curran WJ, Jr, Fuller D, Graham MV, Ko B, Komaki R, Weisenburger TH, Kaiser LR, Leibel SA, Brown RC. Follow-up of non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl:1363-72, 6/2000. PMID: 11037552.
407. Byhardt RW, Sause WT, Curran WJ, Jr, Fuller D, Graham MV, Ko B, Komaki R, Weisenburger TH, Kaiser LR, Leibel SA, Choi NC. Neoadjuvant therapy for marginally resectable (clinical N2), non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl:1331-45, 6/2000. PMID: 11037550.
408. Graham MV, Byhardt RW, Sause WT, Curran WJ, Jr, Fuller D, Ko B, Komaki R, Weisenburger TH, Kaiser LR, Leibel SA. Non-aggressive, non-surgical treatment of inoperable non-small cell lung cancer (NSCLC). American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl:1347-62, 6/2000. PMID: 11037551.
409. Komaki R, Sause WT, Byhardt RW, Curran WJ, Jr, Fuller D, Graham MV, Ko B, Weisenburger TH, Kaiser LR, Leibel SA, Choi NC. Non-small cell lung cancer, nonsurgical, aggressive therapy. American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl:1319-30, 6/2000. PMID: 11037549.
410. Weisenburger TH, Graham MV, Sause WT, Byhardt RW, Curran WJ, Jr, Fuller D, Ko B, Komaki R, Kaiser LR, Leibel SA. Postoperative radiotherapy in non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl:1295-318, 6/2000. PMID: 11037548.
411. Ko B, Sause WT, Byhardt RW, Curran WJ, Jr, Fuller D, Graham MV, Komaki R, Weisenburger TH, Kaiser LR, Leibel SA, Brown RC. Staging of non-small cell lung carcinoma. American College of Radiology. ACR Appropriateness Criteria. Radiology 215 Suppl:1281-94, 6/2000. PMID: 11037547.
412. Stevens CW, Lee JS, Cox J, Komaki R. Novel approaches to locally advanced unresectable non-small cell lung cancer. Radiother Oncol 55(1):11-8, 4/2000. PMID: 10788683.
413. Sause W, Kolesar P, Taylor SIv, Johnson D, Livingston R, Komaki R, Emami B, Curran W, Jr, Byhardt R, Dar AR, Turrisi A, 3rd. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 117(2):358-64, 2/2000. PMID: 10669675.
414. Langer CJ, Swann S, Curran W, Komaki R, Lee JS, Byhardt R, Sause W. Do elderly patients with locally advanced non-small cell lung cancer benefit from combined modality therapy? A secondary analysis of RTOG 94-10. J Clin Oncol, 2000.
415. Swisher SG, Erasmus J, Maish M, Correa AM, Ajani JA, Cox JD, Komaki R, Hong D, Lee HK, Macapinlac M, Putnam JB, Jr, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. FDG-PET imaging predicts survival and pathologic response following preoperative chemoradiation in esophageal cancer. J Thoracic & Cardiovas Surg, 2000.
416. Ajani JA, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh G, Vaporciyan A, Rice DC, Roth JA. Prediction of pathologic complete response after preoperative chemoradiotherapy for carcinoma of the esophagus and outcome after pathologic complete response. J Clin Oncol, 2000.
417. Mason KA, Kishi K, Hunter N, Buchmiller L, Akimoto T, Komaki R, Milas L. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo. Clin Cancer Res 5(12):4191-8, 12/1999. PMID: 10632360.
418. Movsas B, Scott C, Sause W, Byhardt R, Komaki R, Cox J, Johnson D, Lawton C, Dar AR, Wasserman T, Roach M, Lee JS, Andras E. The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies. Int J Radiat Oncol Biol Phys 45(5):1143-9, 12/1999. PMID: 10613306.
419. Nguyen LN, Komaki R, Allen P, Schea RA, Milas L. Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review. Int J Radiat Oncol Biol Phys 44(5):1053-6, 7/1999. PMID: 10421538.
420. Machtay M, Seiferheld W, Komaki R, Cox JD, Sause WT, Byhardt RW. Is prolonged survival possible for patients with supraclavicular node metastases in non-small cell lung cancer treated with chemoradiotherapy?: Analysis of the Radiation Therapy Oncology Group experience. Int J Radiat Oncol Biol Phys 44(4):847-53, 7/1999. PMID: 10386642.
421. Kitamura K, Forster KM, Stevens CW, Starkschall G, Butler LE, Liu HH, Liao Z, Komaki R, Mohan R, Cox JD. Preirradiation evaluation and technical assessment of involved-field radiotherapy using computed tomographic (CT) simulation and neoadjuvant chemotherapy for intracranial germinoma. Int J Radiat Oncol Biol Phys 43:783-8, 3/1999.
422. Cox JD, Scott CB, Byhardt RW, Emami B, Russell AH, Fu KK, Parliament MB, Komaki R, Gaspar LE. Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials. Int J Radiat Oncol Biol Phys 43(3):505-9, 2/1999. PMID: 10078629.
423. Turrisi AT, 3rd, Kim K, Blum R, Sause WT, Livingston RB, Komaki R, Wagner H, Aisner S, Johnson DH. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340(4):265-71, 1/1999. PMID: 9920950.
424. Lee JS, Komaki R, Fossella FV, Glisson BS, Hong WK, Cox JD. A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: a 5-year follow-up report. Int J Radiat Oncol Biol Phys 42(3):479-86, 10/1998. PMID: 9806504.
425. Byhardt RW, Scott C, Sause WT, Emami B, Komaki R, Fisher B, Lee JS, Lawton C. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 42(3):469-78, 10/1998. PMID: 9806503.
426. Komaki R, Scott CB, Byhardt R, Emami B, Asbell SO, Russell AH, Roach M, Parliament MB, Gaspar LE. Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 42(2):263-7, 9/1998. PMID: 9788403.
427. Roth JA, Atkinson EN, Fossella F, Komaki R, Bernadette Ryan M, Putnam JB, Jr, Lee JS, Dhingra H, De Caro L, Chasen M, Hong WK. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 21(1):1-6, 7/1998. PMID: 9792048.
428. Roberts HL, Komaki R, Allen P, El-Naggar AK. Prognostic significance of DNA content in stage I adenocarcinoma of the lung. Int J Radiat Oncol Biol Phys 41(3):573-8, 6/1998. PMID: 9635704.
429. Geara FB, Komaki R, Tucker SL, Travis EL, Cox JD. Factors influencing the development of lung fibrosis after chemoradiation for small cell carcinoma of the lung: evidence for inherent interindividual variation. Int J Radiat Oncol Biol Phys 41(2):279-86, 5/1998. PMID: 9607342.
430. Komaki R, Milas L, Ro JY, Fujii T, Perkins P, Allen P, Sikes CR, Mountain CF, Ordonez NG. Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer. Int J Radiat Oncol Biol Phys 40(4):787-96, 3/1998. PMID: 9531362.
431. Glisson B, Komaki R, Lee JS, Shin DM, Fossella F, Murphy WK, Kurie J, Perez-Soler R, Schea R, Vadhan-Raj S. Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study. Int J Radiat Oncol Biol Phys 40(2):331-6, 1/1998. PMID: 9457817.
432. Komaki R, Scott C, Lee JS, Urtasun RC, Byhardt RW, Emami B, Andras EJ, Asbell SO, Rotman M, Cox JD. Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC): comparison of RTOG 83-11 and RTOG 91-06. Am J Clin Oncol 20(5):435-40, 10/1997. PMID: 9345325.
433. Komaki R, Scott CB, Sause WT, Johnson DH, Taylor SGth, Lee JS, Emami B, Byhardt RW, Curran WJ, Jr, Dar AR, Cox JD. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 39(3):537-44, 10/1997. PMID: 9336129.
434. Lee JS, Pisters KM, Komaki R, Glisson BS, Khuri FR, Schea R, Fossella FV. Paclitaxel/carboplatin chemotherapy as primary treatment of brain metastases in non-small cell lung cancer: a preliminary report. Semin Oncol 24(4 Suppl 12):S12-52-S12-55, 8/1997. PMID: 9331122.
435. Komaki R, Scott C, Ettinger D, Lee JS, Fossella FV, Curran W, Evans RF, Rubin P, Byhardt RW. Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04. Int J Radiat Oncol Biol Phys 38(1):149-55, 4/1997. PMID: 9212017.
436. Kataoka M, Komaki R, Roth JA. Gene therapy for lung cancer injection of wild p53 gene by retrovirus vector. Exp Med 15:251-253, 1997.
437. Komaki R, Fujii T, Perkins P, Ro JY, Allen PK, Mason KA, Mountain CF, Milas L. Apoptosis and mitosis as prognostic factors in pathologically staged N1 non-small cell lung cancer. Int J Radiat Oncol Biol Phys 36(3):601-5, 10/1996. PMID: 8948344.
438. Delclos ME, Komaki R, Morice RC, Allen PK, Davis M, Garden A. Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions. Radiology 201(1):279-82, 10/1996. PMID: 8816560.
439. Kupelian PA, Komaki R, Allen P. Prognostic factors in the treatment of node-negative non-small cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys 36(3):607-13, 10/1996. PMID: 8948345.
440. Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ, Hong WK, Komaki R, Lee JJ, Nesbitt JC, Pisters KM, Putnam JB, Schea R, Shin DM, Walsh GL, Dolormente MM, Han CI, Martin FD, Yen N, Xu K, Stephens LC, McDonnell TJ, Mukhopadhyay T, Cai D. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med 2(9):985-91, 9/1996. PMID: 8782455.
441. Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ, Hong WK, Komaki R, Lee JJ, Nesbitt JC, Pisters KMW, Putnam JB, Schea R, Shin DM, Walsh GL, Dolormente MM, Han CI, Martin FD, Yen N, Xu K, Stephens LC, McDonnell TJ, Mukhopadhyay T, Cai D. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nature Medicine 2(9):985-991, 9/1996.
442. Komaki R. Combined Chemotherapy and Radiation Therapy in Surgically Unresectable Regionally Advanced Non-Small Cell Lung Cancer. Semin Radiat Oncol 6(2):86-91, 4/1996. PMID: 10717166.
443. Lee JS, Scott C, Komaki R, Fossella FV, Dundas GS, McDonald S, Byhardt RW, Curran WJ, Jr. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06. J Clin Oncol 14(4):1055-64, 4/1996. PMID: 8648357.
444. Komaki R. Neurological sequelae in long-term survivors of small cell lung cancer. Int J Radiat Oncol Bilo Phys 34(5):1181-3, 3/1996.
445. Skwarchuk MW, Ochran TG, Komaki R, Cundiff J, Travis EL. The use of radiochromic film to measure dose distributions resulting from high dose rate 192Iridium single catheter treatments. Int J Radiat Oncol Biol Phys 34(1):173-81, 1996. PMID: 12118548.
446. Schea RA, Perkins P, Allen PK, Komaki R, Cox JD. Limited-stage small-cell lung cancer: patient survival after combined chemotherapy and radiation therapy with and without treatment protocols. Radiology 197(3):859-62, 12/1995. PMID: 7480770.
447. Shin DM, Fossella FV, Umsawasdi T, Murphy WK, Chasen MH, Walsh G, Komaki R, McMurtrey MJ, Hong WK. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma. Cancer 76(11):2230-6, 12/1995. PMID: 8635025.
448. Marcial VA, Komaki R. Altered fractionation and extended-field irradiation of carcinoma of the cervix. Cancer 76(10 Suppl):2152-8, 11/1995. PMID: 8635015.
449. Komaki R, Meyers CA, Shin DM, Garden AS, Byrne K, Nickens JA, Cox JD. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 33(1):179-82, 8/1995. PMID: 7642416.
450. Montana GS, Hanlon AL, Brickner TJ, Owen JB, Hanks GE, Ling CC, Komaki R, Marcial VA, Thomas GM, Lanciano R. Carcinoma of the cervix: patterns of care studies: review of 1978, 1983, and 1988-1989 surveys. Int J Radiat Oncol Biol Phys 32(5):1481-6, 7/1995. PMID: 7635793.
451. Meyers CA, Byrne KS, Komaki R. Cognitive deficits in patients with small cell lung cancer before and after chemotherapy. Lung Cancer 12(3):231-5, 6/1995. PMID: 7655832.
452. Inoue T, Kim EE, Komaki R, Wong FC, Bassa P, Wong WH, Yang DJ, Endo K, Podoloff DA. Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 36(5):788-93, 5/1995. PMID: 7738649.
453. Komaki R, Shin DM, Glisson BS, Fossella FV, Murphy WK, Garden AS, Oswald MJ, Hong WK, Roth JA, Peters LJ, et al. Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys 31(4):807-11, 2/1995. PMID: 7860392.
454. Komaki R, Brickner TJ, Hanlon AL, Owen JB, Hanks GE. Long-term results of treatment of cervical carcinoma in the United States in 1973, 1978, and 1983: Patterns of Care Study (PCS). Int J Radiat Oncol Biol Phys 31(4):973-82, 2/1995. PMID: 7860414.
455. Sause WT, Scott C, Taylor S, Johnson D, Livingston R, Komaki R, Emami B, Curran WJ, Byhardt RW, Turrisi AT, et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 87(3):198-205, 2/1995. PMID: 7707407.
456. Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB, Jr, Lee JS, Dhingra H, De Caro L, Chasen M, McGavran M, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 86(9):673-80, 5/1994. PMID: 8158698.
457. Park HS, Shin DM, Lee JS, Komaki R, Pollack A, Putnam JB, Cox JD, Hong WK. Thymoma. A retrospective study of 87 cases. Cancer 73(10):2491-8, 5/1994. PMID: 8174044.
458. Komaki R, Pajak TF, Marcial VA, Rotman M, Grigsby PW, Leibel SA, Eifel PJ. Twice-daily fractionation of external irradiation with brachytherapy in bulky carcinoma of the cervix. Phase I/II study of the Radiation Therapy Oncology Group 88-05. Cancer 73(10):2619-25, 5/1994. PMID: 8174061.
459. Cox JD, Sause WT, Byhardt RW, Komaki R, Perez CA, Pajak TF. Dose intensity of radiation therapy in non-small cell carcinoma of the lung: a review of RTOG data and strategies. Lung Cancer 10 Suppl 1:S161-6, 3/1994. PMID: 8087506.
460. Ito H, Komaki R, Milas L. Protection by WR-2721 against radiation plus cis-diamminedichloroplatinum II caused injury to colonic epithelium in mice. Int J Radiat Oncol Biol Phys 28(4):899-903, 3/1994. PMID: 8138443.
461. Komaki R, Pajak TF, Byhardt RW, Emami B, Asbell SO, Roach M, 3rd, Pedersen JE, Curran WJ, Jr, Lattin P, Russell AH, et al. Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: comparison with CALGB 8433. Lung Cancer 10(3-4):189-97, 12/1993. PMID: 8075966.
462. Chow DC, Komaki R, Libshitz HI, Mountain CF, Ellerbroek N. Treatment of primary neoplasms of the trachea. The role of radiation therapy. Cancer 71(10):2946-52, 5/1993. PMID: 8490822.
463. Komaki R, Wadler S, Peters T, Byhardt RW, Order S, Gallagher MJ, Herskovic A, Pederson J. High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801). Cancer 69(11):2807-12, 6/1992. PMID: 1571912.
464. Pollack A, el-Naggar AK, Cox JD, Ro JY, Sahin A, Komaki R. Thymoma. The prognostic significance of flow cytometric DNA analysis. Cancer 69(7):1702-9, 4/1992. PMID: 1551054.
465. Gauwitz M, Ellerbroek N, Komaki R, Putnam JB, Jr, Ryan MB, DeCaro L, Davis M, Cundiff J. High dose endobronchial irradiation in recurrent bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 23(2):397-400, 1992. PMID: 1587762.
466. Komaki R. Is concomitant cisplatin and radiotherapy more efficacious treatment than radiotherapy alone in state III non-small cell lung cancer. Int J Radiat Oncol Bilo Phys 24(1):185-6, 1992.
467. Ellerbroek N, Komaki R. Maximum tolerated dose for low-dose continuous infusion cisplatin. Int J Radiat Oncol Biol Phys 22(5):1164, 1992. PMID: 1555973.
468. Shin DM, El-Naggar AK, Putnam JB, Komaki R, Hong WK. Pathologic remission of invasive thymoma after induction chemotherapy. Cancer Bull 44:346-348, 1992.
469. Pollack A, Komaki R, Cox JD, Ro JY, Oswald MJ, Shin DM, Putnam JB, Jr. Thymoma: treatment and prognosis. Int J Radiat Oncol Biol Phys 23(5):1037-43, 1992. PMID: 1639638.
470. Zatopek NK, Holoye PY, Ellerbroek NA, Hong WK, Roth JA, Ryan MB, Komaki R, Pang AC, Glisson BS. Resectability of small-cell lung cancer following induction chemotherapy in patients with limited disease (stage II-IIIb). Am J Clin Oncol 14(5):427-32, 10/1991. PMID: 1659177.
471. Durci ML, Komaki R, Oswald MJ, Mountain CF. Comparison of surgery and radiation therapy for non-small cell carcinoma of the lung with mediastinal metastasis. Int J Radiat Oncol Biol Phys 21(3):629-36, 8/1991. PMID: 1651303.
472. Ellerbroek NA, Fossella FV, Rich TA, Ajani JA, Komaki R, Roth JA, Holoye PY. Low-dose continuous infusion cisplatin combined with external beam irradiation for advanced colorectal adenocarcinoma and unresectable non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys 20(2):351-5, 2/1991. PMID: 1846848.
473. Hansen R, Erickson B, Komaki R, Janjan N, Cox J, Wilson JF, Anderson T. Concomitant adjuvant chemotherapy and radiotherapy for high risk breast cancer patients. Breast Cancer Res Treat 17(3):171-7, 1991. PMID: 2039839.
474. Komaki R, Mountain CF, Holbert JM, Garden AS, Shallenberger R, Cox JD, Maor MH, Guinee VF, Samuels B. Superior sulcus tumors: treatment selection and results for 85 patients without metastasis (Mo) at presentation. Int J Radiat Oncol Biol Phys 19(1):31-6, 7/1990. PMID: 2380092.
475. Leibel SA, Guse C, Order SE, Hendrickson FR, Komaki R, Chang CH, Brady LW, Wasserman TH, Russell KJ, Asbell SO, et al. Accelerated fractionation radiation therapy for liver metastases: selection of an optimal patient population for the evaluation of late hepatic injury in RTOG studies. Int J Radiat Oncol Biol Phys 18(3):523-8, 3/1990. PMID: 2180867.
476. Komaki R, Cox JD, Kister SJ, Gump FE, Estabrook A. Stage I and II breast carcinoma: treatment with limited surgery and radiation therapy versus mastectomy. Radiology 174(1):255-7, 1990. PMID: 2104676.
477. Komaki R, Hansen R, Cox JD, Wilson JF. Phase I-II study of prophylactic hepatic irradiation with local irradiation and systemic chemotherapy for adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 15(6):1447-52, 12/1988. PMID: 3198442.
478. Amols HI, Goffman TE, Komaki R, Cox JD. Acute radiation effects on cutaneous microvasculature: evaluation with a laser Doppler perfusion monitor. Radiology 169(2):557-60, 11/1988. PMID: 3051122.
479. Komaki R. Learning through nursing. The importance of an interval in conversation. Kurinikaru Sutadi 9(11):1118-9, 10/1988.
480. Pattillo RA, Komaki R, Reynolds M, Robles J. Bacillus calmette-guerin immunotherapy in ovarian cancer. J Reprod Med 33(1):41-5, 1988. PMID: 3351805.
481. Leibel SA, Pajak TF, Massullo V, Order SE, Komaki R, Chang CH, Wasserman TH, Phillips TL, Lipshutz J, Durbin LM. A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: results of a Radiation Therapy Oncology Group randomized prospective trial. Int J Radiat Oncol Biol Phys 13(7):1057-64, 7/1987. PMID: 3597149.
482. Komaki R. Enlarging one's own world. Scuba diving with your friends. Kurinikaru Sutadi 8(7):702-5, 7/1987.
483. Komaki R, Derus SB, Perez-Tamayo C, Byhardt RW, Hartz A, Cox JD. Brain metastasis in patients with superior sulcus tumors. Cancer 59(9):1649-53, 5/1987. PMID: 3828964.
484. Cox JD, Barber-Derus S, Hartz AJ, Fischer M, Byhardt RW, Komaki R, Wilson JF, Greenberg M. Is adenocarcinoma/large cell carcinoma the most radiocurable type of cancer of the lung? Int J Radiat Oncol Biol Phys 12(10):1801-5, 10/1986. PMID: 3019958.
485. Komaki R, Cox JD, Hartz AJ, Wilson JF, Mattingly R. Prognostic significance of interval from preoperative irradiation to hysterectomy for endometrial carcinoma. Cancer 58(4):873-9, 8/1986. PMID: 3719554.
486. Salazar OM, Rubin P, Hendrickson FR, Komaki R, Poulter C, Newall J, Asbell SO, Mohiuddin M, Van Ess J. Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report. Cancer 58(1):29-36, 7/1986. PMID: 2423225.
487. Cox JD, Byhardt RW, Wilson JF, Haas JS, Komaki R, Olson LE. Complications of radiation therapy and factors in their prevention. World J Surg 10(2):171-88, 4/1986. PMID: 3518250.
488. Niroomand-Rad A, Gillin MT, Komaki R, Kline RW, Grimm DF. Dose distribution in total skin electron beam irradiation using the six-field technique. Int J Radiat Oncol Biol Phys 12(3):415-9, 3/1986. PMID: 3082810.
489. Byhardt RW, Cox JD, Libnoch JA, Komaki R, Holoye PY, Anderson T. Multiagent chemotherapy, prophylactic neuraxis irradiation, and consolidative irradiation for small cell carcinoma of the lung. Am J Clin Oncol 8(6):504-11, 12/1985. PMID: 3002168.
490. Komaki R, Byhardt RW, Anderson T, Libnoch JA, Cox JD, Hansen R, Holoye PY. What is the lowest effective biologic dose for prophylactic cranial irradiation? Am J Clin Oncol 8(6):523-7, 12/1985. PMID: 4083270.
491. Komaki R, Cox JD, Hartz AJ, Byhardt RW, Perez-Tamayo C, Clowry L, Choi H, Wilson F, Lopes da Conceicao A, Rangala N. Characteristics of long-term survivors after treatment for inoperable carcinoma of the lung. Am J Clin Oncol 8(5):362-70, 10/1985. PMID: 3933327.
492. Gillin MT, Kline RW, Komaki R, Greenberg M. Correlation of treatment volume with milligram-hours for intracavitary applications for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 11(7):1407-12, 7/1985. PMID: 4008296.
493. Komaki R. Preoperative and postoperative irradiation for cancer of the lung. J Belge Radiol 68(3):195-8, 1985. PMID: 3905760.
494. Komaki R. Prophylactic cranial irradiation for small cell carcinoma of the lung. Cancer Treat Symp 2:35-39, 1985.
495. Komaki R, Cox JD, Hartz A, Wilson JF, Greenberg M. Influence of preoperative irradiation on failures of endometrial carcinoma with high risk of lymph node metastasis. Am J Clin Oncol 7(6):661-8, 12/1984. PMID: 6528862.
496. Komaki R, Cox JD, Hansen RM, Gunn WG, Greenberg M. Malignant lymphoma of the uterine cervix. Cancer 54(8):1699-704, 10/1984. PMID: 6383595.
497. Komaki R, Cox JD, Holoye PY, Byhardt RW. Changes in the relative risk and sites of central nervous system metastasis with effective combined chemotherapy and radiation therapy for small cell carcinoma of the lung. Am J Clin Oncol 6(5):515-21, 10/1983. PMID: 6310985.
498. Komaki R, Cox JD, Stark R. Frequency of brain metastasis in adenocarcinoma and large cell carcinoma of the lung: correlation with survival. Int J Radiat Oncol Biol Phys 9(10):1467-70, 10/1983. PMID: 6313558.
499. Hansen RM, Komaki R, Hanson GA, Schlueter DP, Anderson T. Indolent diffuse histiocytic lymphoma with sclerosis and chylous effusions. Cancer 51(11):2144-6, 6/1983. PMID: 6687700.
500. Collier BD, Palmer DW, Wilson JF, Greenberg M, Komaki R, Cox JD, Lawson TL, Lawlor PM. Internal mammary lymphoscintigraphy in patients with breast cancer. Correlation with computed tomography and impact on radiation therapy planning. Radiology 147(3):845-8, 6/1983. PMID: 6844625.
501. Komaki R, Mattingly RF, Hoffman RG, Barber SW, Satre R, Greenberg M. Irradiation of para-aortic lymph node metastases from carcinoma of the cervix or endometrium. Preliminary results. Radiology 147(1):245-8, 4/1983. PMID: 6828738.
502. Cox JD, Komaki R, Byhardt RW. Is immediate chest radiotherapy obligatory for any or all patients with limited-stage non-small cell carcinoma of the lung? Yes. Cancer Treat Rep 67(4):327-31, 4/1983. PMID: 6303585.
503. Cox JD, Byhardt RW, Komaki R. The role of radiotherapy in squamous, large cell, and adenocarcinoma of the lung. Semin Oncol 10(1):81-94, 3/1983. PMID: 6188217.
504. Cox JD, Holoye PY, Byhardt RW, Libnoch JA, Komaki R, Hansen RM, Kun LE, Anderson T. The role of thoracic and cranial irradiation for small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 8(2):191-6, 2/1982. PMID: 6282790.
505. Kun LE, Cox JD, Komaki R. Patterns of failure in treatment of stage I and II diffuse malignant lymphoid tumors. Radiology 141(3):791-4, 12/1981. PMID: 7302236.
506. Komaki R, Roh J, Cox JD, Lopes da Conceicao A. Superior sulcus tumors: results of irradiation of 36 patients. Cancer 48(7):1563-8, 10/1981. PMID: 7284959.
507. Komaki R, Cox JD, Whitson W. Risk of brain metastasis from small cell carcinoma of the lung related to length of survival and prophylactic irradiation. Cancer Treat Rep 65(9-10):811-4, 9/1981. PMID: 6268295.
508. Byhardt RW, Libnoch JA, Cox JD, Holoye PY, Kun L, Komaki R, Clowry L. Local control of intrathoracic disease with chemotherapy and role of prophylactic cranial irradiation in small-cell carcinoma of the lung. Cancer 47(9):2239-46, 5/1981. PMID: 6261937.
509. Cox JD, Komaki R, Kun LE, Wilson JF, Greenberg M. Stage III nodular lymphoreticular tumors (non-Hodgkin's lymphoma): results of central lymphatic irradiation. Cancer 47(9):2247-52, 5/1981. PMID: 7226120.
510. Cox JD, Komaki R, Eierst DR. Irradiation for inoperable carcinoma of the lung and high performance status. Jama 244(17):1931-3, 10/1980. PMID: 6775099.
511. Cox JD, Komaki R, Byhardt RW, Kun LE. Results of whole-brain irradiation for metastases from small cell carcinoma of the lung. Cancer Treat Rep 64(8-9):957-61, 8/1980. PMID: 6256074.
512. Komaki R, Wilson JF, Cox JD, Kline RW. Carcinoma of the pancreas: results of irradiation for unresectable lesions. Int J Radiat Oncol Biol Phys 6(2):209-12, 2/1980. PMID: 6967061.
513. Cox JD, Komaki R, Wilson JF, Greenberg M. Locally advanced adenocarcinoma of the endometrium: results of irradiation with and without subsequent hysterectomy. Cancer 45(4):715-9, 2/1980. PMID: 6766796.
514. Cox JD, Byhardt RW, Komaki R, Greenberg M. Reduced fractionation and the potential of hypoxic cell sensitizers in irradiation of malignant epithelial tumors. Int J Radiat Oncol Biol Phys 6(1):37-40, 1980. PMID: 6245044.
515. Cox JD, Byhardt R, Komaki R, Wilson JF, Libnoch JA, Hansen R. Interaction of thoracic irradiation and chemotherapy on local control and survival in small cell carcinoma of the lung. Cancer Treat Rep 63(8):1251-5, 8/1979. PMID: 225027.
516. Komaki R, Donegan W, Manoli R, Yeh EL. Prognostic value of pretreatment bone scans in breast carcinoma. AJR Am J Roentgenol 132(6):877-81, 6/1979. PMID: 108963.
517. Cox JD, Byhardt RW, Wilson JF, Komaki R, Eisert DR, Greenberg M. Dose-time relationships and the local control of small cell carcinoma of the lung. Radiology 128(1):205-7, 7/1978. PMID: 208099.
518. Komaki R, Cox JD, Eisert DR. Irradiation of bronchial carcinoma-II Pattern of spread and potential for prophylactic irradiation. Int J Radiat Oncol Biol Phys 2(5-6):441-6, 5/1977. PMID: 885751.
519. Komaki S, Komaki R, Choi H, Correa-Paz F. Radiation- and drug-induced intracranial neoplasm with angiographic demonstration. Neurol Med Chir (Tokyo) 17(1 Pt 1):55-62, 1977. PMID: 74032.
520. Eisert DR, Cox JD, Komaki R. Irradiation for bronchial carcinoma: reasons for failure. Analysis of local control as a function of dose, time, and fractionation. Cancer 37(6):2665-70, 6/1976. PMID: 949684.
521. Komaki S, Komaki R. Diagnosis of thoracic and lumbar disc disease by gas myelography. Wis Med J 75(4):S29-32, 4/1976. PMID: 1266268.
522. Irisawa H, Noma A, Komaki R. Effect of calcium on the spontaneous activities of the oyxter myocardium in sodium free solution. Japan J Physiol 18(2):157-168, 1968.

Invited Articles

1. Komaki R. JASTRO: Celebrating 25 Years of Scientific Research. JASTRO, 2012.
2. Komaki R, Amini A, Roth JA, Swisher SG, Pisters K, Lin SH. Post operative radiotherapy (PORT) for patients with stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy: Do we need more personalized PORT? Jap J Lung Cancer 51(5):331, 10/2011.
3. Komaki R. National Comprehensive Cancer Network (NCCN): Non-Small Cell Lung Cancer Guidelines. Expert Panel Member CD ROM, 2007.
4. Komaki R. Comprehensive Cancer Network (NCCN): Non-Small Cell Lung Cancer Guidelines. Expert Panel Member CD ROM, 2006.
5. Komaki, Ritsuko R. Interview with ABC TV (Channel 13): “From Hiroshima to Healing,”. N/A, 2004.
6. Yang Q, Cleary KR, Yao JC, Swisher SG, Roth JA, Lynch PM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT. Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen. Dis Esophagus 17(1):38-43, 2004. PMID: 15209739.
7. Komaki R, Liao Z, Forster K, Lee HK, Stevens CW, Cox JD. Target definition and contouring in carcinoma of the lung and esophagus. Rays 28(3):225-36, 7/2003. PMID: 15018311.
8. Sanders KE, Komaki R, Buchholz TA. Target delineation and treatment planning in breast conserving therapy. Rays 28(3):237-45, 7/2003. PMID: 15018312.
9. Cox JD, Schechter NR, Lee AK, Forster K, Stevens CW, Ang KK, Komaki R, Liao Z, Milas L. Uncertainties in physical and biological targeting with radiation therapy. Rays 28(3):211-5, 7/2003. PMID: 15018309.
10. Komaki R. Aggressive palliative radiotherapy for a patient with a malignant superior sulcus tumor and adrenal metastasis. A case report. . The Lung Quarterly Scan 4(4):3, 2003.

Abstracts

1. Bradley J, Hak C, Komaki R, Garces Y, Schild S, Curran W, Machtay M, Hu Chen. A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with our without cetuximab for stage III non-small cell lung cancer: Results on radiatin dose in RTOG 0617. JCO. In Press.
2. Liu A, Xu T, Gomez D, O'Reilly M, Lin SH, Nguyen Q, Levy LB, Komaki R, Mohan R, Liao Z,. Serum CRP is predictive if survival in nono-small-cell lung cancdr patients treated with definitive chemoradiationi therapy. Int J Radiat Oncol Biol Phys 90(15):S814, 2017.
3. Komaki R, Wei X, Allen PK, Liao Z, Skinner HD, Welsh JW, Gomez DR, Nguyen QN, Lin SH, Heymach J, Cox JD. Nadir white blood cell, absolute neutrophil, and absolute lymphocyte counts during concurrent chemoradiation therapy predicted worse outcomes in patient with limited-stage small-cell lung cancer. Oncology 30(1):20, 4/2016.
4. Ho JC, Li H, Allen PK, Zhang X, Liao Z, Zhu XR, Gomez SH, Gilliam MT, Komaki R, Hahn SM, Chang JY. Clinical outcome of intensity modulated proton therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 93(3S):S188, 11/2015.
5. Chun SG, Hu C, Choy H, Komaki R, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch WR, Galvin JM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn R, Raben A, Augspurger M, MacRae RM, Paulus R, Bradley JD. Comparison of 3-D conformal and intensity modulated radiation therapy outcomes for locally advanced non-small cell lung cancer in NRG oncology/RTOG 0617. Int J Radiat Oncol Biol Phys 93(3S):S1, 11/2015.
6. Tang C, Tucker SL, Zhuang Y, Gomez DR, Komaki R, Mohan R, Cox JD, Liao Z. Decreased risk of radiation pneumonitis with proton beam therapy in the definitive treatment of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 93(3S):S151, 11/2015.
7. Tang, Nainge A, de Grott, P, Chang JY, Massarelli E, Parkhurst K, Erdman D, Barrientes S, Fok J, Subbiah V, Fu S, Tsimberidou A, Karp D, Gomez DR, Heymach J, Hahn SM, Komaki R, Hong D, Welsh JW. Phase 1 study of ipilimumab and stereotactic radiation targeting liver or lung lesions in patients with advanced malignancies. Int J Radiat Oncol Biol Phys 93(3S):S208, 11/2015.
8. Welsh JW, Seyedin SN, Hofstetter WL, Ajani JA, Chang JY, Gomez Dr, Swisher SG, Blum MA, Nguyen Q, Minsky BD, Erasmus J, Lee JH, Bhutani MS,Komaki R. Prospective phase 1/2 clinical trial: Evaluating dose-escalation for esophageal cancer. Int J Radiat Oncol Biol Phys 93(S3):S12, 11/2015.
9. Wei X, Komaki R, Choi NC, O'Reilly MS, Fossella FV, Chang JY, Gomez DR, Nguyen Q, Pisters KM, Tsao A, Massarelli E, Zhuang Y. Xu T, Hernandez M, Mohan R, Liao Z. Radiation dose-escalation to the gross tumor volume using simultaneous integrated boost intensity modulated photon or proton therapy with concurrent chemotherapy for stage II-III non-small cell lung cancer: a preliminary report of a phase 1 protocol. Int J Radiat Oncol Biol Phys 93(3S):S88, 11/2015.
10. Lin SH, Merrell KW, Bhooshan N, Correa AM, James SE, Haddock MG, Liao Z, Komaki R, Suntharalingam M, Mehta MP, Chuong MD, Hallemeier CL, Mehran RJ. Radiation modality use and the incidence of postoperative complications and length of hospitalization after trimodality therapy for esophageal cancer: A multi-institutional analysis. Int J Radiat Oncol Biol Phys 93(S3):S12, 11/2015.
11. Komaki R, Wei X, Allen PK, Holliday EB, Farooqi A, Lin S, Welsh J, Cox JD. Does prophylactic cranial irradiation improve overall survival of elderly patients. J Thora Oncol 10(9):S627, 9/2015.
12. Lin S, Xu T, He J, Banks K, Lanman RB, Sebisanovic D, Talasaz AA, Lu C, Buchholz T, Hahn S, Komaki R, Liao Z,. Dynamic changes in cell-free circulating tumor DNA to track tumor response and risk of recurrence in stage III non-small cell lung cancr. J Thora Oncol 10(9):S287, 9/2015.
13. Komaki R. Extensive small cell with excellent response to 1st line RX (PCI,chest and/or oligomet RT) and second line and treatment of thymic malignancies. Journal of Thoracic Oncol 10(9):S164, 9/2015.
14. Chun SG, Hu C, Choy H, Komaki R, Timmerman RD, Schild SE, Bogart JA, Dobelbower MC, Bosch W, Galvin JM, Kavadi VS, Narayan S, Iyengar P, Robinson CG, Wynn RB, Raben A, Augspurger ME, Macrae RM. Outcomes of intensity Modulated and 3D -conformal radiotherapy for stage III non-small cell lung cancer in NRG Oncology/RTOG 0617. J Thora Oncol 10(9):S212, 9/2015.
15. Wei X, Allen PK, Erasmus J Jr, Blumenschein G Jr, Godoy M, Lee J, O'Reilly Ms, Welsh J, Cox JD, Hong WK. PET tumor response by PERCIST predicts local-regional control in locallyadvanced NSCLC after concurrent chemoradiotherapyu with erlotinib. J Thora Oncol 10(9):S660, 9/2015.
16. Chang JY, Mehran R, Balter P, Mcrae S, Feng L, Bery D, Komaki R, Roth J. Phase II clinical trial of stereotactic ablative radiotheray (SABR) in surgically operable stage I non-small cell lung cancer (STARS). J Thora Oncol 10(S565), 9/2015.
17. Lin SH, He J, Edelman M, Xu T, Gao H, reuben J, Qiao Y, Liu H, Amstutz P, Hahn S, Komaki R, Liao Z, Tang C, Adams D. Sequential assessment of DNA damage response and PD-L1 expression in circulation tumor cells of lung cancer patients during radiotherapy. J Thora Oncol 10(9):S266, 9/2015.
18. Komaki R, Allen PK, Wei X, Holliday EB, Carter B, Bilton SD, Cox JD. (S040) Has severe acute esophagitis been reduced by 21st century treatment modalities among patients with limited-stage small-cell lung cancer?. Oncology 29(Supp 1):18, 2015.
19. Nguyen Q, Komaki R, Liao Z, Ly N, Levy L, Gomez D, Chang JY, Cox JD. The 5-year outcome for patients diagnosed with locally advanced non-small cell lung cancer treated with definitive concurrent chemotherapy and proton beam therapy. Int J Radiat Oncol Biol Phys 90(5):S19-20, 11/2014.
20. Komaki R, Wei X, Gomez D, Takahashi O, Allen P, Cox JD,. Implication of treatment approach based on histology of thymic tumors. Oncology 28(Supp 1):91, 2014.
21. Thaker NG, Komaki R, Golden DW, Gunther JR, Hillebrandt E, Mahajan A, Frank SJ, Woodward WA, Das P. Improving the quality of radiation oncology education through an innovative medical student treatment planning curriculum. Int J Radiat Oncol Biol Phys 90(15):S601, 2014.
22. Timmerman RD, Hu C, Michalski J, Straube W, Galvin J, Johnstone D, Bradley J, Barringer R, Bezjak A, Videtic GM, Nedzi L, Werner-Wasik M, Chen Y, Komaki R, Choy H. Long-term results of RTOG 0236: A phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 90(15):S30, 2014.
23. Furutani S, Komaki R, Smith PD, Jurgensmeir JM, Takahashi O, Rabin T, Herbst RS, O'Reilly MS. MEK inhibition by selumetinib enhances the antitumor and anti-metastatic effects of chemoradiation therapy in orthotopic human lung cancer models. Int J Radiat Oncol Biol Phys 90(15):S796, 2014.
24. Wei X, Allen PK, Liao Z, Skinner HD, Welsh JW, Gomez DR, Nguyen Q, Lin SH, Heymach JV, Cox JD, Komaki R. Nadir white blood cell, absolute neutrophil, and absolute lynphocyte counts during concurrent chemoradiation therapy are associated with worse outcomes in patients with limited-stage small cell lung cancer. Int J Radiat Oncol Biol Phys 90(15):S623, 2014.
25. Tatian R, Komaki R, Raju U, Skinner H, Molkentine D, Valdecanas DN, Molkentine J, Mason KA, O'Reilly M. Pre-clinical studies of metformin reveal radiosensitization for human small cell lung cancer in vitro but apparent antagonism in vivo. Int J Radiat Oncol Biol Phys 90(15):S656, 2014.
26. Komaki R, Allen PK, Wei X, Liao Z, Skinner HD, Welsh JW, Gomez DR, Nguyen Q, Lin SH, Heymach JV, Cox JD. Predictors of brain metastasis after prophylactic cranial irradiation for limited-stage small cell lung canver. Int J Radiat Oncol Biol Phys 90(15):S622, 2014.
27. Videtic GM, Hu C, Singh A, Chang JY, Parker W, Olivier K, Schield S, Komaki R, Urbanic J, Choy H,. Radiation therapy oncology group (RTOG) protocol 0915: A randomized pghase 2 study comparing 2 stereotactic body radiation therapy (SBRT) schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer. Int J Radiat Oncol Biol Phys 87(25):S3, 2014.
28. XuT, Gomez D, O'Reilly M, Nguyen Q, Levy LB, Komaki R, Mohan R, Liao Z. Serum VEGF associated with survival in non-small cell lung cancer patients treated with definitive chemoradiation therapy. Int J Radiat Oncol Biol Phys 90(15):S105, 2014.
29. Gomez D, O'Reilly M, Levy LB, Welsh J, Lin SH, Komaki R, Liu Z, Wei Q, Liao Z,. Circulating miR-155 predicts for acute esophageal toxicity in patients with non-small-cell lung cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys 87(2), 10/2013.
30. Wang RK, Liao Z, Komaki R, Cox JD, Gomez DR, Bokhar RH, Sailors ML, Cleeland CS. Patient -report symptom burdens in NSCLC patients undergoing proton, 3DCRT or IMRT. J Clin Oncol 31((15 Suppl 1)):476s Abstract# 7574, 5/2013.
31. Komaki R, Allen P, Wei X, Gomex D, Fossel F, Heymach JV, Welsh J, O'Reilly MS, Lin S, Cox JD. Thoracic radiotherapy with six weeks with concurrent chemotherapy improved outcome of patients with limited-stage small-cell lung cancer (L-SCLC). Oncology 27(1):28, 4/2013.
32. Liao Z, Tucker SL, Gomez DR, Grosshans DR, Zhuang Y, Krafft SP,Martel MK, Mohan R, Komaki R, Cox JD. Heart and lung radiation and overall survival in non-small cell lung cancer patients after chemoradiation therapy. Int J Radiat Oncol Biol Phys 84(3S):S578, 11/2012.
33. Welsh J, Likacheva A, Byers LA, Bhardwaj V, Diao L, Wang J, Ang A, Komaki R, Kim E, Heymach JV,. Implications of KRAS mutations on outcomes in non-small cell lung cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys 84(35):S70, 11/2012.
34. Komaki R. Intensity modulated radiotherapy or proton beam therapy for locally advanced NSCLC. J Thor Oncol 7(11):S437, 11/2012.
35. Fakhreddine M, Liao Z, Zhuang Y, Bhardwaj V, Tucker S, Skinner H, Heymach JB, Gomez, DR, Komaki R, Welsh J. Poor glycemic control during radiochemotheray contributes to reduced local control and overall survival in patients with non-small cell lung cancer. Int J Radiat Oncol Biol Phys 84(35):S69, 11/2012.
36. Wei X, Gomez D, Zhunag Y, Komaki R, O'Reilly MS, Mohan R. Pretreatment poor pulmonary function is prognostic of poor ove3rall survival in patients with stage III non-small cell lung cancer treated with external beam radiation therapy. Int J Radiat Oncol Biol Phys 84(3S):S570, 11/2012.
37. Komaki R, Gomez DR. The role of radiation therapy in thymic malignancies including thymic carcinoma. J Thor Oncol 7(11):S413, 11/2012.
38. Juloori A, Shirvani SM, Allen P, Komaki R, Liao Z, Welsh J, Gomez D, Heymach JV, Chang JY,. Limited-stage small cell lung cancer in the contemporary period: Impact of new technologies on outcomes. J Thora Oncol 7(9):S329, 9/2012.
39. Komaki R, Allen PK, Wei X, Blumenschein GR, Wistuba II, Lee J, Welsh J, O'Reilly MS, Tang XM, Hong WK,. The phase II trial of erotinib and radiotheray folling chemoradiotherapy for patients with stage III non-small cell lung cancer has shown a favorable response profile. J Thorac Oncol 7(9):S279, 9/2012.
40. Komaki R, Allen P, Wei X, Gomez D, Fossella F, Heymach J, Welsh J, O'Reilly MO, Lin S, Cox JD. Thoracic radiotherapy within 6 weeks with concurrent chemotherapy improved outcome of patients with limited stage small cell lung cancer (LS-SCLC). J Thorc Oncol 7(9):S217, 9/2012.
41. Komaki R, Kim YB, Wistuva II, Tang X, Meyn R, Allen PK, Wei X, Lee JJ, O'Reilly MS, Hong WK,. Vimentin (EMT marker protein) score predicts resistance to erlotinib and radiotherapy for patients with stage III non-small cell lung cancer on a prospective phase II trial. J Thorac Oncol 7(9):S220, 9/2012.
42. McAvoy S, Gomez D, Allen PK, Rineer J, Liao Z, Chang JY, Welsh J, Palmer MB, Cox JD, Komaki R,. Efficacy and toxicity of re-irradiation with proton beam therapy for non-small cell lung cancer: An updated institutional experience. Oncology 26(1):7, 4/2012.
43. Komaki R, Blumenschein G, Wistuba I, Lee JJ, Allen P, Wei X, Welsh J, O'Reilly M, Tang XM, Hong WK. The phase II trial of erlotinib and radiotherapy following chemoradiotherapy for patients with stage III non-small-cell lung cancer has shown a favorable response profile. Oncology 26(1):6, 4/2012.
44. Komaki R, Amini A, Roth JA, Swisher SG, Pisters K, Lin SH. Post operative radiotherapy (PORT) for patients with stage III non-small cell lung cancer with persistent N2 diseae after induction chemotherapy: Do we need more personalized PORT?. Jap J Lung Cancer 51(5):331, 10/2011.
45. Marom EM, Milito MA, Moran CA, Liu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SG. Computed tomography findings predicting invasiveness of thymoma. J Thorac Oncol 6(7):1274-1281, 2011.
46. Komaki R, Wisuba I, X Ming Tang, Meyn RE, JJ Lee, Wei X, Allen PK, O'Reilly M, Welsh J, Hong WK. Phase II study of chemoradiation therapy and erlotinib for stage III non-small cell lung cancer. Proceedings of AACR 102nd Annual Meeting Innovaton and collaboration: The path to Progress 52:636, 2011.
47. Komaki R. Phase II trial of erlotinib and radiotherapy following chemoradiotherapy for patients with stage III non-small cell lung cancer. J Clinic Oncol 29(15S):458s, 2011, 2011.
48. Komaki RU, Wei X, Allen PK, O'Reilly MS, Fossella FV, Liao ZX, Heymach JV, Herbst RS, Chang JY, Cox JD. Factors to predict long-term five years overall survival (OS) among patients with limited small cell lung cancer treated with radiation treatment (RT) and chemotherapy. J Thor Onc - Supplement 5(12):S549, 12/2010.
49. Mohan R, Zhang Z, Matney J, Bluett J, Dong L, Balter P, Engelsman M, Choi N, Komaki R, Liao Z. IMRT vs. Passively Scattered Proton Therapy for Locally Advanced Non-Small Cell Lung Cancer Randomized Trial - Is there Equipoise?. Proceedings of ASTRO 52 Annual Meeting 78(3):S201, 11/2010.
50. Shirvani SM, Komaki R, Stewart DJ, Lippman SM, Chang JY. PET/CT guided involved field intensity modulated radiation therapy for limited-stage small cell lung cancer. Proceedings of ASTRO 52nd Meeting 78(3):S34, 11/2010.
51. Likhacheva A, Thomas J, Kim E, Allen PK, Komaki R, Cox J, Herbst R, Welsh J. Predictive implications of KRAS and EGFR gene mutations in non-small cell lung cancer treated with radiation therapy. Proceedings of ASTRO 52nd Meeting 78(3):S128, 11/2010.
52. Liao Z, Wei Q, Martel MK, Gomez D, Liu Z, Guan X, Zhuang Y, Lu C, Komaki R, Tucker SL. Incorporating SNPs as biomarkers to improve the fit of the lyman model for radiation pneumonitis. Proceedings of the 52nd Annual ASTRO Meeting 78(3):S199, 10/2010.
53. Welsh JW, Riley B, Palmer MB, Amin MV, Komaki R, Gomez D, Liao Z, Hofstetter WL, Ajani JA, Cox JD. Intensity modulated proton therapy allows dose escalation and normal-tissue sparing in locally advanced distal esophageal tumors. Proceedings of the 52nd Annual ASTRO Meeting 78(3):S808, 10/2010.
54. Zhang Z, Balter P, Allen PK, Chuang H, Pan T, Lin Q, Komaki R, Chang JY. PET/CT and outcome in lung cancer treated with stereotactic body radiation therapy. Proceedings of ASTRO 52nd Meeting 78(3):S16, 10/2010.
55. Gomez DR, Tucker SL, MArtel MK, Zhuang Y, Balter PA, Lopez JL, Jiang CZ, Komaki R, Cox JD, Liao Z. Predictive dosimetric factors for high grade esophagitis in patients treated for non-small cell lung cancer (NSLC) with definitive 3D conformal therapy (3D-CRT), intensity modulated radiation therapy (IMRT), or proton beam therapy (PBT). Proceedings of the 52nd Annual ASTRO Meeting 78(3):S202, 10/2010.
56. Komaki RU, Khalid N, Kong FS, Langer C, Crozier C, Owen J, Wilson J, Movsas B. Report of quality research in radiation oncology (QRRO) survey for lung cancer patients treated in the USA between 2006 and 2007. Proceedings of the 52nd Annual ASTRO Meeting 78(3):S36, 10/2010.
57. Komaki R. Clinical outcomes and treatment planning strategies for advanced stage non small cell lung cancer (NSCLC) treated by intensity modulated radiation therapy (IMRT) or 3 dimentional conformal radiation therapy (3DCRT) with concurrent chemotherapy (CCT). J Thor Onc 5(5):S29, 5/2010.
58. Komaki R, Allen P, Roth J, Swisher S, Rice D, Fossella F, Herbst R, Oh Y, Munden R, Cox J. Optimal treatment for superior sulcus tumors (SST): Surgery first followed by adjunct RT/ChT improved survival for patients with resectable SST. Suppl Journal of Japan Radiological Society:S65, 4/2010.
59. Komaki R. Pros and cons of intensity modulated radiation therapy (IMRT) with concurrent chemotherapy for patients with inoperable stage III non small cell lung cancer. Suppl Journal of Japan Radiological Society:S90, 4/2010.
60. Yuan X, Tucker S, Komaki R, Martel M, Zhuang Y, Cox J, Milas L, Mohan R, Liao Z. Association between treatment-related pneumonitis and the overall survival after definitive radiotherapy for non–small cell lung cancer. Proceedings of the 51st Annual ASTRO Meeting Yuan X, Tucker S, Komaki R, Martel M, Zhuang Y, Cox J, Milas L, Mohan R, Liao Z 75(3):S473, 11/2009.
61. Xiaomao G, Lia ZX, Komaki R, Wen H, Chang JY, O'Reilly M, Jeter M, Bucci K, Ajani J, Cox JD. Concurrent chemotherapy and proton beam therapy for esophageal cancer. Proceedings of the 51st ASTRO Annual Meeting 75(3):S289-90, 11/2009.
62. Grosshans DR, Bae K, Blumenschein G, Curran W, Robert F, Fossella F, Wasik M, Doescher P, Choy H, Komaki R. Correlation of pulmonary and cardiac dose–volume histogram (DVH) data with the development of radiation adverse events following chemoradiation: Secondary analysis of radiation therapy oncology group (RTOG) 0324. Proceedings of the 51 Annual ASTRO Meeting 75(3):S161-62, 11/2009.
63. Vedam S, Tucker S, Zhuang Y, Mohan R, Komaki R, Liao Z, Martel M. Does the choice of a 4D CT reference dataset for treatment planning affect normal tissue dose response model parameters for non small cell lung cancer patients?. Proceedings of the 51st Annual ASTRO Meeting 75(3):S611, 11/2009.
64. Joyy S, Kong F, Komaki R, Gaspar L, Bonner JA, Sun A, Sandler H, Choy H, Movsas B. Factors associated with patterns of practice for elective nodal irradiation in non-small cell lung cancer patients among US radiation oncologists. Proceedings of the 51st Annual ASTRO Meeting 75(3):S129-30, 11/2009.
65. Chang JY, Komaki R, Bucci MK, Lu C, Wen HY, DeGarcia B, Gillin M, Mohan R, Cox JD. Failure patterns and toxicity of concurrent proton therapy and chemotherapy for stage III non–small cell lung cancer. Proceedings of the 51st Annual ASTRO Meeting 75(3):S446-7, 11/2009.
66. Gao S, Chang JY, Welsh J, Komaki R, Balter P. Influence of the couch and immobilization device used during stereotactic body radiotherapy on skin dose. Proceedings of the 51st Annual ASTRO Meeting 75(3):S682, 11/2009.
67. Palmer MB, Vedam S, Komaki R, Welsh JW. Intensity modulated radiation therapy (IMRT) benchmarks for thoracic malignancies. Proceedings of the 51st Annual ASTRO Meeting 75(3):S476, 11/2009.
68. Wei X, Allen PK, Laio Z, Chang JY Guerrero TM, Cox JD, Komaki R. Prophylactic cranial irradiation is more important to improve the overall survival among patients with limited small–cell lung cancer who received one-cycle induction chemotherapy and had complete response to therapy. Proceedings of the 51st Annual ASTRO Meeting 75(3):S462, 11/2009.
69. Wolfson A, Bae K, Komaki R, Meyers C, Movsas B, Le Pechoux C, Wasik M, Videtic G, Garces Y, Choy H. Secondary endpoints of a phase II randomized trail (RTOG 0212): Impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life patients with limited disease small-cell lung cancer. Proceedings of the 51st Annual ASTRO Meeting 75(3):S34, 11/2009.
70. Liao Z, Yuan X, Komaki R, Milas R, Liu Z, Wang L, Tucker SL, Mao L, Wang S, Martel M. Single nucleotide polymorphism of the TGF-B1 T869C gene associates risks of treatment related pneumonitis and distant metastasis in patients with non–small-cell lung cancer treated with definitive radiotherapy. Proceedings of ASTRO 51st Annual Meeting 75(3):S437, 11/2009.
71. Welsh J, Thomas J, Wei X, Allen P, Mitchell K, Gao S, Komaki R, Chang J. Skin toxicity and pain in patients treated with stereotactic body radiotherapy. Proceedings of the 51st Annual ASTRO Meeting 75(3):S61, 11/2009.
72. Kelly P, Balter PA, Rebueno N, Laio Z, Komaki R, Chang JY. Stereotactic body radiation therapy results in promising local control in patients with recurrent or secondary lung parenchyma cancer after definitive conventional thoracic radiotherapy. Proceedings of the 51st Annual ASTRO Meeting 75(3):S159, 11/2009.
73. Bruner D, Bae K, Siddiqui F, Langer CJ, Coyne J, Gamerman V, Komaki R, Choy H, Curran WJ, Movsas B. The influence of gender, race, and marital status on survival in lung cancer patients: Meta-analysis of radiation therapy oncology group (RTOG) trials. Proceedings of the 51st Annual ASTRO Meeting 75(3):S163, 11/2009.
74. Dawood O, Chang JY, Balter PA, Komaki R, Roth JA. Complexities of lung sterotactic radiotherapy planning target volumes. Supplement of J Thoac Oncol 4(9):S941-2, 9/2009.
75. Siddiqui F, Langer CJ, Bae K, Coyne J, Gamerman V, Bryan C, Komaki R, Choy H, Curran W, Watkins BD, Movsas B. Gender differences in survival amoung lung cancer patients treated in radiation therapy oncology group (RTOG) trails. Supplement of J Thorac Oncol 4(9):S524, 9/2009.
76. Yuan X, Liao Z, Komaki R, Liu Z, Tucker SL, Li M, Martel M, Cox JD, Milas L, Wei Q. Heterozygous CT genotype of TGFB1 at T869C was associated with a worse outcome in patients with non-small-cell lung cancer treated with definitive radiotherapy. Supplement of J Thorac Oncol 4(9):S912, 9/2009.
77. Komaki R, Liao Z, Chang JY, Sejpal SV, Wei X, Mohan R, Allen P, Tucker S, Cox JD. Intensity-modulated related radiation therapy (IMRT) in patients with locally advanced non-small-cell lung cancer treated with concurrent chemotherapy: good or bad. Supplement to J Thorac Oncol 4(9):S161, 9/2009.
78. Takahashi O, Komaki R, Smith PD, Ryan A, Jurgensmeier JM, Welsh JW, Jacoby JJ, Hosho K, Korshunova MV, Erez B, Herbst RS, OReilly MS. MEK1/2 blocakade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib. Supplement of J Thorac Oncol 4(9):S593, 9/2009.
79. Komaki R, Paulus R, Ettinger D, Videtic G, Bradley J, Glisson B, Choy H. Normal tissue toxicities in a phase II study of accelerated high dose thoracic radiation therapy (TRT) with concurrent chemotherapy for limited small cell lung cancer (LSCLC): radiation therapy oncology group (RTOG) 0239. Supplement of J Thorac Oncol 4(9):S392-3, 9/2009.
80. Chang JY, Komaki R, Wen H, Garcia B, Gillin M, Mohan R, Cox JD. Toxicity and patterns of failure of dose-escalated proton therapy in early-stage medically inoperable non-small cell lung cancer. Supplement of J Thoac Oncol 4(9):S525, 9/2009.
81. Komaki R, Paulus R, Ettinger DS, Videtic GM, Glisson J, Choy H,. A phase II study of accelerated high-dose thoracic radiation with concurrent chemotherapy for limited small cell lung cancer: RTOG 0239. Journal of Clinical Oncology - ASCO 27(15S):388s, 5/2009.
82. Komaki R, Liao Z, Jeter M, O'Reilly M, Wei X, Allen P, Chang JY, McAleer M, Cox JD, Kies M. A phase I study of concurrent CPT-11/cisplatin and celecoxib with radiation therapy for patients with unresectable non-small cell lung caner (NSCLC). Oncology - ARS 23(4):12, 4/2009.
83. Liao Z, Yuan X, Komaki R, Liu Z, Tucker SL, Mao L, Martel M, Cox JD, Milas L, Wei Q,. Association between heterogous CT genotype of TGF-Beta 1 gene at RS1982073:T869C and the outcomes of patients with non-small cell lung cancer treated with definitive radiotherapy. Oncology - ARS 23(4):11, 4/2009.
84. Komaki R, Sejpal S, Wei X, Allen P, Amos R, Mohan R, Chang J, Liao Z, Dong L, Cox JD. Proton Beam Therapy (PBT) Reduced Bone Marrow Toxicity (BMT) Compared to Intensity Modulated Radiation Therapy (IMRT) Among Patients with Locally Advanced (LA) NSCLC Treated with Concurrent Chemotherapy (CT). Journal of Japan Radiological Society 25:S89, 4/2009.
85. Wei X, Komaki R, Allen PK, Glisson BS, Stewart DJ, Liao Z, Fossella F, Jeter M, Chang JY, Guerrero T, Blumenschein G, Herbst R, Bucci BK, McAleer MF, Cox JD. Accelerated Hyperfractionated Radiation Therapy (AHF-RT) Increased Survival Compared to Daily Radiation Therapy (QD-RT) For Limited Small Cell Lung Cancer Patients Treated with Concurrent Chemotherapy. Supplement to Oncology 90(Supp 3):S60, 3/2009.
86. Wei X, Komaki R, Allen PK, Glisson BS, Stewart DJ, Liao Z, Fossella F, Jeter M, Chang JY, Guerrero T, Blumenschein G, Herbst R, Bucci GK, McAleer AF, Cox JD. Increased Survival Compared to Daily Radiation Therapy (QD-RT) for Limited Small Cell Lung Cancer Patients Treated with Concurrent Chemotherapy. A Supplement to Oncology 90(Suppl 3):S60, 3/2009.
87. Cox JD, Lee AK, Woo SY, Chang JY, Wei X, Komaki R, Gillin M. Proton Therapy and the Possibility of Clinical Trails. A Supplement to Oncology 90(Supl 3):S19, 3/2009.
88. Komaki R, Sejpal SV, Wei X, Allen PK, Amos R, Mohan R, Chang JY, Liao Z, Dong L, Cox JD. Significant Reduction of Bone Marrow Toxicity (BMT) for Patients with Locally Advanced (LA) NSCLC Treated with Confurrent Chemotherapy (CT) and Proton Beam Theerapy (PBT) Compared to Intensity Modulated Radiation Therapy (IMRT). A Supplement to Oncology 90(Suppl 3):S61, 3/2009.
89. Liao Z, Yuan X, Milas L, Liu Z, Wang LE, Tucker SL, MAo L, Wang XS, Martel M, Komaki R, Cox JD, Wei Q. Single nucleotide polymorphism of the TGF-B1 gene predicts risks of severe treatment related pneumonitis and distant metastasis in patients with non-small cell lung cancer treated with definitive radiotherapy. A Supplement to Oncology 90(Suppl 3):S87-88, 3/2009.
90. Komaki RU, Paulus R, Ettinger D. Videtic G, Bradley J, Glisson B, Choy H. Patterns of first failure in a phase II study of accelerated high dose thoracic radiation therapy (TRT) with concurrent chemotherapy for limited small-cell lung cancer (LSCLC): radiation therapy oncology group (RTOG) 0239. Proceedings of the 51st Annual ASTRO Meeting 75(3):S34, 2009.
91. Komaki R. Significant Reduction of Bone Marrow Toxicity (BMT) for Patients with Locally Advanced (LA) NSCLC Treated with Concurrent Chemotherapy (CT) and Proton Beam Therapy (PBT) Compared to Intensity Modulated Radiation Therapy (IMRT). Proceedings of Chicago Multi disciplinary Symposium in Thoracic Oncology 3(11):S303-, 11/2008.
92. Bucci MK, Ezhil M, Vedam S, Choi B, Dong L, McAleer MF, Munsell M, Komkai R, Balter P. 4D CT-Derived PTV Spares Normal Lung Volume Compared to Free Breathing CT-Derived PTV for Both Early and Late Stage Non-Samll Cell Lung Cancer Patients. A Supplement to Oncology 22(Suppl 1):17, 2008.
93. McAleer Mf, Balter P, Bucci MK, Kuruvila S, Komaki R, Chang JY. Capsular Contracture of Subcutaneous Breast Implant Following Hypofractionated Stereotactic Radiotherapy for Early-Stage Lung Cancer: A Case Report. A Supplement of Oncology 22(Suppl 1):57, 2008.
94. Grosshans D, Palmer M, Spicer C, Erice R, Cox JD, Komaki R, Chang J. Improving Cardiac Dosimetry A Comparison of the Alernative Beam Arrangements for IMRT Planning in Patients with Carcinoma of the Distal Esophagus. A Supplement of Oncology 22(Suppl 1):7, 2008.
95. Kong F, West B, Bonner J, Choy H, Gaspar LE, Komaki R, Sun A, Morris D, Wang L, Sandler HM, Movsas B. Patterns of practice in radiation therapy for non-small cell lung cancer among members of American Society of Therapeutic Radiology and Oncology. Proceedings of ASCO 25:432S, 2008.
96. Yordy JS, Balter P, McAleer MF, Palla SL, Nogueras-Gonzalez GM, Dong L, Komaki R, Bucci K. Physician-Therapist Agreement in Thoracic Patient Set-up Using Image-Guided Radiation Therapy. A Supplement to Oncology 22(Suppl 1):56, 2008.
97. Sejpal S, Komaki R, Wei X, Amos R, Allen P, Liu H, Liao Z, Chang JY, Cox JD. Preliminary Evaluation of Treatment Related Pneumonitis (TRP) by Proton Beam Radiotherapy (PBT) Compared to Intensity-Modulated Related Radiation Therapy (IMRT) in Patients With Locally Advnaced NSCLC Treated with Concurrent Chemotherapy. A Supplement to Oncology 22(Suppl 1):15, 2008.
98. Zhang S, Komaki R, Fang B, Chang JY. Radiation-Resistant Esophageal Cancer Stem Cell. A Supplement to Oncology 22(Supp 1):5, 2008.
99. Komaki R, Sejpal SV, Wei X, Allen P, Chang JY, Liao Z, Mohan R, Dong L, Amos R, Cox JD. Reduction of Bone Marrow Suppression for Patients With Stage III NSCLC Treated by Proton and Chemotherapy Compared with IMRT and Chemotherapy. PTCOG 47 Abstract Book:14, 2008.
100. Liao Z, Cox JD, Liu HH, Tucker SL, Komaki R, Mohan R, Martel M, Wei X, Allen PK. The Impact of Technological Advancement of Outcome for Patients with Unresectable locally advanced Non-Small Cell Lung Cancer (NSCLC) Receiving Concomitant Chemoradiotherapy. A Supplement to Oncology 22(Suppl 1):15, 2008.
101. Chang JY, Balter P, Dong L, Liao Z, Bucci KM, Jeter M, McAleer ,Yang Q, Cox JD, Komaki R. 4D CT Based and Daily In-Room CT-guided Stereotactic Body Radiotherapy (SBRT) in Lung Cancer. Proceedings of ASTRO 69:88S, 2007.
102. Swisher S, Winters K, Komaki R, Ajani J, T. Wu T, W. Hofstetter W, A. Konski,. Willett.C. A Phase II Study of a Paclitaxel Based Chemoradiation Regimen with Selective Surgical Salvage for Resectable Locoregionally Advanced Esophageal Cancer: Initial Reporting of RTOG 0246. Proceeding of ASTRO 69:106S, 2007.
103. Blumenschein Jr G, Moughan J, Curran W, Robert F, Fossella F, Werner-Wasik M, Doescher P, Choy H, Komaki R. A phase II study of cetuximab (C225) in combination with cheomradiation (CRT) in patients (pts) with stage III A/B non-small cell lung cancer (NSCLC): An interim report of the RTOG 0324 trial. Proceedings of ASCO 25:392S, 2007.
104. Lu C, Lee JJ, Komaki R, Herbst RS, Evan WK, Choy H, Desjardins P, Esparaz BT, Truong M, Fisch MJ. A phase III study of /E-941 with induction cheomtherapy (IC) and concomitant chemoradiotherapy (CRT) for stage III non-small cell lung cancer (NSCLC) (NCI T99-0046, RTOG 02-07, MDA 99-303. Proceedings of ASCO 25:391S, 2007.
105. Liao Z, Cox JD, Liu H, Komaki R,Tucker SL, Mohan R, Martel M, Allen PK, Thames HD. Assessing The Impact Of Technological Advancement On Outcome For Patients With Unresectable Locally Advanced Non-small-cell Lung Cancer (nsclc) Receiving Concomitant Chemoradiotherapy. Proceedings of ASTRO 69:160S, 2007.
106. Wei X,. Komaki R, Allen PK, Garza VP, Liao Z, Chang JY, Guerrero TM, Bilton S, Cox JD. Effects of amifostine on acute and late toxicity of once daily and twice daily radiotherapy and concurrent chemotherapy for local advanced non-small lung cancer. Proceedings of ASTRO 69:476S, 2007.
107. McGovern SL, Liao Z, Bucci K, McAleer MF, Jeter MD, Chang JY, Huang EH, Cox JD, Allen PK, Komaki R. Gender Differences in NSCLC Outcomes. Proceedings of ASTRO 69:160S, 2007.
108. Konski A, Bhargavan M, Owen J, Komaki R, Langer C, Byhardt R, Paulus R, H. Choy, Bruner D, Curran Jr W. Less is not Always More”: An Economic Analysis of Radiation Therapy Oncology Group 94-10. Proceedings of ASTRO 69:182S, 2007.
109. Jin, HK, Liao, ZX, Tucker, SL, Liu, HH, Wei, X, Mohan, R, Cox, JD, Komaki, R. Non-smokers and former smokers at increased risk for TRP in Chemoradiation for NSCLC. Proceedings of ASTRO 69:59S, 2007.
110. Sun A, Wang L, Choy H, Gaspar L E., Komaki R, Bonner JA, Sandler HM, Movsas B, Kong FM. Radiation Oncologists from Canada and the United States have significantly different patterns of practice for patients with Non-Small Cell Lung Cancer. Proceedings of ASTRO 69:57S, 2007.
111. Torres MA, Guerrero T, Castillo R, Cody D, Komaki R, Travis EL. Raduction of pulmonary compliance in mice following thoracic radiation. Proceedings of the American Radium Society Suppl 3:47S, 2007.
112. Movsas B, Moughan J, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Byhardt R. Randomized trail of amifostine in locally advanced non-small cell lung cancer (NSCLC) patients receiving chemotherapy and hyperfractionated radiation (HRT): long-term survival results of Radiation Therapy Oncology Group (RTOG). Proceedings of ASCO 25:391S, 2007.
113. Komaki R, Moughan J, Ang K, Curran W, Robert F, Thariat J, Zhang H, Werner-Wasik M, Choy H, Blumenschein G. RTOG 0324: A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): Correlation between EGFR expression and the patients outcome. Proceedings of ASTRO 69:57S, 2007.
114. Furutani K, Komaki R, Imagumbai T, Jacoby JJ, Massarelli E, Korshunova MK, Ryan A, Jurgensmeier JM, Herbst RS, O'Reilly MS. Targeted therapy against VEGFR-1, -2, and -3 by AZD2171 blocks tumor growth and angiogenesis, and enhances paclitaxel efficacy in an orthotopic lung cancer model. Proc for AACR, 2007.
115. Komaki R, Moughan J, Ettinger D, Videtic G, Bradley J, Glisson B, Choy H. Toxicities in a phase II study of accelerated high dose thoracic radiation therapy (TRT) with concurrent cheomtherapy for limited small cell lung cancer (LSCLC) (RTOG 0239). Proceedings of ASCO 25:438S, 2007.
116. Komaki, Ritsuko R. A Randomized Phase II Study of two paclitaxel based chemoradiotherapy for patients with the non-operative esophageal cancer. ASTRO, 11/2006.
117. Zhang X, Chang JY, Liao Z, Komaki R, Cox JD, Amos R, Arjomandy B, Kang Y, Wang X, Liu H, Dong L, Mohan R. TH‐C‐ValB‐06: Thoracic Proton Treatment Planning Strategies Based On the 4D CT Information. Med Phys 33(6):2269, 7/2006.
118. Huang HH, Liao Z, Cox JD, Wei X, Komaki R. Comparison of outcomes for locally advanced inoperable non-small cell lung cancer treated using concurrent chemoradiation with vs. without induction chemotherapy. Proc American Radium Society 20 - Suppl 3:20, 4/2006.
119. Komaki, Ritsuko R. Comparison of outcomes for patients with medically inoperable stage I non-small cell lung cancer treated with two-dimensional vs. three dimensional radiotherapy. Proc American Radium Society 20 - Suppl 3:20, 4/2006.
120. Yaremko B, Guerrero T, Harvey M, Komaki R. Pulmonary function imaging from four-dimensional computed tomography for radiation oncology. Proc American Radium Society 20 - suppl 3:24, 4/2006.
121. Torres MA, Guerrero T, Castillo R, Cody D, Komaki R, Travis EL. Reduction of pulmonary compliance in mice following thoracic radiation. Proc American Radium Society 20 - suppl 3:47, 4/2006.
122. Komaki R. A Randomized Phase II Study of two paclitaxel based chemoradiotherapy for patients with the non-operative esophageal cancer. Proceedings of ASTRO 66:327, 2006.
123. Huang HH, Liao Z, Cox JD, Wei X, Komaki R. Comparison of outcomes for locally advanced inoperable non-small cell lung cancer treated using concurrent chemoradiation with vs. without induction chemotherapy. Proceedings American Radium Society Suppl 3:20S, 2006.
124. Komaki R. Comparison of outcomes for patients with medically inoperable stage I non-small cell lung cancer treated with two-dimensional vs. three dimensional radiotherapy. Proceedings American Radium Society Suppl 3:20S, 2006.
125. Curran W, Scott C, Langer C, Komaki R, Lee J, Hauser S, Movsas B, Wasserman T, Sause W, Cox J. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 94-10. J Clin Oncol 22:621 (#2499), 2006.
126. Yaremko B, Guerrero T, Harvey M, Komaki R. Pulmonary function imaging from four-dimensional computed tomography for radiation oncology. Proceedings American Radium Society Suppl 3:24S, 2006.
127. Liao Z, Komaki R, Milas L, Chen Y, Kies M, Chang J, Jeter M, Guerrero T, Blumenschein G, Cox J. A dose escalation clinical trial using thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer (NSCLC). Proc of IASLC. Lung Cancer 49(Suppl 2):S372 (#P-959), 2005.
128. Werner-Wasik M, Swann S, Curran W, Robert F, Komaki R, Lee CP, Jafar S, Share R, Choy H, Blumenschein G. A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): An interim overall toxicity report of the RTOG 0324 trial. Proc ASCO 23:654s (#7135), 2005.
129. Blumenschein G, Swann S, Curran W, Robert F, Werner-Wasik M, Lee C, Jafar S, Shara R, Choy H, Komaki R. A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): An interim overall toxicity report of the RTOG 0324 trial. Proc of IASLC. Lung Cancer 49(Suppl 2):S78 (#PD-039), 2005.
130. Lu C, Komaki R, Herbst RS, Evans WK, Lee JJ, Truong M, Moore CA, Choy H, Bleyer A, Fisch MJ. A phase III study of AE-941 with induction chemotherapy (IC) and concomitant chemoradiotherapy (CRT) for stage III non-small cell lung cancer (NSCLC) (NCI T99-0046, RTOG 02-70, MDA 99-303): An interim report of toxicity and response. Proc ASCO 23:656s (#7144), 2005.
131. Yom S, Liao Z, Liu H, Allen P, Chang J, Jeter M, Guerrero T, Stevens C, Cox J, Komaki R. Analysis of acute toxicity results of intensity modulated (IMRT) in the treatment of non-small cell lung cancer (NSCLC). Proc of IASLC. Lung Cancer 49(Suppl 2):S52 (#O-152), 2005.
132. Fang CL, Komaki R, Allen P, Guerrero T, Mohan R, Cox J. Comparison of outcomes for patients with medically inoperable stage I non-small cell lung cancer treated with two-dimensional versus three-dimensional radiotherapy. Proc of IASLC. Lung Cancer 49(Suppl 2):S49 (#O-142), 2005.
133. Komaki R, Swann S, Byhardt R, Cox J, Scot C, Sause W. Does response rate in the induction chemotherapy predict survival for locally advanced non-small cell lung cancer (LANSCLC)? Secondary analysis of RTOG 8804/8808. Proc of IASLC. Lung Cancer 49(Suppl 2):S88 (#PD-074), 2005.
134. Komaki R, Allen P, Glisson B, Lu C, Fossella F, Liao Z, Jeter M, Stevens C, Chang J, Guerrero G, Blumenschein G. Hyperfractionated/accelerated thoracic radiation therapy (HFXRT) increased survival compared to daily RT (QDRT) for limited small cell lung cancer (LSCLC) with concurrent chemotherapy (ChT). Proc ASCO 23:659s (#7158), 2005.
135. Chang J, Dong L, Mohan R, Liao Z, Cox J, Komaki R. Image-guided proton radiotherapy for medically inoperable stage I non-small cell lung cancer. Proc of IASLC. Lung Cancer 49(Suppl 2):S93 (#PD-088), 2005.
136. Swann RS, Machtay M, Komaki R, Sause WT, Langer CJ, Byhardt RW, Curran WJ. Impact of overall treatment time during concurrent chemoradiotherapy for locally advanced NSCLC: An RTOG secondary analysis. Proc ASCO 23:635s (#7061), 2005.
137. Basir S, Fossella F, Hwang L, Lu C, Komaki R, Zinner R. Loco-regional progression after induction chemotherapy may predict the development of M1 disease after the initiation of concurrent chemo-radiation in stage III NSCLC. Proc of IASLC. Lung Cancer 49(Suppl 2):S77 (#PD-036), 2005.
138. Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter W, Liao Z, Komaki R, Rashid A, Hamilton SR, Wu T-T. Number of lymph nodes with metastasis predict survival in patients with esophageal or esophagogastric junction adenocarcinoma treated with preoperative chemoradiation. Proc ASCO 23:319s (#4046), 2005.
139. Komaki R, Allen P, Roth J, Swisher S, Rice D, Fossella F, Herbst R, Oh Y, Munden R, Cox J. Optimal treatment for superior sulcus tumors (SST): Surgery first followed by adjunct RT/ChT improved survival for patients with resectable SST. Proc of IASLC. Lung Cancer 49;Suppl 2:S79 (#PD-044), 2005.
140. Machtay M, Swann S, Komaki R, Sause W, Langer C, Byhardt R, Curran W. Overall treatment time during concurrent chemoradiotherapy and outcomes: An RTOG secondary analysis. Proc of IASLC. Lung Cancer 49(Suppl 2):S17 (#O-042), 2005.
141. Guerrero T, Sanders K, Castillo R, Ribera B, Cody D, Price RBidaut L, Komaki R. Pulmonary compliance imaging in rodents. Proc BioMech, 2005.
142. Machtay M, Swann S, Komaki R, Byhardt R, Paulus R, Sause W, Curran W, Albain K, Movsas B. What is the meaning of local-regional control after chemoradiation for locally advanced NSCLC? An RTOG analysis . Proc of IASLC. Lung Cancer 49(Suppl 2):S17 (#O-041), 2005.
143. Komaki R. Cytoprotection and target volume definition based on PET/CT. The 4th Takahashi Memorial International Workshop on 3 Dimensional Conformal Radiotherapy, Nagoya Japan, 98-99, 2004.
144. Komaki R, Allen PGlisson B, Milas L, Charles L, Kaplan B, Fossella F, Liao Z, Jeter M, Stevens C, Chang J, Guerrero T. Hyperfractionated and accelerated thoracic radiation therapy (HFXATRT) increased survival compared to daily TRT (QDTRT) for limited small cell lung cancer (LSCLC) patients treated with concurrent chemotherapy. Proc ASTRO 60:S203 (#123), 2004.
145. Swisher SG, Ajani JA, Chirieac L, Vaporciyan AA, Wu TT, Hunt KK, Correa AM, Komaki R, Rice DC, Walsh GL, Roth JA. Impract of pathologic response on pTNM esophageal cancer staging system following preoperative chemoradiation (CRT). Proceedings of 116th Meeting of the Southern Surgical Association, Palm Beach FL, 55-5, 2004.
146. Phan AT, Rashid A, Luthra R, Lopex-Alarez A, Swisher S, Komaki R, Bresalier R, Ajani JA. Molecular predictors of patients with localized upper gastrointestinal cancers after chemoradiation. Proc ASCO 23:316 (#4015), 2004.
147. Komaki R, Spitz MR, Wu X, Chang JY, Allen PK, Milas L, Fossella CW, Stevens CW, Liao Z, Cox JD. Mutagen sensitivity (MS may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer (NSCLC) treated by chemoradiotherapy. Proc ASCO 23:671 (#7232), 2004.
148. Chang JY, Wu X, Komaki R, Sasaki R, Allen P, Liao Z, Stevens CW, Lu C, Fossella FV, Cox JD, Spitz MR. Mutagen sensitivity predicts poor overall and disease specific survival in patients with stage III non-small cell lung cancer treated with chemo/radiotherapy. Proc ASTRO 60:S237 (#175), 2004.
149. Liao Z, Komaki R, Milas L, Chen Y, Chang JY, Jeter M, Guerrero T, Stevens CW, Blumenschien G, Smith CM, Cox JD. Phase I clinical trial using selective cyclooxygenase-2 (Cox-2) inhibitor celecoxib with concurrent thoracic irradiation in patients with poor prognostic non-small cell lung cancer (NSCLC). Proc ASTRO 60:S151 (#37), 2004.
150. Wu T-T, Chirieac LR, Swisher SG, Komaki RU, Correa AM, Roth J, Rashid A, Hamilton SR, Ajani JA. Post-chemoradiation surgical pathologic stage accurately predicts outcome of patients with esophageal or gastroesophageal junction carcinoma. Proc ASCO 23:319 (#4028), 2004.
151. Komaki R, Allen PK, Wei X, Liao Z, Skinner HD, Welsh JW, Gomez DR, Nguyen Q, Lin SH, Heymach JV, Cox JD. Predictors of brain metastasis after prophylactic cranial irradiation for limited-stage small cell lung cancer. Int J Radiat Oncol Biol Phys 90(15):S622, 2004.
152. Sanders K, Guerrero T, Zhang G, Bilton S, Stevens C, Lu C, Stewart D, Komaki R. Quantitative measurement of regional tumor response to therapy. Proc ASTRO 60:S204 (#126), 2004.
153. Liao Z, Chen Y, Komaki R, Cox JD, Milas L. A phase I study combining thoracic radiation (RT) with celecoxib in patients with non-small cell lung cancer (NSCLC). Proceedings ASCO 22:216 (#867), 2003.
154. Lu C, Komaki R, Herbst RS, Evans WK, Smith TL, Moore CA, Kilbye SL, Choi NC, Choy H, Bleyer A. A phase III study of AE-941 (Neovastat) with induction chemotherapy (IC) and concomitant chemoradiotehrapy (CRT) for stage III non-small cell lung cancer (NSCLC) (NCI T99-0046, RTOG 02-70, MDA 99-303): An interim analysis of toxicity and response. Lung Cancer 42(Suppl 2):S90, 2003.
155. Bradley JD, Graham MV, Winter KW, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B. Acute and late toxicity results of RTOG 9311:A dose escalation study using 3D conformal radiation therapy in patients with inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 57:S137 (#23), 2003.
156. Werner-Wasik M, Scott C, Movsas B, Langer C, Sarna L, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Byhardt R. Amifostine as mucosal protectant in patients with locally advanced non-small cell lung cancer (NSCLC) receiving intensive chemotherapy and thoracic radiotherapy (RT): Results of the Radiation Therapy Oncology Group (RTOG) 98-01 study. Int J Radiat Oncol Biol Phys 57:S216 (#152), 2003.
157. Forster KM, Stevens CW, Kitamura K, Chang JY, Cox JD, Guerrero TM, Jeter M, Liao Z, Starkschall G, Komaki R. Changes of tumor motion patterns during a course of radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 57:S234 (#181), 2003.
158. Machtay M, Swann RS, Komaki R, Langer C, Byhardt RW, Sause WT, Curran WJ. Cisplatin dose delivery and survival in concurrent chemoradiation for stage III NSLC: An RTOG secondary analysis. Lung Cancer 42(Suppl 2):S77, 2003.
159. Swisher S, Ajani JA, Komaki R, Putnam J, Walsh G, Liao Z, Yao J, Faust J, Wu T-T, Roth J. CPT-11-taxotere-5-FU regimen for induction and concurretn chemoradiotherapy prior to surgery in patients with resectable esophageal or GEJ carcinoma. Proceedings ASCO 22:272 (#2093), 2003.
160. Itasaka S, Komaki R, Herbst RS, Hunter NR, Onn A, Bucana CD, Milas L, Ang KK, O’reilly MS. Endostatin blocks endothelial repopulation after radiation therapy. Proceedings of the AACR 44 (#115), 2003.
161. Komaki R. Hyperfractionated and accelerated thoracic radiation therapy (HFXA/TRT) incrased survival compared to daily TRT for limited small cell lung cancer (LSCLC) patients treated with concurrent chemotherapy(ChT). Cancer J 9:489 (#18), 2003.
162. Komaki R, Glisson B, Allen P, Fossella F, Liao Z, Stevens C, Blumenschein G, Hong WK, Herbst R, Pisters K. Hyperfractionated and accelerated thoracic radiation therapy (HFXA/TRT) increased survival compared to daily TRT for limited small cell lung cancer (LSCLC) patients treated with concurrent chemotherapy. Lung Cancer 42; Suppl 2:S24, 2003.
163. Langer C, Moughan J, Movsas B, Komaki R, Ettinger D, Owen J, Wilson J. Patterns of care survey (PCS) in locally advaned non-small cell lung cancer (LA-NSCLC) and limited small cell lung cancer (LD-SCLC): How well does current practice follow the literature. Int J Radiat Oncol Biol Phys, 2003.
164. Komaki R, Swann S, Ettinger D, Glisson B, Sandler A, Movsas B, Byhardt R. Phase I dose-escalation study of thoracic irradiation with concurrent chemotherapy for patients with limited small cell lung cancer (LSCLC). Radiation Therapy Oncology Group (RTOG) protocol 9712. Lung Cancer 42(Suppl 2):S104, 2003.
165. Komaki R, Swann S, Ettinger D, Glisson B, Sandler A, Movasa B, Byhardt R. Phase I dose-escalation study of thoracic irradiation with concurrent chemotherapy for patients with limited small cell lung cancer (LSCLC). Radiation Therapy Oncology Group RTOG 9712. Int J Radiat Oncol Biol Phys 57:S139 (#25), 2003.
166. Komaki R, Swann S, Ettinger D, Glisson B, Sandler A, Movsas B, Byhardt R. Phase I dose-escalation study of thoracic irradiation with concurrent chemotherapy for patietns with limited small cell lung cancer (LSCLC). Radiation Therapy Oncology Group (RTOG) protocol 97-12. J Clin Oncol 22:631 (#2539), 2003.
167. Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Axelrod R, Byhardt R. Phase III study of amifostine in patients with locally advanced non-small cell lung cancer (NSCLC) receiving chemotehrapy & hyperfractionated radiation (CHEMO/HFXRT): Radiation Therapy Oncology Group (RTOG) 98-01. J Clin Oncol 22:636 (#2559), 2003.
168. Wakelee HA, Stephenson P, Keller SM, Wagner H, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH. Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIa non-small cell lung cancer (NSCLC) leads to higher than expected risk of death from intercurrent disease. J Clin Oncol 22:633 (#2545), 2003.
169. Movsas B, Moughan J, Komaki R, Chou H, Byhardt R, Langer C, Goldberg M, Graham M, Ettinger D, Johnstone D, Owen J. Radiotherapy patterns of care study in lung carcinoma. Lung Cancer 42(Suppl 2):S30, 2003.
170. Komaki R. Reducing toxicity of combined therapies (Plenary Lecture PL5.2). Proc 17th Asia Pacific Cancer Conference (APCC), Kuta Bali, Indonesia:29, 2003.
171. Graham MV, Paulus R, Ettinger DS, Bradley J, Pilepich M, Machtay M, Komaki R, Atkins J, Curran WJ, Scott C. RTOG 9705, A phase II atrial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIA non-small cell lung cancer (NSCLC) patients – promising long term survival results. Int J Radiat Oncol Biol Phys 57:S140 (#28), 2003.
172. Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, Roth J, Putnam JB, Moran C, Cox JD. SUV by FDG-PET predicts outcome of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 57:S166 (#71), 2003.

Book Chapters

1. Komaki R, Tsao A, Mehran R. Lung cancer. In: Monogram: Houston, Texas. In Press.
2. Selek U, Bolukbasi Y, Topkan E, Komaki R. Radiotherapy in Thymic Tumors. In: Principles and Practice of Radiotherapy Techniques in Thoracic Malignancies. Ed(s) Ozyigit G, Selek U, Topkan E. Springer International Publishing: Switzerland, 336-387, 2016.
3. Nguyen QN, Komaki R, Gomez D, Liao Z. Non-small Cell Lung Cancer. In: Intensity-Modulated Radiation Therapy. Ed(s) Nishimura Y, Komaki R. Springer: Japan, 249-260, 2015.
4. Ghia AJ, Komaki R. Brain Metastasis from Lung Cancer. In: Brain Metastases from Primary Tumors: Epidemiology, Biology, and Therapy. 1. Ed(s) Hayat MA,. Elsevier: India, 571-588, 2014.
5. Cheng SK, Parashar B, Komki R, Murshed H. Lung Cancer. In: Practical essentials of intensity modulated radiation therapy, 3. Ed(s) Chao Clifford K.S. Lippincott Williams & Wilkins: Hagerstown, MD, 295-315, 2013.
6. Komaki R, Tsao A, Mehran R. Non-small cell lung cancer. In: 60 Years of Survival Outcomes at The University of Texas MD Anderson Caner Center. Ed(s) Rodriguez MA, Walters RS, Burke TW. Springer Science + Business Media New York: New York, 45-63, 2013.
7. Erasmus JJ, Stewart DJ, Komaki R, Swisher SG. Lung Cancer. In: Oncologic Imaging: A multidisciplinary approach. Elsevier Saunders: Philadelphia, PA, 35-61, 2012.
8. Blumenschein GR, Paulus R, Curran WJ, Robert F, Fossella F, Wasik MW, Herbst RS, Doescher PO, Choy H, Komaki R. A Phase II study of cetuximab (C225) in combination with chemoradiation in patients with stage IIIa/b non-small cell lung cancer (NSCLS): Radiation Therapy Oncology Group Study RTOG0324. In: J Clin Oncology, e-Book.
9. Bedford JS, Dinger KH, Howell RW, Komaki R, Shaw RP. In: NCRP Report No. 167. 167. National Council on radiation Protection and Measurement: Bethesda, MD, 2011.
10. Jeter M, Komaki R, Cox JD. Radiation time, dose, and fractionation in the treatment of lung cancer. In: Advances in Radiation Oncology in Lung Cancer, 2. Ed(s) Jeremic B. Springer-Verlag: Berlin Heidelberg, 129-141, 2011.
11. Komaki R, Chang JY, Liao Z, Cox JD, Mason, KA, Milas L. Radioprotectors and chemoprotectors in the management of lung cancer. In: Advances in radiation Oncology in Lung Cancer, 2. Ed(s) Jeremic B. Springer-Verlag: Berlin Heidelberg, 223-245, 2011.
12. Iyengar P, Chan S, Komaki R. Targeting tumors and personalizing individual treatments for radiation therapy. In: Targetd therapy for solid tumors and hematologic malignancies. Nova Science: New York, 295-310, 2011.
13. Hristov B, Lin S, Christodouleas J. Small cell lung cancer. In: Radiation Oncology: A Question-Based Review. Lippincott Williams & Wilkins: Philadelphia, 2010.
14. Liao Z, Komaki R, Cox J. The esophagus. In: Radiation Oncology, Ninth. Mosby: Philadelphia, PA, 461-92, 2010.
15. Komaki R, Travis E, Cox JD. The lung, pleura, and thymus. In: Radiation Oncology - Ninth Edition. Mosby: Philadelphia, PA, 424-58, 2010.
16. Komaki R, Cox JD. Radiation therapy for carcinoma of the lung cancer. In: General Thoracic Surgery. 2, 7. Ed(s) Shields TW, LoCicero J, Reed C, Feins R. Lippincott Williams and Wilkins: Philadelphia, PA, 1457-1495, 2009.
17. Ang K, Cox JD. Thorax. In: Radiation Oncology - 9th Edition, 2009.
18. Liao Z, Fossella F, Komaki R. Combinations of radiation therapy and chemotherapy for nonsmall cell lung carcinoma. In: Lung Caner, 3rd Edition. Blackwell: Malden MA, 283-314, 2008.
19. Chang JY, Bradley J, Govindan R, Komaki R. Lung. In: Principles and Practice of Radiation Oncology. Lippincott Williams & Wilkins: Philadelphia, 2007.
20. Onn A, Vaporciyan A, Chang JY, Komaki R, Roth JA, Herbst RS. Cancer of the lung. In: Cancer Medicine 7, 1179-1224, 2006.
21. Swisher SG, Komaki R, Lynch PM, Agani JA. Esophageal carcinoma. In: Gastrointestinal Cancer, M. D. Anderson Cancer Care Series. Springer-Verlag: New YOrk, 232-245, 2005.
22. Komaki R, Liu H, Murshed H. Lung Cancer. In: Practical Essentials of Intensity Modulated Radiation Therapy. Lippincott Williams & Wilkins, 255-274, 2005.
23. Komaki R Cox JD. Radiation Therapy for Carcinoma of the Lung. In: General Thoracic Surgery. Lippincott Williams & Wilkins, 1377-1388, 2005.
24. Travis E Komaki R. Treatment-related lung damage. In: Lung Cancer Principles and Practice. Lippincott Williams & Wilkins, 545-567, 2005.
25. Swisher SG, Komaki R, Lynch PM, Ajani JA. Esophageal carcinoma. In: Anderson Associates Monograph on Gastroinstestinal Cancer 2004. Springer Verlag, 268-280, 2004.
26. Komaki R, Chang J, Liao Z, Cox JD, Mason KA, Milas L. Radioprotectors and chemoprotectors in the management of lung cancer. In: Medical Radiology-Advances in Radiation Oncology in Lung Cancer. Springer-Verlag, 2004.
27. Komaki R Chang E. Whole-brain Radiation Therapy. In: Intracranial Metastases. Blackwell Publishing, 126-138, 2004.
28. Bradley J, Govindan R, Komaki R. Lung. In: Principles and Practice of Radiation Oncology. Lippincott Williams & Wilkins, 1201-1243, 2003.
29. Komaki R Cox JD. The esophagus. In: Radiation Oncology. Mosby, 429-443, 2003.
30. Komaki R, Travis EL, Cox JD. The lung and thymus. In: Radiation Oncology. Mosby, 399-426, 2003.

Books (edited and written)

1. Nishimura Y, Komaki R. Ed(s) Nishimura Y, Komaki R. Intensity-Modulated Radiation Therapy Clinical Evidene and Techniques. Springer: Japan, 2015.
2. Roth J, Hong WK, Komaki R. Ed(s) Roth J, Hong WK, Komaki R. Lung Cancer. In: Lung Cancer. Blackwell: Massachusetts, 2014.
3. . Ed(s) Komaki R. Personalized Management of Lung Cancer. In: First. Future Medicine, 2013.
4. Cox JD, Chang JY, Komaki R. Ed(s) Cox JD, Chang JY, Komaki R. Image-Guided Radiotherapy of Lung Cancer. Informa, 2007.
5. Fossella FV, Komaki R, Putnam JB. Implementation of multidisciplinary care in the treatment of patients with lung cancer. In: Lung Cancer - Japanese Edition. Springer: Germany, 2003.
6. Putnam Jr JP, Fossella FV, Komaki R. Implementation of multidisciplinary care in the treatment of patients with lung cancer. In: Lung Cancer. Springer-Verlag: New YOrk, 2002.
7. Komaki R. Nonsurgical treatment of early-stage and locally advanced non-small cell lung cancer. In Lung Cancer, M. D. Anderson Cancer Care Series, pp. 142-157. Springer-Verlag: New York, 2002.
8. Komaki R. Treatment of limited-stage small cell lung cancer. In Lung Cancer, M. D. Anderson Cancer Care Series. Springer-Verlag: New York, 2002.

Last updated: 5/1/2016